Nano Business Press Releases will be deleted after one month.
Sponsor ads as Social Investors for your Product or Event are available on this website.
Contact Judith.LightFeather@TNTG.org to discuss your needs.
Mad City Labs Sites European Headquarters in Switzerland
New York, January 10 - Nanopositioning products and instrumentation company Mad City Labs has opened its European headquarters in Switzerland, reports Daniel Bangser, Director North America for Switzerland Trade & Investment Promotion. Mad City Labs GmbH facilities in Zurich handle customer service, pre-order technical discussions, ordering and post-delivery support as well as technical exhibits and product demonstrations, Mr. Bangser said.
Jenice A. Con Foo, PhD, marketing director for Mad City Labs said "Zurich is our first direct international office and many factors were considered in our decision to locate there. First, it provides a central European location with good transportation links to major European cities and to our US headquarters in Madison, WI. Moreover, there is a highly educated, multi-lingual workforce necessary to support our company?s growth."
"Switzerland is an underserved domestic market for our products," she added. "There are also opportunities to work with many Swiss institutions such as the Federal Institute of Technology Zurich (ETHZ) and IBM's nearby European research facility. A particular advantage of the location is our finding that the Swiss business environment, of all European countries, is most similar to the US business environment."
Mad City Labs offers a wide variety of nanopositioners, micropositioners, and instrument solutions. Custom OEM options are available for the majority of the company?s products. www.madcitylabs.com
NanoInk Launches New Automated Protein NanoArray Assay Platform
The Nano BioDiscovery Division of NanoInk, Inc. announced today the release of a new automated platform for the analysis of its protein NanoArray assays. NanoInk’s NanoArray Assay System enables detection, identification, and quantitation of clinically relevant, low abundance proteins from a wide variety of sample types for applications such as biomarker analysis, translational medicine, and toxicology. NanoInk assays consume much smaller sample and reagent volumes than do traditional ELISA and bead-based assays, generating more proteomic data with less starting material and lowering assay costs for tests that are typically expensive to run.
These benefits are fully explained in a state-of-the-art high definition video entitled, “NanoArray Assays: More Proteomic Data from Less Sample,” and is now available on at http://nanoink.net/protein_analysis/multi-media.html
Innovative Solutions Bulgaria Buys MEMS Fab
Innovative Solutions Bulgaria the manufacturer of BudgetSensors AFM probes has announced the acquisition of Bulgaria’s largest MEMS Fab
Sofia/Bulgaria, December 6, 2011
Innovative Solutions Bulgaria Ltd., announced the acquisition of Bulgaria’s largest MEMS fab, which is located in the north of Sofia and has been newly built and equipped in 2004. This new facility provides Innovative Solutions Bulgaria, manufacturer of the BudgetSensors® line of AFM probes and AFM calibration standards, with the much needed space for the expansion of its production capacity.
The acquisition of the new fab will be formally completed until the end of 2011.
“The purchase of our new MEMS fab is a milestone in the development of our company!
Our current production facilities have been approaching our capacity limits over the last two years. We needed to take action to meet the increasingly high demand for our products from all over of the world.
With this added production capacity we will be able to support our sales growth for another five to ten years. We are very excited about the perspectives this new facility is providing for our BudgetSensors® line of AFM probes and calibration standards and our business in the future!”, said Dr. Kamen Nikolov, Founder and CEO of Innovative Solutions Bulgaria Ltd.
During the last 10 years, through quality control without compromise, as well as excellent customer service combined with the best shipment and lead times in the world, we have built up BudgetSensors® as the world-wide leading AFM probes brand in the low-cost market segment. Our cumulated average sales growth over the last 10 years has been in the high double digits range. Even during the last three years, in times of high macroeconomic uncertainty, we have been able not only to maintain our position on the market, but to grow further with impressive +30% rates. Our newly expanded production capacity will strongly contribute to the continued growth of the company.” Dr. Nikolov added.
About Innovative Solutions Bulgaria Ltd.
Founded in 2001, Innovative Solutions Bulgaria Ltd. (ISB) is mainly focused on the manufacturing and distribution of Probes and Calibration Standards for Atomic Force Microscopy (AFM) under the brand BudgetSensors®. In 2005 the Swiss NanoWorldHolding AG purchased 100% of the ISB shares from its founder, Dr. Kamen Nikolov. Being part of the largest manufacturer of AFM probes and accessories in the world, ISB has grown BudgetSensors® into the world-wide market leader in the low cost AFM probes segment. BudgetSensors® products are being distributed world-wide through a well developed network of affiliated companies and local distributors.
Heliatek achieves new world record for organic solar cells with certified 9.8 % cell efficiency
Dresden, Germany, December 5, 2011 - Heliatek GmbH, a global leader in high-end solar PV technology, has once again set a new world record for organic solar cells after Fraunhofer ISE CalLab certified a cell efficiency of 9.8 % for a 1.1 cm² tandem cell manufactured with a low temperature deposition process. This new record makes the third time in a row that Heliatek has set a world record for efficiency in the field of organic photovoltaic and demonstrates its continuous technology leadership in organic solar.
One year ago, Heliatek GmbH set a world record for efficiency of 8.3 % for an active surface of 1.1 cm². Thanks to its most recent developments, Heliatek has now been able to make a remarkable 1.5 % leap in cell efficiency, to 9.8 %. This new record was measured and certified by the independent Fraunhofer ISE CalLab (Freiburg, Germany) under standard test conditions.
Dr. Martin Pfeiffer, co-founder and CTO of Heliatek, explains: "Heliatek is the only solar company in the world focused on the deposition of small molecules with low temperature processes, a method that has already been widely adopted by the market for use with organic LEDs (OLEDs). Heliatek develops and synthesizes in-house the molecules responsible for capturing light in solar cells and converting this light into electricity. The new world record is a clear indication that Heliatek is headed in the right direction. Organic solar cells from Heliatek have now reached the level of efficiency of conventional solar cells made from amorphous silicon."
Two Heliatek record cells with 9.8% efficiency on an active area of 1.1 cm² each.
© Heliatek GmbH
Heliatek has both its own chemistry research department as well as a physics research department. This unique combination creates efficient synergies, enabling simultaneous work on material quality and cell design. Heliatek was able to optimize the absorber layer system of the record-breaking cells through synthetizing the right materials. Furthermore, by improving the deposition process, cell morphology was significantly improved, leading to an increase in power output and in fill factor.
The record-breaking cell construction will gradually be integrated into Heliatek?s manufacturing process after the scheduled start of production in the second half of 2012. Heliatek?s in-house measurements have shown that scaling up the record-breaking cells to a panel with a size factor >120 results in an efficiency over 9 % for the active module area.
Semi-transparent organic solar module between glass made by Heliatek.
© Heliatek GmbH
Thibaud Le Séguillon, CEO of Heliatek, concludes: "I am delighted by this new result which confirms our technology leadership in this field. The next step on our way to 15 % will be a cell with over 10 % efficiency sometime next year. This latest record validates once again the decision taken at the outset by our investors and our team to commit ourselves to the production of organic solar based on small molecules using low temperature processes. Our flexible, thin and light panels open up new fields of applications that were so far impossible to address with conventional PV technologies. After our third investment round scheduled for 2012 - during which we plan to raise some 50 million in new capital from current and new investors - we plan to expand our production capacity with additional manufacturing lines. This will allow us to market our high-performance panels into new areas, such as windows and facades for BIPV. This technology has really the potential to revolutionize the solar industry."
For achieving this new record efficiency result, Heliatek acknowledges comprehensive financial support of its R&D projects by the German Federal Ministry of Education and Research (BMBF) under project numbers 13N9869 and 13N9716, as well as the European Regional Development Fund (ERDF) and Freistaat Sachsen under project number 71070.
Dr. Martin Pfeiffer (CTO of Heliatek GmbH), together with his fellow researchers Prof. Karl Leo (Director of IAPP) and Dr. Jan Blochwitz-Nimoth (Novaled AG), has been nominated for the 2011 Deutschen Zukunftspreis for successful research in the field of organic electronics. On December 14, German President Christian Wulff will announce the winner from the three teams of scientists in the running for the prize.
About Heliatek's Technology:
Organic photovoltaic technology (OPV) is the third generation of solar technology, after classic crystalline and thin film solar technology. OPV can be divided into two approaches: polymer-based (large molecules) and oligomer-based (small molecules) OPV, such as those used at Heliatek. The advantage of Heliatek's technology based on small molecules lies in better process control, higher efficiency, and longer lifespan, in contrast to OPV based on printed polymers currently available on the market.
Heliatek's competitive edge stems from its patents portfolio covering the production of organic solar cells with doped transport layers. Using patented tandem cell technology (two solar cells stacked on top of each other) it is possible to absorb a very broad solar spectrum using extremely thin organic layers, altogether only 500 nm thin - one decisive factor for higher efficiency. Heliatek's unique and highly coordinated activities in chemical synthesis and device physics result in a sharp climb in technological progress.
Heliatek plans to use a low-temperature roll-to-toll process to fabricate solar panels, a process that is extremely cost efficient in mass production. Since 'small molecules' have already replaced the use of polymers in the organic electronics industry (OLED displays and lighting), Heliatek can benefit from their manufacturing experience.
Heliatek's solar panels will offer four major key benefits compared to conventional solar panels, thus opening up new dimensions for the application of solar technology:
As the low process temperatures allow for the use of plastic film as substrate material, the modules will be flexible, ultra-thin and extremely lightweight. The modules at only 0.5 kg/m² (versus 12 to 17 kg/m² for conventional PV) provide solar options for all kind of mobile applications and for roofs with low bearing loads.
The great design freedom offers various choices in module color, dimensions and transparency levels. Windows with semi-transparent OPV can perform a dual function of solar energy collection and shading and they can even be made with a range of tints to suit the architect?s design requirements.
In addition, Heliatek modules also excel in real-life performance compared to common solar panels: Whereas the efficiency of traditional solar modules drops off as the temperature rises, Heliatek OPV modules maintain its efficiency independent of the module temperature. Similarly, if the light intensity decreases, average modules become less efficient yet Heliatek panels offer the same efficiency from full sun down to a tenth (1/10th) of full sun, typical for very cloudy winter days. This makes Heliatek modules perfectly suitable for sunny regions as well as for northern regions, for integrated solutions with little module ventilation and for integration into facades or roofs that suffer from poor orientation.
Finally, Heliatek's organic solar technology is the truly green solar technology. The solar cells are made of fully organic, readily available material and they do not contain any known toxic ingredients or heavy metals. Only 1 gram of organic material is required to produce one square meter of solar panel. The non-toxic manufacturing process is environmentally friendly as it doesn?t require any solvents or high input of energy. Transportation costs with their associated carbon footprint are also significantly less for the ultra-lightweight panels compared to common modules with their heavy, fragile sheets of protective glass.
About Heliatek:
Heliatek, a global leader in high-end solar PV technology, was spun-off in 2006 from the Technical University of Dresden (IAPP) and the University of Ulm. The company's founding brought together internationally renowned expertise in the fields of organic optoelectronics and organic oligomer synthesis. As the global technology leader in the field of organic photovoltaics (OPV) based on small molecules, Heliatek is currently making the transition from technology development to industrial manufacturing. Heliatek's goal is to mass-produce organic photovoltaic panels using the world's first roll-to-roll low temperature process for deposition of small molecules in 2012.
Heliatek maintains a total staff of some 70 employees and specialists at its facilities in Dresden and Ulm. Investors in Heliatek include leading industrial and financial companies such as BASF, Bosch, RWE, and Wellington Partners. Research and development work, as well as the installation of production technology, have been funded by the Free State of Saxony, the BMBF (Federal Ministry for Education & Research), the BMWi (Federal Ministry of Economics and Technology), and the European Union. More information can be found at www.heliatek.com
CAMBRIDGE BIOSCIENCE NAMED EXCLUSIVE DISTRIBUTOR
FOR NANOINK IN THE UNITED KINGDOM AND IRELAND
Representing the NanoFabrication Systems Division line of instruments and tools
for micro and nanopatterning applications
CHICAGO, Ill. -- November 29, 2011 -- NanoInk’s® NanoFabrication Systems Division is pleased to announce that it has reached an agreement with Cambridge Bioscience to serve as its exclusive distributor in the United Kingdom and Ireland. Cambridge Bioscience will distribute NanoInk’s desktop nanofabrication equipment including the NLP 2000 System and the DPN 5000 System, which have a wide range of applications ranging from nanoarray-based protein analysis to nanoengineering and biomaterial research. As a leading distributor of life science products and equipment, Cambridge Bioscience has a passion for bringing new and exciting technologies to researchers.
‘‘Cambridge Bioscience has already established strong relationships within NanoInk’s target customer base in the United Kingdom and Ireland. Its sales and marketing team has the background required to understand the scientific market and they have proven expertise in selling technically-sophisticated equipment into that space. With these strengths, Cambridge Bioscience is the ideal partner for driving sales of NanoInk’s unique nanofabrication platforms in the United Kingdom and Ireland,’’ said Robert Marchmont, general manager, NanoInk’s NanoFabrication Systems Division, EMEA. ‘‘We look forward to a close and successful long-term partnership with Cambridge Bioscience as we expand our reach in Europe by promoting the unique capabilities and benefits of NanoInk’s line of patterning systems.’’
‘‘We are delighted to be appointed as the distributor for NanoInk in the United Kingdom and Ireland,’’ said Jay Champaneri, business manager for Cambridge Bioscience. ‘‘NanoInk’s systems provide a strong synergy with the innovative life science research products that Cambridge Bioscience already brings to scientists and we look forward to working closely with the NanoInk team.’’
NanoInk’s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable setting. NanoInk’s NLP 2000 System is a desktop nanofabrication system that allows researchers to rapidly design and create custom engineered and functionalized surfaces, using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area.
The DPN 5000 System is a full-featured, dedicated instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision. With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling the tip movements during the writing process
Cambridge Bioscience works with over forty specialist suppliers around the world and offers an innovative, extensive and diverse range of over 400,000 products supporting research in many areas including cell biology, regenerative medicine and protein analysis. More information is available at:
To obtain more information or place an order through Cambridge Bioscience for NanoInk’s desktop nanofabrication equipment, please contact Jay Champaneri at jay.champaneri@bioscience.co.uk.
WIN Semiconductor chooses VIPER RF as approved design partner
SUNDERLAND, UK: 03 October 2011 — VIPER RF, a specialist in microwave and RF IC design and development, and WIN Semiconductors Corp., the world’s largest pure-play Gallium Arsenide (GaAs) foundry, have announced that they have entered into an agreement under which VIPER RF will offer design support and specialised RF expertise to help customers develop chips using WIN Semiconductors’ process technologies and design tools.
VIPER RF is a UK microwave and RF consultancy and product-based company that serves a range of markets including defence and security, communications and wireless applications, covering frequencies in the range DC – 100GHz.
WIN Semiconductors has two advanced GaAs wafer fabs working on 150mm (6-inch) wafers, which provide dedicated foundry services to both design houses and IDM partners. The foundry services the growing demand for low cost manufacturing of high speed and high quality GaAs monolithic microwave ICs (MMICs) and radio frequency ICs. WIN has extensive experience in GaAs HBT and pHEMT MMIC fabrication, and its team provides continuous research and development to meet its customers' technology requirements.
“VIPER RF has a wealth of experience in GaAs MMIC and RFIC design, particularly in the application areas that we address, such as high-end cellular communications, WLAN products, satellite communications and automotive radar,” said Brian Lee, Vice President Sales and Marketing at WIN Semiconductor. “We are confident that they will be able to give our customers a high level of design support and help them to achieve the best from using the WIN GaAs process.”
“WIN Semiconductor is one of the world’s leading GaAs foundries, and we are honoured to have been chosen as one of their design resource partners,” added Jim Mayock, CEO of VIPER RF. “We are delighted to be working with them, and look forward to a long and mutually profitable relationship helping customers to use WIN’s foundry services.”
Both VIPER RF and WIN Semiconductor will be exhibiting at European Microwave Week in Manchester, UK, on 11 – 13 October 2011. VIPER RF will be on Stand Number 427, and WIN Semiconductor will be on Stand Number 223.
Nanostart-holding MagForce AG announces treatment of recurrent glioblastoma patient with NanoTherm therapy
Frankfurt / Berlin, October 10, 2011 – Nanostart (OTCQX: NASRY)-holding MagForce AG (FSE: MF6), a leading medical technology company focusing on nanomedicine in oncology, announced today the treatment of a recurrent glioblastoma patient with the company’s NanoTherm® therapy. Based on an individual patient agreement, the treatment costs are being covered by a German state insurance company. The first part of the therapy (instillation of the nanoparticles) was carried out at the University Giessen and subsequent steps (nanoparticle activation and the accompanying radiotherapy) were performed at the Charité University Medical Center Berlin.
“We are pleased that treatment with NanoTherm therapy for brain tumors patients has begun, and especially that treatment costs have been supported by a number of state insurance companies through individual patient agreements. This is a great milestone for both our novel technology and for MagForce as a company,” said Dr. Peter Heinrich, CEO of MagForce. “Through our collaborations with experts in both Germany and internationally, we plan to further develop this treatment approach for a variety of solid tumor indications with high medical need.”
Glioblastoma is the most common and most aggressive malignant primary brain tumor in adults. Recurrent glioblastoma is the reoccurring growth following treatment of the primary tumor.
About Nanostart:
Nanostart AG (OTCQX: NASRY), headquartered in the German financial capital of Frankfurt, is a leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary Nanostart Asia and the venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.
About MagForce:
MagForce AG is a leading medical technology company focusing on nanomedicine in oncology. The company’s proprietary procedure, NanoTherm® therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of magnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator™ are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan and NanoActivator are trademarks of MagForce AG in selected countries. For further information please visit: www.magforce.com
About NanoTherm® therapy:
NanoTherm® therapy involves the direct injection of magnetic nanoparticles into the tumor and their subsequent heating by an alternating magnetic field. The water-soluble nanoparticles are approximately 15 nanometers in diameter and contain an iron oxide core with an aminosaline coating, which causes the particles to agglomerate following injection. The particles are then activated by a magnetic field that changes its polarity 100,000 times per second, and heat is produced within the tumor. Depending on the temperature reached and length of treatment, the tumor cells are either directly destroyed or sensitized for the accompanying chemotherapy or radiation.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.
Yokohama’s Orange Oil Tire Technology to be Highlighted at the Museum of Science, Boston
Two-year exhibit starts in fall 2011 and will feature BluEarth-1™, Yokohama’s next generation eco-friendly tire that utilizes oil from orange peels to reduce use of petroleum
FULLERTON, CA - October 10, 2011 – It’s rare for a tire to be showcased in a museum, but Yokohama Tire Corporation’s BluEarth-1™ – the company’s latest orange oil-infused passenger car tire – is an exception. Its breakthrough eco technology will be highlighted in a special two-year exhibit at the Museum of Science, Boston starting in the fall of this year.
The “Making a Greener Tire” interactive display, which will be in the museum’s Transportation, Renewable Energy and Nanotechnology area, revolves around the BluEarth-1’s technology, which combines oil extracted from orange peels with silica and natural rubber to form “Super Nano-Power Rubber™” (SNPR). This technology was initially utilized in Yokohama’s innovative and groundbreaking dB Super E-spec™ tire.
The SNPR allows for less petroleum to be used in the manufacturing process and conserves fuel as it reduces rolling resistance by up to 20 percent – minimizing the energy wasted (as heat) as the tire rolls down the road. Yokohama is the first – and only – tire manufacturer in the world to employ orange oil technology.
“The exhibit is extremely gratifying for Yokohama because it validates our commitment to technology that will protect Earth,” said Yasushi Tanaka, Yokohama president and CEO. “The Museum of Science, Boston is a leading educational and cultural institution that is ranked among the top science centers in the world.
“Yokohama is a technology-driven company with a global mandate to protect the environment. In fact, our new overall global environmental initiative is called ‘BluEarth,’ which includes the BluEarth-1 tire. BluEarth is our product engineering philosophy aimed at producing tires that are environmentally-, socially-, and human-friendly. That’s why we are honored the museum feels our eco-friendly orange oil technology is significant enough to be presented in an exhibit.”
According to Paul Fontaine, Vice President of Education at the Museum of Science, the BluEarth exhibit reflects the Museum’s commitment to highlighting environmental issues and enhancing technological literacy. “We are constantly working to expand the public’s understanding of new technologies through exhibits, programs, events and publications. This display is especially timely because it showcases an innovative, green approach to manufacturing. We welcome the opportunity to bring this cutting edge technology to our visitors.”
Also featured in the museum’s exhibit will be the BluEarth-1’s AIRTEX™ Advanced Liner that is designed to reduce the amount of air from seeping out from the tire. Maintaining appropriate inflation levels is crucial because under-inflated tires consume more power, thus using more fuel.
The BluEarth-1, available now in Japan and Europe, will launch in the U.S. in 2012 in three sizes for hybrids and other vehicles, including the Toyota Prius, MINI Cooper, and VW Golf and Jetta.
Source: Yokohama Tire
From Detonation to Diapers: Los Alamos Computer Codes at Core of Advanced Manufacturing Tools
LANL computer codes assist industry in competitiveness initiative
LOS ALAMOS, New Mexico, July 27, 2011—Computational tools developed at Los Alamos National Laboratory to help ensure the reliability of the nation’s nuclear weapons deterrent in the absence of testing are helping industry giants ensure the reliability of their manufacturing processes.
These specialized computer codes are now available to U.S. industry as part of President Barack Obama’s recently announced advanced manufacturing initiative, designed to help make American companies more competitive and create new jobs.
Under a Cooperative Research and Development Agreement, LANL and Procter & Gamble have been collaborating for about two decades to incorporate computational technologies developed for national security into cutting-edge tools for advanced manufacturing. Among results of the collaboration, Los Alamos researchers and P&G engineers enlisted computer codes developed to model the flow, transport, and interaction of fluids and particles to help design a more efficient diaper manufacturing process. Further collaboration using Los Alamos statistical modeling tools led to creation of a comprehensive system, called Reliability Technology, that helped P&G reduce interruptions to production lines—saving the company billions of dollars in the process.
The Reliability Technology method is owned by Procter and Gamble and provides the ability to analyze failure modes of all components of the production line. The beauty of Reliability Technology is its ability to “learn and adapt” when provided with data from actual production runs.
The Reliability Technology method has allowed P&G to remain competitive in U.S. manufacturing, helping the company design highly advanced manufacturing plants that employ skilled workers who use this cutting-edge technology to their advantage. With the help of Ernst & Young, P&G will make this innovative system available to other industries.
The computer codes used for predictive fluid modeling are part of the Los Alamos Computational Fluid Dynamics Library (CFDLib)—a software package that includes traditional and state-of-the-art computer modeling codes developed to solveproblems related to the dynamic behavior of materials, particularly multiphase fluid flow in simple or complex geometries. Basic methodologies behind the codes date from the 1950s to the present, including many of the most recentdevelopments found in the computational fluid dynamics literature, a significant number of which are unavailable in commercial software packages.
Common types of behaviors the codes can model are, for example, rain falling through the air, the transport of coal slurry through piping, or the initial mixing of coffee and milk. Physics models built into the codes include equations of state for non-ideal compressible materials, species diffusion within materials, and heat transport and exchange within, or among, materials. Consequently, the codes can be used to increase fundamental design confidence, reduce material costs, and reduce the time to market.
Use of the CFD library will require a significant level of knowledge in computational fluid dynamics. The code is intended for end-user problem solving and is not licensed for resale and redistribution. It comes with no user support by Los Alamos; however, there is a broad-based user and applications knowledge community that can be tapped, and Procter and Gamble offers at no cost a front-end script to ease integration into innovation work practices.
Los Alamos’s Technology Transfer Office is working on a mechanism to release the CFDLib as well as P&G’s proprietary wrapper that allows industry users to more simply set software parameters.
“We are pleased to see that the problem solving methodologies developed at Los Alamos National Laboratory to help ensure the reliability of the nation’s nuclear weapons stockpile are being used to help ensure the reliability and competitiveness of American manufacturing,” said Terry Wallace, Principal Associate Director for Science, Technology and Engineering at LANL. “It is gratifying to know that our multidisciplinary science can serve the nation in so many ways.”
About Los Alamos National Laboratory (www.lanl.gov)
Los Alamos National Laboratory, a multidisciplinary research institution engaged in strategic science on behalf of national security, isoperated by Los Alamos National Security, LLC, a team composed of Bechtel National, the University of California, The Babcock & Wilcox Company, and URS for the Department of Energy’s National Nuclear Security Administration.
Switzerland is Largest Foreign Direct Investor in the US in 2010
at >$42 Billion
New York - According to the recently released annual U.S. Department of Commerce report 'Foreign Direct Investment in the United States,' Switzerland was the largest single investor in the United States in 2010 at more than $42 billion, reports Mario Brossi, North American Senior Advisor to Switzerland Trade and Investment Promotion. The alpine nation headed the list of 8 countries that together represented 84% of total investment that year. Others in descending order were the U.K., Japan, France, Germany, Luxembourg, Netherlands and Canada.
On a historical stock basis, namely the investments made by countries sequentially over time, Switzerland ranks in 6th place, with a cumulative total of $192 billion.
"Conversely, United States companies are by far the single largest investors in Switzerland, significantly outpacing investments from neighboring Germany, France or other European neighboring countries," Mr. Brossi commented. "Overall Switzerland is the 7th largest recipient for US FDI globally, amounting to $148.2 billion. More than 800 North American companies are operating in Switzerland with a combined payroll of 72,500."
According to Mr. Brossi, since the beginning of 2011 at least 24 projects from North America have landed in Switzerland generating an estimated $625 million in investment and leading to about 1,737 new jobs. "Leading location determinants, aside from the growth potential of the market itself, are currently the proximity to other markets/customers, the availability of a skilled workforce, overall business climate and the presence/absence of industry clusters," he said.
Switzerland continues to compete well in these economic development criteria. The country continuously works on improving overall framework conditions to make it even more attractive to foreign investors and foreign investment as recent projects from Takeda Pharmaceuticals, Toshiba and Newell Rubbermaid, among others, make plain.
Source: http://www.esa.doc.gov/sites/default/files/reports/documents/fdiesaissuebriefno2061411final.pdf
USED AFM's on SALE
We have great news for anyone who wants to save on an Atomic Force Microscope (AFM). Nanoscience Instruments is selling several used AFMs from our demonstration lab at up to half off. These instruments have been well maintained by our applications staff.
For a limited time, on a first come, first served basis, are we offering the following demo instruments for sale:
1) Nanite AFM system: Complete AFM system with motorized and programmable x/y stage and separate boom stand. The Nanite AFM comes with contact mode, dynamic mode and mode extension capabilities (phase contrast, EFM, MFM, conductive AFM).
We are offering our demo Nanite AFM system for $49,900, including a 1 year warranty! (This Nanite AFM?s regular price is $99,800) http://www.nanoscience.com/products/Nanite/nanite.html
2) FlexAFM system: The FlexAFM offers ultraflat and fast scanning capabilities and makes measurements in liquids as simple as measuring in air. Our demo FlexAFM system is configured with contact and dynamic mode (tapping) and dual video camera (Mode extension is optional). It features a compact, rugged & high performance scanner. The specially designed cantilever holder for the Flex AFM scanner allows for wet samples to be measured in the same manner as dry samples. Thanks to the patented Sure-AlignTM optics, adding liquid doesn?t change the laser path. The AFM probe exchange is simple, quick and error-free. The auto-alignment helps with ease of use and performance and makes imaging in liquids a fun experience.
Our Demo FlexAFM is available for $49,990 (This Flex AFM?s regular price: $80,694)
Demo FlexAFM with mode extension module: $55,000 (This Flex AFM's regular price: $88,594)
http://www.nanoscience.com/products/easyScan2/FlexAFM/index.html
We'd also like to let you know that we are offering Phenom desktop SEMs and Zeta 3D optical profilers. Nanoscience Instruments provides easy-to-use, robust, and affordable surface analysis instrumentation.
Please contact us for additional information on the demo AFM systems or any of our other products.
Sebastian Kossek, Ph.D.
Nanoscience Instruments
9831 S.51st Street, C119
Phoenix, AZ 85044
Tel: 480-940-3940
Fax: 480-940-3941
ONCOLOGY ALLIANCE:
APEIRON, CCRI AND SIOPEN JOIN FORCES AGAINST NEUROBLASTOMA
Vienna (Austria), 22 June 2011 - Vienna based biotech company APEIRON Biologics AG (Apeiron) strengthens its oncology pipeline: The company will support the clinical development of an immune therapy against high-risk neuroblastoma that is being conducted by the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). It is presently under investigation in a phase III trial across various European clinical centers. In return, Apeiron obtains the rights to file for regulatory approval and to market the final product. The approach is based on a monoclonal antibody (ch14.18) and constitutes Apeiron's most advanced project. It also marks another milestone for the company and its development strategy to treat neuroblastoma. This strategy was initiated earlier this year with the licensing of a clinical phase II project from Merck KGaA.
Vienna based APEIRON Biologics AG (Apeiron) announced the conclusion of an agreement with the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). Thereby, Apeiron obtains the rights to further develop, file for regulatory approval and market the antibody ch14.18. This monoclonal antibody exhibits therapeutic effect against high-risk neuroblastoma, an aggressive form of infant cancer. The antibody specifically targets the antigen GD2, a feature on the surface of neuroblastoma cells and thereby initiates an immune reaction against these cells.
As part of the agreement, Apeiron will provide substantial support for an ongoing European clinical phase III trial with ch14.18. Due to the limited number of clinical centers specializing in the treatment of high-risk neuroblastoma, Apeiron is considering marketing the therapy on its own.
The Austrian company Polymun Scientific, a long-time business partner of Apeiron, has already been producing clinical supplies for the CCRI/SIOPEN sponsored clinical studies. Apeiron has now commissioned Polymun to continue production and to prepare for manufacture of material at market standard.
Dr. Hans Loibner, CEO of Apeiron, commented on the successful completion of the agreement: "This novel form of collaboration with CCRI and SIOPEN is a milestone for Apeiron. These non-profit organizations have accomplished remarkable clinical development achievements which we can now complement with our industrial know-how. With this collaboration, we add a project to our portfolio that is both innovative and close to the market."
Professor Ruth Ladenstein, head of the coordination center for clinical studies at CCRI, senior physician at St. Anna Kinderspital and European president of SIOP said: "We are convinced to have found an ideal partner in Apeiron for our project. Together, we will take the final steps of development for an urgently needed therapy against high-risk neuroblastoma. By applying immune therapy and other treatment improvements, we hope to increase the chances of survival for children with high-risk neuroblastoma by 30%, thereby rendering future survival rates of 60-70% realistic."
Financial details were not disclosed.
About Apeiron (as of June 2011):
Apeiron is a privately financed Biotech company based in Vienna, Austria. Apeiron focuses on biological and immunological treatments against cancer and related conditions. Including the agreement for the antibody ch14.18, Apeiron's project portfolio includes five projects that are under clinical evaluation. This includes the immunocytokine hu14.18-IL2 that is about to enter a phase II/III (for certain neuroblastoma patients) shortly and is also being clinically tested against melanoma. Also in a clinical stage is a liposomal formulation of recombinant human Superoxide Dismutase to prevent or treat skin damage due to radiation treatment in cancer. A further clinical project, recombinant human Angiotensin Converting Enzyme 2, was licensed to GlaxoSmithKline early 2010. It is expected to commence a phase II study for the treatment of Acute Respiratory Distress Syndrome in the near future and has considerable potential in other disease areas. Apeiron is operational since 2006 and employs approx. 20 people.
About ch14.18:
Ch14.18 is a mouse-human chimeric monoclonal antibody against the antigen GD2 (a disialoganglioside) that is strongly expressed on the surface of neuroblastoma cells. The antibody is produced in Chinese Hamster Ovary cells, the most common cell type for the commercial production of monoclonal antibodies, and purified from the supernatant. The anti-tumor effect of ch14.18 is first and foremost based on the triggering of the body's own immunological mechanisms to destroy tumor cells to which the antibody binds due to its specificity for GD2. Ch14.18 has already shown clinical efficacy in form of remissions in children with high-risk neuroblastoma in a phase I study conducted by SIOPEN. It is currently being tested in a broad multicentric phase III trial and other studies in many European countries. This phase III study also evaluates whether the concomitant subcutaneous administration of interleukin-2 improves the efficacy of ch14.18. Interleukin-2 is a commercially available protein that activates the body's immune cells. Positive results of this phase III may be used for registration of the product.
About CCRI:
The CCRI (Children's Cancer Research Institute) started its activities in 1988 under the leadership of Professor Helmut Gadner. In the last 23 years, the CCRI has accomplished pioneering work in many areas to improve the treatment quality and the chances for cure of children and adolescents suffering from cancer. Today, an internationally renowned multi-disciplinary scientific team of physicians, molecular biologists and technicians is successfully working in ten cooperating groups in the fields of tumor cytogenetics, immunology, molecular and cell biology of children cancer cells as well as clinical research. Every three years, an international expert commission reviews the CCRI to assess its scientific achievements and to give advice on further development. Since inception, the institute works on lean administration and is primarily financed by donations and competitively raised external funds.
About SIOPEN:
SIOPEN (Society of Paediatric Oncology European Neuroblastoma Network) is a European research network for clinical studies and integrated research with the goal to improve the survival of high-risk patients and to introduce risk-adjusted treatments to increase quality of survival. Harmonized procedures and quality management systems have paved the way towards new insights in tumor biology of neuroblastoma. A web-based database and communication system enables the joint performance of clinical studies in 18 European countries and to link them with relevant research data. This concept is currently being successfully applied to the European phase III study in high-risk neuroblastoma patients with minimal residual disease. This trial evaluates the efficacy of an immune therapy with the antibody ch14.18 with or without interleukin-2.
Super Resolution Microscope Stages are More Stable
with Capacitive Feedback
Auburn, MA – PI (Physik Instrumente) LP has added two higher-performance models to its successful PInano™ superresolution (SR) microscope stage series.
Higher Stability and Reduced Noise with Capacitive Sensors,
Lower Cost Piezoresistive Models Still Available
The new models are equipped with direct-measuring capacitive sensors. This type of sensor can provide higher linearity and long term stability than the lower cost piezoresistive sensor-equipped stages which are still available. Capacitive sensors are also less sensitive to noise due to a high-frequency measurement principle as opposed to the DC-based sensing technique used in piezoresistive sensors. The net effect is similar to the higher quality and lower noise on FM radio channels compared to AM radio.
Bottom Mount Slide Allows Full Turret Rotation, Protects Objectives
The large aperture accommodates microscopy accessories such as slide holders, Petri dish holders, etc. The recessed bottom slide mount allows full rotation of the turret without in and out Z-motion, protecting valuable objectives from crashing into the stage on turret rotation.
XY and XYZ Models, 200µm Travel / Axis
Both XY and XYZ stages are available. The low profile design of 20 mm (0.8”) facilitates the integration into inverted microscopes from the four major manufacturers Leica, Nikon, Olympus and Zeiss.
Datasheets & More Information:
http://www.nanopositioning.net/XYZ_nanopositioning_stage.php?#nano
Optional Long-Travel Motorized Microscope Stage
An optional 25x25 mm positioning stage with self-clamping ultrasonic ceramic motors serves as a stable basis for the piezo scanning stage and allows imaging of large samples.
Image Acquisition Software
The microscope stages are compatible with all major image acquisition software packages such as Micromanager™, Metamorph™, etc.
Features & Advantages
- Sensor Choice: High Stability Capacitive or Lower Cost Piezoresistive Sensors
- 24 Bit Controller with USB, Ethernet, RS-232 Interface and Analog Control
- 200 µm XY or XYZ Travel, Closed-Loop Control for Sub-Nanometer Precision
- Bottom Slide Mount for Full Turret Rotation facilitates Integration
- Many Options: Slide Holders & Petri dish Holders; Motor XY Stage, Manual Stage
- Longer Lifetime due to Ceramic Encapsulated Piezo Drives
- Software Support for Leading Image Acquisition Packages
Versatile High-Resolution Controller Included
A newly designed piezo controller is included and comes with three 24-bit digital interfaces (USB, TCP/IP, and RS-232) and a wide-band analog interface for compatibility with all control signals. With its 24-bit DAC converters, commanded resolution is improved by two orders of magnitude over the still widely used 16-bit converters.
Improved Linearity with Special Servo Circuit
For highly stable, closed-loop operation, capacitive sensors directly and precisely measure the displacement of the platform. This direct measurement provides better linearity and long term stability than is possible with piezoresistive sensors which rely on an inferred measurement principle. A proprietary servo circuit further improves the motion linearity compared to conventional controllers.
Keywords & Application Examples
Single Molecule Microscopy, 3D Imaging, Autofocusing, Bio-Nanotechnology, SR-Microscopy; Piezo-Stage, Super-Resolution Microscope Stage, Piezo stepper, Deconvolution Microscopy, Autofocusing, Scanning Microscope, Biotechnology
About PI
PI is a globally leading manufacturer of piezo stages, precision motion control equipment, nanopositioning systems, piezo motors and actuators for microscopy, photonics, bio-nanotechnology, medical engineering & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries, R&D / engineering on 3 continents and total staff of 600+.
PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Nanobiosym CEO Dr. Anita Goel and Former UK PM Tony Blair
Tackle Global Challenges at Novartis Forum
Dr. Anita Goel and former UK P.M. Tony Blair
MADRID, Spain – Nanobiosym® Chairman and CEO Dr. Anita Goel, MD, PhD and Former UK Prime Minister Tony Blair delivered keynote addresses at the annual Novartis Forum for Excellence in Spain on June 2, 2011. Mr. Blair outlined five key challenges facing our planet today, while Dr. Goel unveiled game-changing nanotechnology solutions in development by Nanobiosym to address the most pressing global challenges in healthcare, energy and the environment.
The Novartis Forum for Excellence exemplifies the Novartis commitment to research, development, and commercialization of innovation and excellence in business. According to Francisco Ballester, CEO of Novartis Pharmaceuticals, "Innovation and commitment will always come with leadership. These leaders have a visionary, different attitude and ideas that shine." Times of great uncertainty demand leaders that can articulate a clear vision for the future. One that defines us, unites us and inspires us. This fourth Novartis forum was held in the framework of ExpoManagement, the largest management conference in Spain where elite business leaders gather to discuss the latest challenges and innovations in science, technology and social responsibility.
Considered one of the world’s most influential global leaders, Mr. Blair addressed the key challenges facing the world today, including, managing the new interdependent global economy, energy supply security, peace in the Middle East, a new direction for Europe and the emergence of China. Mr. Blair highlighted the need for leadership in science and technology to accelerate sustainable development across the globe.
One of the world’s top science and technology innovators, Dr. Anita Goel showcased nanotechnology-enabled solutions that she and Nanobiosym are developing to address some of the most pressing global challenges. A Harvard-MIT trained physicist and physician, and an internationally recognized nanotechnology expert and entrepreneur, Dr. Goel unveiled some of Nanobiosym’s breakthrough technologies like Gene-RADAR®, a nanotechnology device platform that reduces the infrastructure required for diagnosing diseases from a centralized pathology lab to a mobile device much like a cellphone. She invited the audience to join the Nanobiosym Global Innovation Ecosystem to help scale up these game-changing technologies and collectively tackle the largest problems facing our planet today. “I believe that science and technology alone, no matter how game-changing, are not enough. We need to raise the consciousness with which we deploy these technologies across the globe.” She also outlined a roadmap to harness nanotechnology to drive the new global economy defining key leadership roles that Europe and the United States, as well as emerging economies can play.
Inspired by the underlying unity of nature, Dr. Goel embarked upon a quest over 15 years ago to bring the worlds of physics and biomedicine together using nanotechnology – the ability to probe and control nature at very small scales- less than a billionth of a meter. “We already have the tools within science and technology to address many of the world’s problems today such as access to healthcare, sustainable supplies of energy, food and water.” Dr. Goel urged the need for a more holistic approach that transcends the conventional boundaries between various fields of science, technology, industries and geopolitics, enabling new quantum leaps in how we solve global problems.
Video From Novartis: Nanobiosym Chairman Dr. Anita Goel and Fmr UK PM Tony Blair Jointly Keynote Novartis Forum - Innovatively Address Global Challenges (Spain, June 2nd)
http://www.youtube.com/watch?v=7EWunAJewaE
About Nanobiosym. www.nanobiosym.com Nanobiosym® (NBS) is an innovation engine dedicated to creating a new science that emerges from the holistic integration of physics, biomedicine, and nanotechnology. NBS focuses on incubating transformational technologies that have the potential for game-changing impact and commercializing and scaling up these technologies for deployment in developed and developing world markets. NBS leverages science and technology to address our planet’s greatest unmet needs in global health, energy and the environment. Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of the Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health.To maximize global humanitarian impact, Dr. Goel has spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.
NSTI nano tech Boston 2011 – FutureCarbon goes US
Bayreuth/Germany, May 11.06.2011: FutureCarbon, the leading provider of super-composites based on carbon nanomaterials, is making a first-time appearance at this year's NSTI nano tech show in Boston from June 14 through 15. FutureCarbon is thus actively continuing its course of expansion. Visitors can find FutureCarbon at booth 1407.
FutureCarbon is bringing along an attractive portfolio. In Carbo e-Therm the innovative Bayreuth-based company is presenting a high-tech heated coating based on carbon metamaterials. Different product variants, working on a non-hazardous low voltage of 12 or 24 V for example, are able to heat forms and surfaces up to temperatures as high as 500°C – walls, floors, interior surfaces in automobiles, rotor blades of wind power parks or lab flasks for instance.
Another interesting exhibit is CarboBond – an electrically conducting adhesive that offers the possibility of matching specific electrical resistance for antistatic regions up to conductivity of 100 O·cm. Plus, CarboBond comes with excellent processing and adhesive properties, enabling the user to simply integrate it into their processes.
CarboShield is an innovative FutureCarbon coating for highly efficient shielding of electromagnetic radiation. What is special about this product is its extremely wide and constant absorption spectrum from just a few megahertz to more than 50 gigahertz. CarboShield can be applied by simple methods to a whole variety of geometries and surfaces, guarding rooms in buildings, technical installations or electronic systems against the negative impact of electromagnetic radiation.
FutureCarbon looks forward to seeing you at NSTI nano tech in Boston at booth 1407 of the German Ministry of Education and Research. If you would like to spend more time with us, arrange a time and date in advance. Just phone +49-(921)-507388-40 or e-mail to sales@future-carbon.de. Visit: www.future-carbon.de
Konarka Announces Largest OPV Installation,
First Semi-Transparent BIPV Curtain Wall
Konarka’s Transparent Solar Panels Enable Glass Curtain Wall and Color Solar Installations Not Possible with Crystalline Technology
Lowell, Mass. – June 6, 2011 – Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a lightweight, flexible solar material that converts light to electricity, today announced the largest OPV installation of its kind and the first OPV semi-transparent BIPV curtain wall. Easily laminated onto glass, Konarka’s semi-transparent solar panels were installed in the company’s New Bedford, Massachusetts facility.
“Konarka’s Power Plastic made with proprietary, semi-transparent material and laminated inexpensively onto glass is easily integrated into building walls,” commented Howard Berke, chairman, CEO and co-founder of Konarka. “Organic PV is much less energy intensive to manufacture compared with crystalline silicon. Konarka’s transparent photovoltaic film is ideal for glass curtain walls because of its superior low light sensitivity, thermal performance, light weight and performance over a wide range of sunlight angle of incidence.”
In the New Bedford facility, Konarka’s Power Plastic is installed in both south and east facing walls. Being able to integrate solar panels into multiple walls delivers greater electrical output. Typical solar installations occur on rooftops, although there is generally far more area to accommodate PV system integration in building walls, especially in multi-story buildings.
A world leader in OPV technology, Konarka’s solar panels are lightweight, flexible and versatile, offering various large and small scale applications including curtain walls, components within windows and other building integrated (BIPV) and building applied (BAPV) categories. Konarka’s roll-to-roll manufacturing process facilitates fabrication of custom sizes preferred by architects in new construction and retrofit applications. Solar panels are available in a variety of colors and degrees of optical transmissivity.
Konarka is exhibiting at Intersolar Europe 2011, Wednesday, June 8 – Friday, June 10, 2011 at the New Trade Fair Centre in Munich, Germany, booth #A2.151. For more information, visit: http://www.intersolar.de.
NANOINK LAUNCHES THE NANOARRAY ASSAY SYSTEM
A fully integrated, nanoscale protein assay and analysis solution
SKOKIE, Ill. – June 6, 2011 – NanoInk’s® Nano BioDiscovery™ Division announced today the
launch of a new instrument system for nanoscale protein analysis and discovery. Coupling powerful array deposition techniques with the latest generation of fluorescent detection technologies, the NanoArray Assay System™ is a user friendly, affordable desktop unit that can quickly and costeffectively integrate into any proteomic lab. The platform is based on NanoInk’s patented, tip-based Dip Pen Nanolithography® (DPN®) technology, which can create highly reproducible protein arrays over millimeter areas with nanometer precision and then fluorescently image these nanoarrays at high resolution.
Components of the NanoArray Assay System include the NanoArrayer 3000™, the NanoScan 900
Scanner, and user-friendly software for flexible and precise array patterning and intuitive data acquisition and image analysis. When combined with NanoInk’s line of fully automatable proteomic assays, the NanoArray Assay System is a complete solution for the detection, identification, and quantitation of clinically relevant proteins from a wide variety of sample types.
According to Bruce Dudzik, vice president of the Nano BioDiscovery Division, “Other protein analysis platforms require large amounts of sample material and reagents. The NanoArray Assay System generates more data with just 2 µl of sample so that even low-abundance biomarker studies on rare and hard-to-collect samples (like rodent serum, spinal fluid, tissue extracts, tears and dried blood spots) are possible. And with femtofluidic liquid handling, the NanoArray Assay System delivers rapid reaction kinetics and lowers reagent volumes, reducing assay costs.”
The NanoArrayer 3000 is capable of depositing thousands of uniform protein features in the area occupied by just one spot on a conventional protein microarray. This miniaturization and precision enables high throughput protein analysis on a single slide. NanoArrayer 3000 arrays are also completely customizable. Multiplexed proteins can be patterned into each sub-array, and modified assay slides can be produced in 18, 48, and 96 sub-array formats.
By incorporating two extremely sensitive photomultipliers, the confocal NanoArray 900 Scanner detects fluorescence uniformly across the entire arrayed surface and delivers exceptional sensitivity and signal-to-noise ratios. Miniaturized and multiplexed NanoArray Assay System assays achieve femtograms/ml sensitivity with 2 µl of sample, comparable to or better than the sensitivities of ELISA and bead-based assays that consume 50 µl of sample.
Please visit www.nanoink.net/nanobio or call (847)679-3432 for more information on the NanoArray Assay System and other Nano BioDiscovery Division assay kits and contract services for nanoscale protein studies.
New Nanopositioning Systems Catalog
Piezo Stages, Motors, Nanopositioning Controllers
PI (Physik Instrumente) L.P. -- a leading manufacturer of nanopositioning stages and precision motion-control equipment for bio-medical, semiconductor, imaging and nanotechnology applications -- has released a new catalog on nanopositioning systems.
The 160-page catalog focuses on piezo flexure based nanopositioning systems capable of repeatedly moving distances as small as the diameter of an atom. It covers single axis stages, XY and XYZ stages as well as tip/tilt platforms for active optics, imaging and laser beam steering. Parallel kinematic positioners (2-axis systems to complex 6-axis hexapods) and novel hybrid systems as well as ceramic precision linear motors are also shown.
A nanopositioning controller section discusses software, explains interfacing options and different digital servo control models and algorithms that increase linearity in static and dynamic applications.
The Nanopositioning Systems catalog can be downloaded at:
http://www.nanopositioning.net/nanopositioning/nanopositioning_systems.pdf
About PI
PI is a leading manufacturer of precision motion control equipment, piezo nanopositioning systems, piezo motors and actuators for photonics, bio-nanotechnology, medical engineering & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries, R&D / engineering on 3 continents and total staff of 600+.
PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
NANOINK’S NANOFABRICATION SYSTEMS DIVISION
TO EXHIBIT AND PRESENT AT THE 2011
TECHCONNECT CONFERENCE AND EXPO
NanoInk to make four presentations as part of the Nanotech Conference and Expo
SKOKIE, Ill. – May 26, 2011 – NanoInk’s® NanoFabrication Systems Division is pleased to announce that it will exhibit and give four presentations at the 2011 TechConnect World Conference and Expo, presented by the Nano Science and Technology Institute (NSTI) and the Clean Technology and Sustainable Industries Organization (CTSI). The conference will be held from Monday, June 13 through Thursday, June 16 at the Hynes Convention Center in Boston, Mass. TechConnect World is a unique combination of five interconnected conferences focused on technology commercialization:
Clean Technology, Nanotech, BioNano, MicroTech and the TechConnect Summit.
Dr. Ruby Lam, an applications scientist at NanoInk, will give a presentation titled, “Rapid, Flexible Prototyping of Cellular Scaffolds,” on Tuesday, June 14, at 3:30 p.m. in room 206. The presentation will demonstrate a methodology for the placement of nano- to micro-sized topographical and biochemical features with nanoscale precision by tip-based lithography. More information about Dr. Lam’s presentation is available at: http://www.techconnectworld.com/World2011/a.html?i=785
Jason Haaheim, a senior R&D engineer at NanoInk, will give a presentation titled, “Advances in Direct- Write Nanoscale Deposition and Patterning,” on Wednesday, June 15, at 1:50 p.m. in room 103. The presentation will demonstrate the capability of Dip Pen Nanolithography® (DPN®) to generate large areas of homogenous nanopatterns. More information about Haaheim’s presentation is available at:
http://www.techconnectworld.com/World2011/a.html?i=3062
Dr. Jae-won Jang, an applications scientist at NanoInk will give a presentation titled, “Sub-Wavelength Metal Nanostructure Fabrication by Parallel Dip-Pen Nanolithography,” on Thursday, June 16, at 10:30 a.m. in room 103. The presentation will demonstrate the low cost and convenient scale-up fabrication method for metal nanostructures using Dip Pen Nanolithography (DPN). More information about Dr. Jang’s presentation is available at:
http://www.techconnectworld.com/World2011/a.html?i=1222
Sergey Rozhok, a senior research engineer at NanoInk, will have a poster on display in the Expo Hall throughout the conference titled, “High-throughput multiplex protein analysis for limited sample size on a single slide.” The poster demonstrates how Dip Pen Nanolithography (DPN) allows parallel printing of hundreds of molecules over an area that is 100 times smaller than that of conventional microarray formats and uses significantly fewer materials. More information about Rozhok’s poster is available at: http://www.techconnectworld.com/World2011/a.html?i=1364
NanoInk will also exhibit at booth #1818 where its NLP 2000 desktop nanofabrication system will be available for demonstrations. The NLP 2000 system allows researchers to rapidly design and create custom engineered and functionalized surfaces on the micro and nanoscale, using Dip Pen Nanolithography to transfer minute amounts of materials over a large, environmentally controlled work area.
TechConnect World has become the largest venue for emerging technology development and commercialization in the world. The conference is expected to draw over 5,000 attendees from over 70 countries, across major industry segments and along the technology path from research to implementation. The exposition, which features several international pavilions, is expected to host more than 400 companies, universities, equipment manufacturers and solutions providers. These exhibitors will meet with thousands of prospects and potential buyers, who come to the expo to evaluate the latest technology and services. For more information, please visit:
http://www.techconnectworld.com/Nanotech2011/
NanoInk’s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable setting.
More information is available at: www.nanoink.net/divisions.html#NanoFabrication
AFFiRiS AG STRENGTHENS ITS DEVELOPMENT PIPELINE WITH THE FOUNDATION OF A CHRISTIAN-DOPPLER-LABORATORY
Vienna (Austria), 31 May 2011 - AFFiRiS AG is the industrial Partner of the newly-established Christian-Doppler-Laboratory for Cardiometabolic Immunotherapy. In partnership with the Medical University of Vienna the laboratory will work on basic research for the development of a vaccination therapy against Type 2 Diabetes and cardiovascular diseases. The reason for AFFiRiS' commitment is its decision to establish an additional top priority field. In this way, the company's versatile AFFITOME®-technology will also be applied for the development of vaccines against cardiometabolic diseases.
Today AFFiRiS AG announced its role as industrial partner in the newly-established Christian-Doppler-Laboratory for Cardiometabolic Immunotherapy at the Medical University of Vienna. Headed by Prof. Thomas Stulnig, Department of Internal Medicine III at the General Hospital Vienna, the Christian-Doppler-Laboratory (CD-Laboratory) will work on chronic inflammatory processes of adipose tissue and of the cardio-vascular system and thereby contribute to the basic research for a vaccination therapy against Type 2 Diabetes mellitus and cardio-vascular diseases. The initial plan for the CD-Laboratory is for seven years and is financed by public funding and AFFiRiS as an investor.
Additionally, AFFiRiS provides the CD-Laboratory with its proprietary AFFITOME®-technology, which allows the development of highly specific therapeutic vaccines and is the basis for all previous achievements of AFFiRiS in the development of vaccinations. These have to date focused mainly on neurodegenerative diseases. The collaboration with the CD-Laboratory now implements a new field of attention: Vaccines against inflammatory diseases. CEO and co-founder of AFFiRiS, Walter Schmidt comments: "Inflammatory processes are more and more identified as a contributory cause of many chronic diseases. Taking this into account, we are now investing in the basic research of the corresponding pathophysiological principles, so that our technology can contribute to combating inflammatory-induced chronic diseases. This perfectly fits with our strategy of sustainable diversification and risk spreading."
The CD-Laboratory will initially focus its activities on the evaluation of relevant target structures with functions in the immune system and inflammatory processes. These same structures will be investigated and characterized within the framework of the CD-Laboratory. Günther Staffler, Head of the Immunology Department at AFFiRiS, adds: "There is increasing evidence that some of the body's own structures are involved into the cause of inflammatory reactions of the adipose tissue. As a consequence, these reactions contribute to the emergence of Type 2 Diabetes and cardio-vascular diseases in a way that's still not fully understood. The underlying fundamental inflammatory mechanisms will now be investigated at the CD-Laboratory. It will also be explored, whether and how an active immunization approach based on our AFFITOME®-platform-technology can unfold its therapeutic efficacy/impact."
Frank Mattner, CSO and co-founder of AFFiRiS, explains the strategic relevance of an investor in a CD-Laboratory: "Investments in the basic research of a disease are important for the sustainable generation of innovative therapies - for nations as well as for companies. Programs like that of the CD-Laboratory in which the Republic of Austria and an industrial investor both contribute to the funding together, are therefore future-oriented and contribute significantly to the appeal of Austria as a business and industry location, allowing the growth of research-intensive companies like AFFiRiS AG."
David Edwards joins Nanostart-holding BioMers as its new CEO
Frankfurt / Singapore – May 11, 2011 – David Edwards is the new Chief Executive Officer of the Singaporean Nanostart (OTCQX: NASRY) holding BioMers Pte Ltd. The top executive will be leveraging his extensive experience in building brands to drive BioMers’ commercial expansion and launch of flagship product, SimpliClear™. The SimpliClear product range is the world’s only completely translucent orthodontic system. Mr. Edwards is based in BioMers‘ Singapore headquarters and is responsible for the company‘s worldwide business, reporting to the Board of Directors.
Mr. Edwards brings broad management experience and global brand development expertise in the consumer and med-tech space to the company, and has an impressive track record in growing businesses in the US, Europe and Asia.
Most recently, Mr. Edwards was responsible for annual sales of over USD 500 million as the President of Asia-Pacific at Bausch & Lomb, one of the leading producers of eye health products, responsible for the Asian eye health portfolio. Under his leadership, Bausch & Lomb’s business in Asia was turned around and new products were successfully launched. Bausch & Lomb has more than 10,000 employees across 35 countries. Its total revenues amount to more than USD 2 bn.
Mr. Edwards also spent more than ten years with Johnson & Johnson in several top management positions. This includes leading roles as business unit head at Johnson & Johnson’s diabetes business (encompassing Western Europe, Eastern Europe, Middle East and Africa), the vision care business (Asia Pacific, including China and India) and the consumer nutritionals business (Europe). He achieved strong growth in his relevant areas, with the successful launch of numerous products and product innovations. Johnson & Johnson has around 140,000 employees worldwide across 57 countries. In 2010 the company achieved revenues of about USD 62 bn.
Further positions include local, regional and global roles at Nestlé in the US, in Europe and at the global headquarters in Vevey, Switzerland.
David Edwards comments on his new position: “I am looking forward to my new role at BioMers. SimpliClear is a proven product, which has been long awaited by orthodontists and patients. It represents a breakthrough innovation in the growing market for aesthetic orthodontic appliances and delivers superior clinical outcomes.”
Andreas Kröll, managing director of Nanostart Asia, comments: “We are excited that David Edwards has joined us as CEO of BioMers. His impressive experience and highly efficient management style combine with the SimpliClear product to create ideal conditions for blockbuster business success – and ensure a solid foundation for BioMers success.”
David Edwards succeeds Dr. Mervyn Fathianathan as CEO. Dr. Fathianathan is one of the founders and a director of BioMers. He will continue as the CTO of BioMers, and shall be responsible for customer and product development. He added: “With David Edwards, we have brought a top executive into BioMers who will contribute to make the company a global leader in orthodontics. His commitment highlights the value of our products and company. This marks the start of rapid expansion of the company's business on a global scale.”
Nanostart holds its position in BioMers through the Nanostart Singapore Early Stage Venture Fund. The fund’s shareholding in BioMers is about 25 percent.
Industry veteran joins Peratech, the Touch Technologists, to accelerate the growth of the company
RICHMOND, North Yorks., England - 9 May 2011. Neil Jarvie, an electronics industry veteran, has joined Peratech, the innovators in touch technology. In his role as Vice President of Sales, Jarvie will be responsible for continuing the development of Peratech?s business that is based on its award winning, patented QTC technology (Quantum Tunnelling Composite).
He joins Peratech from Cypress Semiconductor where he worked in Global Account development with major international brands customers for nearly twelve years. These included Sony Ericsson, where his efforts over the past five years will result in seven out of ten Sony Ericsson phones shipping with a Cypress-enabled touch screen in 2011, Nokia and Motorola where he achieved multimillion dollar increases in sales. Jarvie previously headed international account development roles at Rohm and Murata.
"We are delighted that someone with the outstanding industry experience of Neil has recognised the tremendous potential of Peratech and joined us from such a senior position with a major electronics company," said Philip Taysom, Peratech?s Joint CEO. "His contacts and experience with top international companies over two decades will be instrumental in accelerating the growth of the company."
Since the announcement of licenses with Nissha and Samsung Electro-Mechanics last year, Peratech has closed a further seven significant licenses, and the company expects to close a further two shortly.
"Peratech has an amazing Intellectual Property (IP) portfolio which means that it owns a complete area of material science," added Neil Jarvie. "There are so many ways in which QTC can be used throughout the electronics industry to deliver improved performance and, excitingly, make possible devices that could not be made before. Its business is essentially the IP licensing model that has been proven to be rapidly scalable and highly profitable for the likes of ARM and many others. I am really excited by the opportunity to work with this technology and to help grow Peratech into a major international company."
Peratech is a privately held, British company. It currently has 16 employees with plans to expand to over 25 by the end of 2011. It is profitable with 98% of sales being to overseas customers making it an excellent example of British innovation bringing in global revenue.
Dutch Company SolMateS Enables Next Generation of MEMS Products
SolMateS receives a three million dollar investment for the final development phase of their piezoelectric deposition machine PiezoFlare 1200.
SolMateS, the highly innovative supplier of PZT thin film solutions, announced that they have received a three million dollar investment from private equity funds Twente Technology Fund and Participatiemaatschappij Oost Nederland (East-Netherlands Holding Company) on April 27th, 2011. SolMateS will use the investment to accelerate product development and international expansion for its unique production system.
Piezoelectric layers are to be used in all kinds of miniaturized systems were precise actuation is needed, for instance in small motors, RF MEMS components or micro pumps. Currently those layers are deposited by notoriously unreliable and costly wet processing; production price and quality do not meet the high volume electronic industry standards. SolMateS technology has been developed at the University of Twente, and is the most advanced manufacturing solution currently available to deposit piezoelectric thin films. It marks the beginning of a whole new era of MEMS and will be used to create essential components for the next-generation mobile electronics, thin film actuators and medical devices.
PiezoFlare 1200 is a revolutionary manufacturing technology to produce chips with precise actuation functionality. It is an automated deposition system for PZT thin films on 6" or 8" wafers, based on pulsed laser deposition and offers high-yield piezo performance and flexibility for customized PZT compositions. The technology enables, for the first time, high volume reliable production capability for PZT thin film deposition. ?The international demand for a machine like the PiezoFlare 1200 is exceeding our expectations?, SolMateS CEO Arjen Janssens states. ?We are pleased our investors share our visions and with their help we will be able to accelerate our growth and meet current and future market needs?.
SolMateS is a fast growing and ambitious company with 15 employees, located at Science Park Twente, in Enschede, the Netherlands. SolMateS has already been awarded with several technology and business awards since its launch in 2006.
Konarka Appoints Executive Vice President and
Chief Technology Officer
30-Year Technology Veteran of Eastman Kodak, Dr. James R. Buntaine Brings Decades of Global Technology Expertise and Product Commercialization Experience to Konarka
Lowell, Mass. – May 3, 2011 –Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to electricity, today announced the company has named Dr. James R. Buntaine as executive vice president and chief technology officer. Reporting directly to Howard Berke, chairman, CEO and co-founder of Konarka, Jim will lead the company’s technology creation and product development team. He joins Konarka after more than 30 years of successful technical leadership at Eastman Kodak Company.
“Jim has developed broad and deep experience in leadership of applied research, advanced technology development, IP strategy and product commercialization in the fields of printing, coating, materials, devices and systems during his decades at Eastman Kodak,” commented Howard Berke. “We are fortunate to have him apply his leadership skills, as well as his extensive experience in developing business-to-business relationships to produce joint technologies and successful products to further the deployment of Konarka’s Power Plastic.”
Jim joined Eastman Kodak in 1980 in the Solid State Chemistry Laboratory. After holding many leadership positions within Kodak, he moved to the Display and Components Business Unit as technology director in 2004 where he repurposed Kodak’s coating machines for non-photographic applications. From 2007-2009, he served as CTO of Kodak’s OLED Systems Business, ultimately leading to the OLED Business sale to the LG Group. Most recently, he was CTO of the Graphics Prepress and Packaging Business responsible for new technology creation, commercialization and external technology collaborations. He also developed an extensive IP portfolio while at Kodak.
From 2005-2009, Jim served on the Board of Directors for the FlexTech Alliance, an organization dedicated to the growth and profitability of the electronic display and flexible, printed electronics supply chain. He holds a bachelor’s degree with double major in chemistry and mathematics at Clark University, a doctorate degree in inorganic chemistry from Cornell University, and is a program graduate of the Kellogg Graduate School of Management, Northwestern University.
“Konarka has been a technology leader in the organic photovoltaic market with their unique Power Plastic material and device technologies,” commented Jim Buntaine. “I am eager to further the company’s technology and product leadership positions over both the short- and long-term.”
Rayovac Marks National Teacher Appreciation Week with Teachers Bring Science to Life Contest
Nominate a Teacher to Win a Trip to Steve Spangler’s Science in the Rockies
MADISON, Wisconsin, April 27, 2011 – Do you know a teacher that brings learning to life and inspires kids to want to learn? In celebration of National Teacher Appreciation week, May 2 – 6, Rayovac is recognizing inspiring teachers by hosting the Teachers Bring Science to Life Contest. Students, parents, administrators and teachers have the opportunity to nominate an amazing K-6 educator for a chance to win one of three all-expense paid trips to Steve Spangler’s Science in the Rockies – an intensive three-day, hands-on science training held in Denver, Colorado. The experience offers creative science integration strategies for teachers who are focused on making science more meaningful and fun for their students.
“There are so many amazing educators that bring inspiration, guidance, encouragement and fun to the classroom," said Kent Klagos, Division Vice President, Rayovac. "Through the Teachers Bring Science to Life Contest, we hope to recognize a few of the many outstanding teachers as well as give them an amazing science experience they can bring back and share with their students."
Rayovac will accept teacher nominations at www.rayovac.com/science beginning on Monday, May 2, 2011 through 11:59 p.m. (CST) on May 16, 2011. Those that would like to recognize an extraordinary teacher can fill out the online entry form and submit an essay up to 300 words explaining how the teacher inspires students and brings learning to life. Teachers can even nominate themselves for this unique, hands-on professional development workshop where they’ll learn great classroom techniques and engaging experiments sure to inspire and captivate their students. From the submissions, three inspiring teachers will be selected by Rayovac to win an all-expense paid trip to attend Science in the Rockies 2011. Additionally, the individuals with the winning essays nominating the three winning teachers will also receive one of three $100 gift cards from a major retailer. More information, the official contest rules and the entry form can be found at www.rayovac.com/science.
When it comes to inspiring and motivating teachers to perform at their peak level, Steve Spangler is top on the list. That’s why Rayovac – a leading manufacturer of batteries and pioneer in advancing battery technology - is teaming up with Steve Spangler Science and his team of award-winning teachers to send three teachers to Spangler’s hands-on science institute called Science in the Rockies, July 6-8, 2011.
"Our goal is to give teachers the necessary training and tools to inspire students to use the scientific method as they wonder, discover, explore and ask their own questions,” says Spangler, who parlayed his experiences as a classroom teacher and professional development coach into this unique training for teachers. “Teachers need more than cute ideas or clever tricks… they need real science activities that engage and teach kids how to think critically and to solve problems if they’re going to be competitive in the future workforce.”
Rayovac, Dedicated to Science
As a company with products backed by science, Rayovac is dedicated to science and technology education. The Rayovac Headquarters in Madison, Wis., is home to a state-of-the-art, on-campus science and technology lab where scientists and technology experts collaborate to bring the latest innovations to customers. This summer, the brand is bringing this experience to life with the launch of the Rayovac Science and Technology Institute (RSTI). The online resource center at www.rayovac.com/science will offer students, parents and educators a plethora of activities designed to bring science to life in a fun and memorable way. RSTI visitors will be able to get a behind-the-scenes look at the science of Rayovac, interact with Rayovac scientists, engage in educational games as well as view and explore fun science experiments they can recreate at home. Visit www.rayovac.com/science for more information.
Konarka Names New Vice President of Sales,
Marketing and Business Development
Long-Time AT&T/Lucent Executive, Kenneth McCauley, Brings Broad-Based Worldwide Sales, Marketing and Business Development Experience in Solar Thin Film and BIPV
Lowell, Mass. – April 27, 2011 – Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to electricity, announced today they have named Kenneth McCauley as vice president - sales, marketing and business development. Ken brings an exemplary record of accomplishment in leading global organizations to profitable growth. Serving AT&T/Lucent Microelectronics for 21 years, he and his team booked $1 billion in revenue during his leadership of the telecom and wireless customer segment.
Most recently, Ken served as vice president and general manager of Earthsponse, a renewable energy products subsidiary of Modern Marketing Concepts, Inc., where he developed a new brand while constructing and training a distribution/contractor network and direct sales team. Prior to Earthsponse, Ken initiated the BIPV operating division at EPV Solar for its amorphous thin-film silicon technology, and in just two years personally developed a project pipeline exceeding $300 million.
“Ken is an impeccable match for Konarka with his technical background in thin-film photovoltaics, working for a wide range of organizations from small scale start-ups through Fortune 50 companies,” commented Howard Berke, chairman, CEO and co-founder of Konarka. “While he brings large company experience with his many years at AT&T/Lucent, he also has brought start-ups from a zero base to extensive profitable growth. His broad-based experience in sales and business development, and particularly his extensive OEM relationships throughout the Asia/Pacific region, will serve us well in expanding distribution sales and design wins for Konarka’s Power Plastic globally.”
Ken began his career at AT&T/Lucent as a chemical process engineer then served in various sales and business development roles over two decades throughout the world, including five years as a resident in the Asia/Pacific region. He was vice president of worldwide sales and marketing at NanoOpto, a manufacturer of nanoscale optical components, as well as vice president of business development at IQE, a leading supplier of epitaxial compound semiconductor wafer growth services. Ken has received numerous sales and sales management awards. He holds a Bachelor of Science in Chemical Engineering from Bucknell University and a Master of Business Administration from University of Richmond.
“I have enjoyed many years developing strong customer relationships and delivering a competitive advantage with differentiated products and technologies driving successful business growth for AT&T/Lucent during the first part of my career, and more recently, for solar energy focused organizations,” commented Ken McCauley. “With Konarka’s inspiring, world class team, its industry leading solar cell efficiency, recently achieving the world record at 8.4 percent and its unique technology offering several advantages over other OPV technologies, the company is well positioned to further develop numerous markets in diverse applications throughout the world.”
BMW CHOOSES INNOVATIVE 3D-TECHNOLOGY FROM emotion3D
Vienna, 26th April 2011 - The Austrian company emotion3D achieved commercial success with the preparation of a new advertising spot for the BMW X3. emotion3D won a valuable contract with BMW thanks to its powerful software solution for post-processing 3D films. The 3D advertising clip will be shown in numerous showrooms worldwide, at selected locations in auto-stereoscopic 3D, i.e. without the need for the user to wear special 3D glasses. emotion3D converted the 3D cinema version of the advertisement to a 3D film format for "glasses-free" displays, enabling viewers to be drawn into a futuristic virtual world.
The 3D market has a future. Nearly all box office hits are now released in 3D. Due to the increasing demand for 3D films, the need for professional editing tools for 3D film material is growing correspondingly - a trend that emotion3D recognized in 2009 as a business opportunity. This market demand motivated emotion3D to develop an innovative software solution for post-processing 3D film-material, which synthesizes camera perspectives at positions between the filmed cameras. This enables film sequences to be optimally customized to any kind of 3D display - not only traditional ones that require the user to wear glasses, but also the latest generation of "glasses-free" 3D displays.
THE COUP
Recently, the firm secured a deal with BMW to re-format the BMW X3 advertising spot for "glasses-free" 3D viewing. emotion3D stood out from the competition due to the considerably higher quality and efficiency of its service. Christian Breit of BMW Group emphasizes: "The video contained some challenging sequences. Only emotion3D could satisfy our high quality requirements. Additionally, emotion3D was the most attractive bidder."
VIRTUAL PERSPECTIVE
The maturity of emotion3D's technological innovations testifies a clear focus on commercial success, convincing not only customers but also end users of the high quality, efficiency and affordability of its solution. The core of emotion3D s film-editing lies in the ability to generate additional virtual camera perspectives in 3D videos. "Films that have been recorded with two or more cameras contain information about the scene geometry, specifically the relative distance of objects away from the camera. Based on this a so-called Depth Map can be computed. This enables us to artificially generate new pictures with virtual perspectives, as though they had been recorded by additional cameras in different positions during filming", explains Mr Florian Seitner, CTO of emotion3D. This technology is used to convert from 3D cinema film to the format required by the novel 3D displays that give viewers a fascinating visual experience without 3D glasses, which has applications not only in the film and advertising industry, but also in high-value consumer goods. BMW uses this innovative "glasses-free" 3D presentation medium in selected showrooms.
To grow further, the innovative and dynamic company intends to further strengthen its market position. As Dr Tom Wilson, CEO of emotion3D explains: "So far we've been using our software solution in-house to provide a service, and have refined the tools based on customer feedback to the stage where we now can put these into the hands of filmmakers." The software product was launched in April 2011 at the NAB (National Association of Broadcasters) Show to the international market of film producers under the brand "Stereoscopic Suite X1".
About emotion3D (April 2011):
Austria-based emotion3D serves the 3D film and advertising industry with services, consultancy and software products for 3D content creation. emotion3D's Stereoscopic Suite X1 software product empowers 3D film-makers to overcome the unique challenges associated with 3D post-production and deployment on multiple target screens, such as cinema, TV, mobile devices and glasses-free displays. emotion3D is supported by JITU - Seedfinancing of the BMVIT, distributed by the austria wirtschaftsservice (aws). In addition, emotion3D is part of the INiTS incubator, funded by the University of Vienna, Technical University of Vienna and ZIT, under the AplusB Program.
Nanotech Paper: Complex 3D-Nano Patterns with Indentation Lithography and Piezo Technology
A collaboration between the Whitesides Group at Harvard University and CSM Instruments has culminated in an important advance in lithography of different materials at the nanoscale. The motivation for this development was the ability to produce unique lithographical patterns of different shapes and sizes for use in research applications (e.g. lab-on-a-chip) where conventional techniques such as electron-beam lithography (EBL) and photolithography cannot be used. The new method utilizes the standard Ultra Nanoindentation Tester (UNHT) and the Nano Scratch Tester (NST) without anymodification.
The precise shape of the patterns is achieved with a PI (Physik Instrumente) P-733.2CD piezo nanopositioning scanning stage which is mounted directly on the Open Platform and allows sub-nanometer positioning resolution in the X and Y axes.
Download the paper at:
http://www.piezo.ws/pdf/NanoIndentation_Piezo_3D_NanoPattern.pdf
About CSM
CSM Instruments has been leader in the development of instruments for surface mechanical properties characterization for over 30 years in both research and industrial fields. CSM Instruments provides equipment that allow the mechanical characterization of a wide range of surfaces and bulk materials. Adhesion of paints, optical thin films or hard coatings can be defined using one of our Scratch Testers. These span the nano to the macro range to analyze the widest range of materials.
More: http://www.csm-instruments.com/en/Nano-Scratch
About PI
PI is a leading manufacturer of precision motion control equipment, piezo nanopositioning systems, piezo motors and actuators for photonics, bio-nanotechnology, medical engineering & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries, R&D / engineering on 3 continents and total staff of 500+ PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Dr. Anita Goel, M.D., Ph.D. and Fmr UK PM Tony Blair
to Jointly Keynote Novartis Forum
Tony Blair Dr. Anita Goel
Tony Blair - New Challenges
As Prime Minister of Great Britain and Northern Ireland from 1997 to 2007, Tony Blair became one of the most influential leaders of his generation.
Anita Goel - Innovation, Science and Social Responsibility
Considered one of the "35 most innovative young people in the world in science and technology" by MIT Technology Review, Dr. Anita Goel, medical physics and a Ph.D. from Harvard and MIT and has over 15 years of research in the field of nano/bio/physics, cutting-edge field of science where physics converge, nanotechnology and biomedicine.
Nanobiosym Chairman & CEO, Dr. Anita Goel and Former United Kingdom Prime Minister Tony Blair will jointly Keynote a Novartis Forum on “Innovatively Addressing Global Challenges” in Spain on June 2, 2011.
Here is the link to get more information: http://www.foronovartisexcelencia.com/ [A translation to English is available.]
Dr. Goel is a Founding Member of the Center for Healthcare Innovation’s Global Advisory Council.
Source: Novartis Forum
New nanotechnology significantly increases fuel efficiency as demonstrated by 54' super light-weight boat called Piranha
Zyvex Technologies announced that its 54’ boat named Piranha completed sea trials near Puget Sound in the Pacific Ocean and demonstrated record fuel efficiency. After six months of extensive testing, the Piranha completed its final sea trial; a 600-nm, rough-weather test in the Pacific Ocean in Washington and Oregon.
Piranha finished the tests in time to travel to its debut at the Sea Air Space show in Washington, DC, on April 11th. There, defense contractors are evaluating the Piranha for use as an unmanned platform with a variety of mission applications, including anti-piracy, harbor patrol, and oceanographic surveying
A conventional aluminum or fiberglass boat would have consumed 50 gallons or more per hour, while test results prove that Piranha consumed only 12 gallons of fuel per hour while cruising at 25 knots. The Piranha demonstrates Zyvex Technologies’ ability to produce products with nano-enhanced materials that are 40% stronger than metals, such as aluminum, and 75% lighter, resulting in increased fuel efficiency.
Zyvex produced Piranha in just 90 days. The makers believe it can help coastal city leaders in ports like Seattle, San Diego, Miami, Norfolk, and New York better protect their harbors. In 2009, the New York City Police Commissioner testified before Congress that even with the Coast Guard's assistance, the department could not fully protect the harbor, especially considering the vast amounts of uninspected cargo that enters the Ports of New York and New Jersey, pointing out that Mumbai was just another reminder. Two years later, there is still an urgent need for better port and maritime security.
The recent Oman piracy tragedy for four Americans from Seattle underscores the need for additional civilian and commercial security. In addition to the U.S. Navy, unmanned surface vessels such as Piranha can be deployed by Customs and Border Patrol, Port authorities and harbor police in high risk areas. Pirates can be tracked over long ranges with a clear picture of location so commercial vessels can avoid them. Piranha is an alternative to costly aircraft carriers. With its range and endurance, military personnel could remain on station for weeks and still protect designated areas. Piranha can be leased as an escort for commercial or private sailors through dangerous areas.
Source: Zyvex
Peratech's new, see through QTC Clear
will revolutionise touch screens
RICHMOND, North Yorks., England - April 2011. Peratech, the innovators in touch technology, have developed a see through version of their award winning, Quantum Tunnelling Composite (QTC?) material called QTC Clear?. This force sensing material can be used to create a whole new class of Force Sensitive touch screens that can completely replace current Resistive touch screen technologies or enhance Capacitive ones to create superior solutions with more features such as 3D input.
"Both Resistive and Capacitive touch screen technologies have their drawbacks," explained Philip Taysom, Peratech?s Joint CEO. "Resistive is not very accurate and can't do multi-touch so it is becoming less popular than Capacitive, but the latter uses a lot of power constraining it to smaller screen sizes. Our new, QTC Clear touch screen design offers the best of both technologies without their drawbacks. It can be made in any size and provides multi-touch, high sensitivity with great accuracy, ultra low power consumption and additional intuitive features with the third dimension of pressure to more easily manipulate and control information on the screen."
Resistive touch screen manufacturers can upgrade to using QTC Clear and use their existing manufacturing procedures and equipment to produce this new class of Force Sensitive touch screens. Capacitive touch screen manufacturers can augment with the addition of QTC Clear to provide additional features from the force sensitivity such as touch activation of the capacitive matrix to save power, 3D menus, variable line widths, and more intuitive gaming interaction. Very little alteration is needed to the control electronics in either case except to take advantage of the new features.
The QTC Clear layer is only 6-8 microns thick with a transparency that is very similar to the existing touch screen technologies. This is sandwiched between two layers of ITO (Indium Tin Oxide), which is in turn sandwiched between two hard sheets, typically glass. It is so sensitive that it can detect deflections of only a few microns so that the top surface can be rigid and robust, e.g. glass, unlike current Resistive designs that have to be soft enough to deform easily making them susceptible to damage. QTC's unique properties means that virtually no current flows unless a force is applied. This overcomes the drawbacks of Capacitive designs that constantly draw current and create design challenges to overcome EMI issues.
QTC Clear is available under license from Peratech and has already been licensed to a leading touch screen manufacturer. Licensing terms are competitively positioned so that manufacturing costs are only slightly greater to reflect the additional commercial benefits that using QTC Clear brings.
Paul O'Donovan, Principal Analyst at Gartner's semiconductor division, commented, "This is a very interesting new technology that could revolutionise the whole touch screen industry from automotive to computers."
Background information on Capacitive and Resistive touch screens
Current Resistive touch screens designs use a sandwich of a soft top layer and a hard bottom layer with small spacer bumps to keep them apart. When the soft top layer is pressed it deforms and contact is made between two thin films of conductive material (ITO) on the inside of the two structural layers. The drawbacks are that the top layer has to be soft enough to deform easily when pressed which makes it vulnerable to damage by scratching etc. and it cannot be used to provide the increasing important multi-touch functionality. No current flows unless pressure is applied, there are no EMI issues and they can be made any size. They can be used with gloves and in any humidity conditions.
Capacitive touch screens have become more popular as they overcome the drawbacks of Resistive because they have a robust, hard top surface and provide multi-touch. However, the design uses a lot of current to provide the touch detection which is a constraint on screen size and potential interference issues that require careful design to overcome, making large Capacitive screen solutions expensive. Also gloves and high humidity prevent them from working.
About QTC
QTC's are electro-active polymeric materials made from metallic or non-metallic filler particles combined in an elastomeric binder. These enable the action of 'touch' to be translated into an electrical reaction, enabling a vast array of devices to incorporate very thin and highly robust 'sensing' of touch and pressure. QTC's unique properties enable it to be made into force sensitive switches of any shape or size. QTC switches and switch matrices can be screen printed allowing for development and integration of switches that are as thin as 75 microns.
QTC is also low power and interfaces can be designed with no start resistance so that without pressure, the switch draws no power and passes no current. Importantly, when pressure is applied, the resistance drops in proportion to the amount of pressure which allows sophisticated human machine interface designs that react to variations in pressure. QTC technology has no moving parts and requires no air gap between contacts. This makes it extremely reliable and suitable for integration into the thinnest electronic designs and with industry leading operational life.
About Peratech
Peratech is the inventor and world leader in Quantum Tunnelling Composite (QTC) technology. Already widely used in robotics and defence, Peratech commercialised its QTC technology at the beginning of 2006 and is currently working with a number of key technology clients who are implementing QTC sensing technology within their own products.
QTC materials give enormous flexibility in the design, shape, thickness and style of a switch or pressure sensor and can be made in a range of elastomeric forms, including emulsive coatings (down to thicknesses of 10 microns), ?bulk? silicone or rubber and textile forms. Peratech pioneered the creation of electronic switches made from textiles as early as 2001. QTC has been recognised through numerous International awards and accolades including 'Tomorrow's World Industry Award 2002', 'Saatchi & Saatchi Innovation Award 2000' and 'European Electronics Industry Award 2004'.
QTC materials have been used by organisations such as NASA, ILC Dover, Shadow Robotics and numerous government agencies world wide. Peratech also owns SOFTswitch the pioneering creator of textile switching and Eleksen, the world leader in touch sensitive interactive textiles for electronics interface design. Further information is available from www.peratech.com
Aldrich Materials Science Collaborates with Agfa to Further Expand Organic and Printed Electronics Portfolio
Extending PEDOT:PSS Availability for Use in Printed and Organic Electronics
ST. LOUIS, MO – April, 2011 – Aldrich® Materials Science, a technology growth initiative of Sigma-Aldrich (NASDAQ: SIAL), today announced that it has entered into collaboration with Agfa Materials, a division of Agfa-Gevaert N.V., a world renowned imaging and information technology company. Under the terms of the collaboration, the two companies plan to produce and distribute OrgaconTM conductive polymers for use in high technology applications including, organic photovoltaics, touch screens and printed sensors. Information regarding the products produced via the new collaboration can be found at sigma-aldrich.com/conductingpoly.
The products available under this Agfa/Aldrich Materials Science initiative are specifically targeted at research requiring the highest conductivity PEDOT:PSS, (Poly(3,4-ethylenedioxythiophene): poly(styrenesulfonate) materials and formulations for use in printed electronics applications. The distinct advantages of these materials include enhanced conductivity, transparency, printability, flexibility and patternability.
This agreement supplements other material offerings from Aldrich Materials Science, including silver inks and pastes, in a continued effort to enable research in all areas of organic and printed electronics.
The introduction of four specific OrgaconTM materials complements the existing Aldrich Materials Science PEDOT:PSS portfolio and include
· Two raw high-conductive PEDOT:PSS materials that can enable researchers to make their own formulations, including a neutral pH version also suitable for high-tech applications such as polymer tandem solar cell devices.
· Two formulated high-conductive PEDOT:PSS materials for researchers who prefer to use highly-optimized, ready-to-use formulations directly in the application. These materials can be readily deposited via a variety of methods including spin coating, drop casting as well as inkjet printing.
"This agreement is a strategic step forward for both companies, as it will allow the addition of these key performance products to the comprehensive and growing Organic and Printed Electronics portfolio offered by Aldrich Materials Science,” commented Dr. Frank Louwet, Orgacon Business Manager at Agfa. He further noted, “The availability of these materials in R&D quantities provides researchers worldwide with resources to accelerate application development and commercialization of Orgacon™ in the emerging fields of printed electronics, OPV and OLED lighting."
The collaboration between Aldrich Materials Science and Agfa offers researchers worldwide a continuous supply of these PEDOT:PSS materials from research through development and manufacturing, with Aldrich Materials Science handling all global research scale distribution and Agfa covering larger scale commercial opportunities.
“We are pleased to offer these high-performance, conductive polymers,” noted Kaushik Patel, Ph.D., Global Product Manager at Aldrich Materials Science, adding, “This agreement serves to further enhance the mission of Aldrich Materials Science as a key materials partner offering valuable research solutions in the powerful and potentially transformative fields of organic and printed electronics.”
The products distributed via this collaboration are listed in Aldrich Materials Science’s technical publication, Material Matters™, Volume 6, No. 1, and online at sigma-aldrich.com/conductingpoly.
Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "plan to", "can enable", " can be", “will allow,” “will provide,” "distinct advantages,” "enhance,” or similar expressions, or by expressed or implied discussions regarding potential future revenues from the Orgacon products described herein. You should not place undue reliance on these statements. There can be no guarantee that the Orgacon products described in this release will meet the demands of the marketplace. Nor can there be any guarantee that any of these products will achieve any particular levels of revenue in the future. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding these products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company’s assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich’s current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company committed to Enabling Science to Improve the Quality of Life. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,700 employees providing excellent service worldwide. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.
Aldrich and Sigma-Aldrich are registered trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.
About Agfa: The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops, manufactures and markets analog and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.
About Agfa Materials: OrgaconTM Electronic Materials is part of the Advanced Coatings & Chemicals division of Agfa Materials, a market leading low cost producer of film and related products. Agfa Materials serves Agfa Graphics and Agfa HealthCare, as well as third parties in the printing and the medical sector and plays a prominent role in industrial markets outside printing and healthcare, such as the printed circuit board industry, aerial photography, motion picture film and e-consumables (e.g. conductive polymers, identity & security systems). Agfa Materials is working to develop several new businesses using expertise and know-how in film making and coating processes, as well as by making targeted R&D investments. Materials currently under development include new customized foils, chemicals and services for various industrial applications, such as the graphic arts, photovoltaics, security, fuel cell and electronics industry. All materials are produced in Agfa's state-of-the art film manufacturing facilities. www.agfa.com/orgacon
OrgaconTM is the trade name for Agfa Materials’ conductive polymer product line.
Cytori Therapeutics Selects Switzerland for
European Sales Headquarters
Cytori Exchange Workshop and Seminar Series also Based in Zug
New York, March 30 - Cytori Therapeutics, a provider of innovative, regenerative medicine-based products directed toward serving unmet medical needs, has established its European, Middle East and Africa (EMEA) sales headquarters in Switzerland, reports Mario Brossi, North American Senior Advisor to Switzerland Trade and Investment Promotion. Located in Zug, the new headquarters will also serve as the base for the Cytori Exchange educational program held at participating clinics in the company's EMEA service area, Mr. Brossi said.
Eric Daniels, Managing Director of Cytori GmbH, said that staffing at the new facility will reach approximately six by year-end 2011 and will consist of transferred and local hires. "A key initiative is ramping up the Cytori Exchange series of live surgery seminars and workshops focused on regenerative medicine and aesthetics," he said. "Our goal is to extend this program globally from its EMEA origins."
Commenting on the Swiss location, Mr. Daniels said that it was selected for Cytori's EMEA headquarters after evaluating sites in the UK and the Netherlands. "Key site selection factors included a central location in Europe, a talented labor pool and the strong medical and biotechnology resources found in the Zug region," he said. Other factors include political stability, strong IP protection laws and an excellent lifestyle.
Mr. Brossi noted that Cytori's decision to locate in Switzerland adds to the country?s position as a center of medical technology. "The latest count shows some 1,400 companies as active in this sector, with 10,000 different product families," he said. "Implants lead the way in the fields of orthopedics, traumatology and dentistry. Almost 48,000 jobs are generated by the industry in Switzerland, accounting for roughly 10% of the European total."
Northwestern University Purchases NanoInk's NLP 2000 Desktop Nanofabrication System
NanoInk’s NanoFabrication Systems Division is pleased to announce that Northwestern University’s NIFTI Center purchased an NLP 2000 System to expand the multi-user facility’s range of nanolithography instruments. Specifically, the NLP 2000 will be used in patterning and controlled deposition of biomaterials, nanoparticles, and functional molecular and soft architecture. Such exquisitely controlled patterning and deposition of soft and hybrid surface architecture will be utilized for advancing many phenomena and proof-of-concept device designs for a wide range of applications including biotechnology, energy harvesting, conversion and storage. NanoInk’s NLP 2000 System is a desktop nanofabrication system that allows researchers to rapidly design and create custom engineered and functionalized surfaces on the micro and nanoscale, using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area.
Don't Miss NanoInk's NanoFabrication Systems Presentations in April
NanoInk’s NanoFabrication Systems Division is pleased to announce that it will exhibit and present at the Society of Manufacturing Engineers’ (SME) NanoManufacturing Conference, held on Tuesday, April 5 and Wednesday, April 6 at Drury Lane Conference Center in Oak Brook, Ill. Saju Nettikadan will give a presentation on the applications of tip-based lithography in nanomedicine on Tuesday, April 5, from 3:50 p.m. to 4:30 p.m. NanoInk will also exhibit at booth #207.
Additionally, NanoInk’s NanoFabrication Systems Division is pleased to announce that it will exhibit and present a poster at the Society for Biomaterials’ 2011 Meeting and Exposition, held on Wednesday, April 13 through Saturday, April 16 at Disney’s Contemporary Resort in Orlando, Fla. Dr. Ruby Lam will present a poster entitled “Biomolecules Immobilization on Microfabricated Functional Hydrogels,” that shows how functionalized hydrogels have been proven to be very useful in biomedical applications. NanoInk will also exhibit at booth #412.
Brochure: Motion Control Systems for
Non-Magnetic & Vacuum Applications
Auburn, MA, PI (Physik Instrumente) L.P. -- a leading manufacturer of precision motion-control and piezo nanopositioning products -- has released a new brochure on vacuum compatible and non-magnetic positioning systems.
The publication presents a comprehensive overview of PI's precision motion control products for extreme operating conditions that are essential for many of today’s leading edge applications in fields as diverse as:
semiconductor test & manufacturing, high energy physics, scanning electron microscopy (SEM), astronomy, aerospace and medical engineering.
The brochure features a variety of high-end piezoceramic stages, Hexapod-6 axis positioners and linear actuators. Classical motorized precision positioners as well as non-magnetic piezo-worm type motors and ultrasonic motors and positioners are discussed.
The vacuum / non-magnetic products brochure can be downloaded at:
http://www.piezo.ws/pdf/Vacuum_Positioners_Piezo_Systems_Hexapods.pdf
About PI
PI is a leading manufacturer of precision motion control equipment, piezo systems, piezo motors and actuators for photonics, bio-nanotechnology, medical engineering & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries, R&D / engineering on 3 continents and total staff of 500+ PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Australian Institute welcomes Vistec Electron Beam Technology
March 28th, 2011 - Melbourne, Australia / Watervliet, USA - Vistec Lithography, Inc. a leading supplier of Electron Beam Lithography systems is pleased to announce the delivery and successful installation of the EBPG5000pES Lithography system at the newly established Melbourne Centre for Nanofabrication (MCN) in Australia. The MCN will be performing research in the areas of nanostructures and a wide range of other applications also associated with the nearby Australian Synchrotron.
The MCN is a collaborative initiative between the Victorian and Federal Government, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Monash University, the University of Melbourne, LaTrobe University, Deakin University, the Royal Melbourne Institute of Technology and Swinburne University.
"Our institute benefits from one of the most powerful nano-technology instruments", said Doctor Abid Khan, Senior Research Strategist and former Director of the Monash Institute for Nanoscience and Manufacture. "This investment ensures that we remain at the cutting edge of nano-research throughout the next decade and in many respects, the facility is the doorway to further success for engineers and scientists nationwide."
The EBPG5000pES is based upon reliable and well-proven system architecture. Its 100kV electron-optics provides a spot size down to <2.2nm, which enables nano-lithography structures smaller than 8nm to be routinely generated. The system incorporates an interactive graphical user interface (GUI) that provides ease of use for diverse, multiuser, University type environments.
Due to these features and its high degree of flexibility and user-friendly interface, the EBPG Series is appreciated worldwide in leading Research Centres and Universities with more than 80 systems shipped.
The machine will help the MCN to develop new technologies. "We will be able to write and etch features on surfaces in an extremely small size. This technique is used for applications such micro-texturing of surfaces, manufacture of micro and nano-fluidic devices and x-ray optical elements," Dr. Khan said.
Rainer Schmid, General Manager at Vistec Lithography Inc., comments on the successful Customer Acceptance Test: "We are proud, that all tests have been carried out successfully in a very short time and we now can refer to our first EBPG system in Australia." Having received several EBPG orders within the past year, the latest evaluation clearly indicates that Vistec?s product family is the system of choice for the requirements of Universities and Research institutes. Schmid: "In the upcoming year we would like to continue our positive development and further strengthen our worldwide market position."
Electrically conducting materials and unique heated coatings at European Coatings and JEC Composites shows
FutureCarbon is going on show in a double pack from March 29 through 31 at European Coatings in Nuremberg and JEC Composites in Paris. Exhibits will include special electrically conducting adhesives plus high-flexibility heated coatings for leather and textiles. Also presented will be CarboShield, the innovation in screening against electromagnetic radiation, CarboGran, an extremely simply dispersed CNT granulate, and CarboCond, a 100% ATEX compliant coating, based on epoxy resin, to discharge electrostatic. Journalists and visitors can learn at first hand about the latest developments and products from FutureCarbon.
In CarboBond FutureCarbon has created adhesives of exceptional electrical conductivity – up to 100 O · cm – and with very good adhesion properties. The conductivity needed for a particular application is easily set through the composition, with possible uses for CarboBond extending from antistatic safeguards through to high conductivity.
Based on polyurethane comes the latest product from the Carbo e-Therm family. What is special about this variant – suitable for temperatures up to 100°C – is its extreme mechanical ruggedness. It can be bent and still maintains its functionality. The product will adhere excellently to the likes of real or artificial leather, textiles and rubber, and exhibits very good resistance to solvents and weather effects.
FutureCarbon looks forward to seeing you at booth N52 at the JEC Composites show in Paris and/or at booth 7A-133 of our sales partner CSC Jäkle Chemie in hall 7A at the European Coatings show in Nuremberg. If you would like to spend more time talking to us about something of interest, you can arrange a time and date in advance: phone +49 (921) 507388-40 or e-mail sales@future-carbon.de.
PI to Invest $13 Million for Extension of Piezo Ceramics Factory
Lederhose, Germany, March 16 – Motion control specialist PI (Physik Instrumente) and piezo ceramics specialist PI Ceramic are planning to invest approximately $13 million for the third extension of their piezo ceramics factory and R&D center in Thuringia over the next three years. At the ground breaking ceremony Dr. Karl Spanner, CEO of Physik Instrumente, mentioned that even after adding 50 employees in 2010 at PI Ceramic, the company was getting close to its output capacity.
Since PI Ceramic owns enough land for an expansion, it was an easy decision was easy to move forward with the additional building. For 2011 the company is expected to hire another 20 to 30 people to keep up with the global demand for its high quality piezo ceramic components and subassemblies.
About PI Ceramic
PI Ceramic is the piezo ceramic division of Physik Instrumente (PI) -- the global leader of ultra-high-precision piezo motion control systems. PI Ceramic provides world-class piezo electric components and sub-assemblies for sensors, transducers, linear motors and precision actuators. Customers for the high-end piezo products come from all important high-tech markets such as life sciences, medical instrumentation, semiconductors , aerospace engineering, astronomy, high-energy physics, industrial automation and telecommunications.
PI has subsidiaries in 8 countries, R&D and manufacturing on 3 continents and employs approximately 600 people worldwide.
More on PI Ceramic at http://www.piceramic.com
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
6-Axis Hexapod Parallel Positioner for Small Vacuum Chambers
Auburn, MA, PI (Physik Instrumente) L.P. – a leading manufacturer of precision parallel kinematics motion control systems — has released a new miniature hexapod for vacuum applications. A non-vacuum version is also available.
The new M-811.STV miniature vacuum-compatible hexapod measures only 130 mm in diameter and 115 mm in height, yet provides precision motion in all six degrees of freedom.
Versatile, for Small Vacuum Chambers
Because of its small size, the M-811.STV is easily integrated into vacuum chambers. Its versatility and ease of use – the user can randomly set the center of rotation by a simple software command – highly facilitate operations in vacuum.
Features & Advantages
- Small but High Load Capacity: 11 lb (5 kg)
- High Precision: Actuator Resolution 0.04µm, Repeatability : ±0.5µm
- Versatile Motion: 6 Degrees of Freedom + Randomized Center of Rotation
- Velocity to 10 mm/sec
- XYZ-Travel: 35/35/13mm; Rotations: XYZ: 20°/20°/40°
- Digital Controller and Software Included
More Information: http://www.hexapods.net/vacuum-comp_hexapods.php
Software, Programming and Controller
Like all PI parallel kinematic Hexapod positioners, the miniature vacuum Hexapod comes bundled with software and a highly specialized digital controller with high-speed Ethernet connectivity. Programming and commanding the Hexapod is simple and straight-forward, as all positions are conveniently given in Cartesian coordinates (XYZ, Theta X, Theta Y, Theta Z).
Parallel Kinematics vs Conventional Serial Kinematics
Parallel-kinematics positioning systems have several advantages over conventional stacked multi-axis positioners. All six actuators directly affect one common platform, significantly reducing mass and inertia. Moreover, there is no accumulation of the lateral and angular runout errors of the individual axes. Unlike rotation stages and goniometers which come with a fixed center of rotation, the PI Hexapod concept lets the user set and change the pivot any time via software.
Hexapod Applications, Range
Today, hexapod applications are found in all technology fields: high-energy physics, medical engineering, X-ray microscopy, photonics alignment, semiconductor test & metrology, astronomy, precision machining, aeronautics, etc. PI is the leading manufacturer of precision micropositioning and nanopositioning hexapods. The company introduced its first hexapod 2 decades ago for a precision alignment system in an astronomical telescope and provides a large variety of different models with load capacity from 2 kg to more than 2,000 kg.
About PI
PI is a leading manufacturer of precision motion control equipment, piezo systems, piezo motors and actuators for photonics, bio-nanotechnology, medical engineering & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries, R&D / engineering on 3 continents and total staff of 500+ PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Nanostart-held ItN Nanovation completes
major water project in Saudi Arabia
Frankfurt / Saarbrücken – March 16, 2011 – ItN Nanovation AG (FSE: I7N), a portfolio company of Nanostart AG, has successfully completed another major project in Saudi Arabia using its CFM Systems® nanoceramic-based filtration system for water purification. In addition to the incremental revenue impact of roughly EUR 0.8 million, the project is of great significance because it proves the economic and technical superiority of the company’s unique flat filter membrane technology in real day-to-day operation. Results have surpassed the customer’s already high expectations.
The CFM Systems®filter units are used to pretreat water from deep wells so that it can be subsequently purified into clean drinking water using a reverse osmosis process. Tests have shown that prefiltration with CFM Systems® provides significant advantages over conventional polymer-based hollow fiber membranes and sand-based filtration, even at high temperatures and high iron and manganese concentrations in the water being treated. The CFM Systems® filter units also last considerably longer than conventional polymer membranes for prefiltration. In addition, their use extends the operating life of the downstream reverse osmosis membranes and ultimately serves to improve the quality of drinking water. A significant additional advantage is that drinking water throughput is increased by some 20 percent. This is of great importance because of the relatively high cost of reverse osmosis plants for water purification.
Because of its very limited supply of well water, and the practical issues at present of meeting its water needs from alternative sources, the Kingdom of Saudi Arabia places great importance on making the most efficient possible use of its groundwater resources. The country currently treats some one million cubic meters of drinking water each year using filtration technology. The demand for high-performance solutions is thus enormous. ItN Nanovation is, together with its Saudi partners, playing an active role in helping to meet this growing demand. Of particular commercial interest is the newly developed market for replacing aging sand-based filters with the more efficient CFM Systems®, which presents significant new revenue potential.
About Nanostart:
Nanostart AG (OTCQX: NASRY), headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About ItN Nanovation:
ItN Nanovation AG, founded in 2000, is one of the leading nanotechnology companies in the world, developing innovative ceramic products, such as filtration systems and coatings, for large industrial customers. The nanoscale powder needed for those products is manufactured by the company itself. The filtration products from ItN Nanovation can be used for drinking water purification, waste water treatment, as beverage filters and for the separation of oil and water. Ceramic coatings based on nanotechnology are used in a variety of ways as protective and catalytic coatings in various industries: from baking ovens to aluminum foundries to coal-fired power plants. The company's success is founded on an extensive product portfolio, combined with comprehensive development and application know-how. Rurther information about the company can be found at www.itn-nanovation.de.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the Canada, Australia or Japan.
APEIRON ACQUIRES OPTION TO LICENSE RIGHTS TO NOVEL ONCOLOGY COMPOUNDS FROM CLEVELAND CLINIC
Vienna (Austria)/Cleveland (USA), 15 March 2011 - APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents. This transaction follows in the wake of successful in-licensing deals that Apeiron completed in the last six months.
Apeiron Biologics AG, Vienna (Austria) and Cleveland Clinic Foundation, Cleveland (USA), have entered into a set of agreements setting the framework for a collaboration on novel anti-cancer compounds currently in development at Cleveland Clinic. The collaboration includes an option to Apeiron to enter into a worldwide, exclusive license agreement with the Clinic relating to the compounds, and an Apeiron sponsored research agreement with the Clinic relating to these compounds and approach.
The compounds, tyrosine phosphatase inhibitors (TPI), have been designed to inhibit SHP-1, a protein tyrosine phosphatase, which is a key negative regulator of immune cell activation. Inhibition of SHP-1 leads to activation of the immune system to combat cancer.
Commenting on the agreements, Hans Loibner, CEO of Apeiron, said: "This is a great collaboration for Apeiron. We regard the compounds developed at Cleveland Clinic as an attractive opportunity since they are designed to activate the patient's own immune system." He added: "Cleveland Clinic is a leading R&D institution and one of the top hospitals in the US."
"We have been encouraged by the developments we have seen in regards to these novel compounds, and we hope these therapeutics will one day benefit patients," said Chris Coburn, Executive Director of Cleveland Clinic Innovations.
No financial details are disclosed.
About Apeiron (March 2011):
Apeiron Biologics AG is a privately financed Biotech company based in Vienna. Following a licensing deal with GSK in 2010 relating to project APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2), Apeiron expanded its project portfolio with a focus on biologic / immunologic therapy of cancer and related conditions. Building on an existing range of innovative in-house projects, Apeiron acquired exclusive rights to hu14.18-IL2 (APN301), a Phase II antibody-based biologic for treatment of neuroblastoma, melanoma and other cancers, and recombinant human Superoxide Dismutase (APN201), a naturally occurring enzyme for treatment of cancer treatment-related side-effects, also in Phase II.
Crossing Automation Extends 200 mm Semiconductor Fab Life; New Line of SMIF Loadports Drive Performance and Cleanliness
Shanghai, China—March 15, 2011— Today at industry tradeshow SEMICON China, Crossing Automation, Inc. (www.crossinginc.com), a leading supplier of efficient, cost-effective automation solutions and engineering services, introduced a new line of adaptive standard mechanical interface (SMIF) loadport (LPT) solutions for open cassette 200 mm process, metrology and inspection tools. The new adaptive SMIF-LPT solutions offer cost-effective upgrades of non-SMIF tools to SMIF, thereby enabling the conversion of existing 200 mm facilities for semiconductor manufacturing at technology nodes below 180 nm.
“Given the compelling capital investment cost advantage for 200 mm equipment, many manufacturers are looking to take advantage of SMIF for their tool sets,” said May Su, vice president of product marketing for Crossing Automation. “These new options allow SMIF to be added to open cassette tools and bring the benefits of SMIF to a broad array of 200 mm equipment.”
The three new configurations are designed to address original equipment manufacturer (OEM) tool configurations with difficult cassette landing stages. The new SMIF-LPT Tr is a rotational head designed for non-perpendicular cassette placement. The SMIF-LPT Tx offers a lateral cassette motion to address narrow cassette-to-cassette spacing, while the SMIF-LPT Ty has an offset arm to accommodate narrow chamber openings. These new features can also be combined or upgraded on an existing SMIF-LPT. All of the adaptive SMIF solutions deliver improved particle performance to achieve Class 1 particle performance in a Class 100 clean room environment.
“This new line of products is truly reflective of our goal to continually deliver added value to our customers and markets served. With over 12,000 units shipped, Crossing Automation is the demonstrated leader in delivering proven loadport technology and its associated value to semiconductor manufacturers worldwide,” added Su.
To learn more about Crossing Automation’s new adaptive SMIF products and full range of automation solutions please visit SEMICON China, Booth 1553, Hall W-1 in the Shanghai New International Expo Centre in Shanghai, China from March 15 to 17, 2011. Alternatively, please visit http://www.crossinginc.com.
AFFiRiS AG: ALZHEIMER'S VACCINATION SHOWS PROMISING RESULTS
Vienna (Austria), 11th March 2011 - AFFiRiS' Alzheimer's vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.
AFFiRiS AG previously announced that their Alzheimer vaccine candidate AD02 met the primary endpoints of phase I clinical testing by demonstrating safety and tolerability. 24 subjects were vaccinated, 12 received the vaccine with adjuvant and 12 without.
The recently completed analysis from this study of secondary clinical endpoints of AD02 based treatment - regarding cognitive performance of the subjects, body weight development and vaccine induced immune responses - suggests evidence for potential disease modifying activity of this vaccine candidate.
CEO and co-founder of AFFiRiS, Dr. Walter Schmidt, comments: "We really observed some positive results from this phase I trial. Most important was the stabilisation of the cognitive capabilities of 9 out of 12 subjects treated with the adjuvanted AD02 formulation over the complete observation period of 18 months. During the clinical trial all adverse events were mild to moderate in nature, like pain at the injection site and itching."
COGNITIVE PERFORMANCE BETTER THAN EXPECTED
These Phase I results indicated a surprisingly robust and persistent stabilisation of the cognitive functions. The subjects' cognitive decline did not occur as expected from the natural course of disease. Furthermore, a boost vaccination was applied and the positive trend was prolonged.
The obtained disease stabilisations were related to the subjects' MMSE(1) values at study entry. It became evident that patients with a MMSE score of 20 and above were found to have stable scores at the end of the study, while this could not be observed for the study participants with an entry score below 20.
These results were further supported by findings from the development of the body weight of the subjects. This is a potential biomarker(2)(3) that has hardly been considered in clinical studies in the past. Typically, Alzheimer patients lose weight during the course of their disease. Their sense of taste might be disturbed or they might just simply forget to eat. In contrast, patients treated with adjuvanted AD02 experienced a stabilisation of their body weight.
Finally, the analysis of the immunological data regarding antibody titers induced upon vaccination further supported the possible correlation between AD02 based vaccination and the observed stabilisation of cognitive functions.
Dr. Walter Schmidt adds: "It is important to keep in mind that the promising Phase I data with AD02 have been observed in a relatively small cohort of 24 subjects only. This is a normal number of subjects to be treated in phase I studies to demonstrate safety and tolerability; however, this number is typically too small to draw significant conclusions based on broad statistical significance. We are aware of this situation and we are cautious to make sure not to overestimate or overinterpret our positive findings. Our actively ongoing phase II study is designed to further investigate and reproduce the experienced observed positive trends with a cohort of several hundred Alzheimer subjects to meet the respective clinical and statistical significance."
PHASE II STUDY STARTED
Since the end of last year, vaccine candidate AD02 is in clinical phase II testing designed to evaluate the efficacy in Alzheimer patients. The study design already takes into account the indicative results of the phase I study. The study is currently in the recruitment phase with 30 study centers in Austria, Germany, France, Croatia and Slovakia (Czech Republic in preparation) being involved. A total of 420 patients will be included:http://klinische-studien-vienna.info
Preliminary results regarding this study are expected to be available by the end of 2012.
Co-founder and CSO of AFFiRiS, Dr. Frank Mattner, comments on the successful development of the Alzheimer vaccine programme: "We are very delighted about the positive results of AD02 in its first clinical testing. This vaccine candidate was delivered by our AFFITOME®-platform technology. However, due to the relative small number of patients, we are aware of the fact that we should handle these data with care. Nevertheless, do we see them as first indicators implying that product candidates based on our AFFITOME®-platform technology are capable of yielding proof of concept in humans. Based on the existing clinical data, we gathered valuable knowledge for our vaccine candidates in other indications including Parkinson's disease and atherosclerosis which were also derived from our AFFITOME®-platform technology. This knowledge will now be included into the design of the respective clinical phase I trials which are scheduled to start later this year."
The collaboration is based on a license and option agreement announced in October 2008. The deal has a total potential value of up to EUR 430 million plus royalties. EUR 36 million have already been paid within the framework of this collaboration. Recently, the company announced that Alzheimer vaccination development partner GlaxoSmithKline Biologicals exercised its option on alternative vaccine candidates including AD03. This triggered a payment of EUR 2.5 million and opens the therapy options via targeting modified beta-amyloid variants.
(1) The Mini-Mental State Examination (MMSE) Test is a standard test to determine the disease severity of Alzheimer patients by applying a measurement scale from 0-30. The smaller the determined value, the more progressed is the state of the disease.
(2) Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. M. Grundman et al., Neurology, 1996; 46: 1585 1591
(3) Weight loss in people with Alzheimer's disease: a prospective population based analysis. D. Cronin-Stubbs, British Medical Journal 1997; 314: 178
About AFFiRiS AG (date March 2011):
On the basis of the company's own patent positions AFFiRiS develops tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, Hypertension and several other conditions with unmet medical need and attractive market sizes. Alzheimer's is the current lead indication. For the Alzheimer's vaccine programme, a license and option agreement with GlaxoSmithKline was closed in October 2008, triggering an upfront payment of EUR 22.5 million. The contract envisages (milestone-dependent) payments of up to EUR 430 million. A first milestone payment of EUR 10 million was made in October 2009 followed by EUR 3.5 million as announced recently. AFFiRiS currently employs 80 highly-qualified staff at the Campus Vienna Biocenter in Vienna, Austria (www.affiris.com)
Nanostart subsidiary MagForce Nanotechnologies AG Hires Key Members of Sales and Marketing Team
Berlin / Frankfurt – March 10, 2011 – Nanostart subsidiary MagForce Nanotechnologies AG (FSE:MF6), a leader in nanomedicine-based cancer treatment, announced today that its sales and marketing team for Germany is in place and commercialization activities are set to begin. With a Commercial Director and four key account managers in place, MagForce will now seek to make its NanoTherm therapy available in clinics across Germany. The company has received EU approval for its medical devices, which use magnetic nanoparticles for the treatment of brain tumors. Through the application of an alternating magnetic field, the nanoparticles are activated, and heat is produced from within the tumor.
Solveig Salomon joins the company as European Commercial Director and will lead the commercialization team. She has over twenty years of experience in the pharmaceutical industry, including sales and marketing experience in the area of oncology. Her professional experience includes leading positions held at Sandoz International GmbH, Amgen GmbH, Janssen-Cilag GmbH, and Grünenthal GmbH.
“I am excited to welcome Solveig Salomon and the key account managers to MagForce. The start of commercialization is a significant milestone and represents a further success in transforming MagForce from a research-led enterprise to a commercially operating company,” said Dr. Peter Heinrich, CEO of MagForce. “Launching a new technology requires experienced individuals with a proven track record and an enthusiasm for innovation. NanoTherm therapy offers an additional treatment option for patients suffering from malignant brain cancer, and I am confident that our team has the commitment and expertise to successfully bring this novel therapy to the European market. Perspective patients are currently being evaluated, and we expect the first patient to begin treatment in the coming weeks.”
Christina-Beata Baumgarten, who will be responsible for Northeast Germany, joins MagForce with twelve years of medical device sales experience in the area of interdisciplinary endoscopic ultrasound systems, including positions at Toshiba Medical Systems GmbH Germany, Fujion Europe GmbH, and Philips Healthcare.
Michael Blau, who will be responsible for Northwest Germany, has five years of pharmaceutical sales and marketing experience in the areas of neurology and immunology, including positions held at Biogen Idec GmbH and Careforce-Marketing & Sales Service GmbH.
Jörg Ivanschitz, who will be responsible for Southwest Germany, joins MagForce following fourteen years of pharmaceutical experience including his position as a hospital representative at Essex Pharma GmbH focusing on oncology, infectiology, and hepatology.
Karin Potzies, who will be responsible for Southern Germany, joins with 12 years of pharmaceutical experience including positions at Sanofi-Aventis in the areas of uro-oncology and radiology along with cardiovascular and nuclear medicine. In addition she was at Brystol-Myers Squibb in the area of neurology.
About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de
About MagForce Nanotechnologies:
MagForce Nanotechnologies AG is a leader in the area of nanotechnology-based cancer treatment. The proprietary procedure which it has developed, Nano-Cancer® therapy, enables the targeted treatment of solid tumors through the intratumoral release of heat from magnetic nanoparticles. Its products used in the therapy, NanoTherm® and NanoActivator®, have received EU-wide regulatory approval as medical devices for the treatment of brain tumors.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Catalog: Planar Piezo Scanners for AFM, Scanning Probe Microscopes
The Piezo Scanner Catalog can be downloaded at:
http://www.piezo.ws/pdf/Catalog_AFM_Planar_Piezo_Stage_Scanner_C.pdf
PI (Physik Instrumente) L.P. -- a leading manufacturer of piezo nanopositioning systems and scanners for microscopy, bio-medical and nanotechnology applications -- has released a new catalog on planar piezo scanners for Atomic Force and Scanning Probe Microscopes.
The new catalog covers a variety of novel closed-loop planar piezo scanners, and controllers with advanced digital features for higher scanning rates, improved linearity and responsiveness.
Compared to conventional piezo tube scanners, the low-bow, flexure guided piezo stages are run in closed-loop mode and provide significantly lower out of plane motion (flatness) and better linearity. A special stage designed with a new lead-free piezo material allows resolution down to 20 picometers and less than 1 nanometer hysteresis.
Flexure stages with travel ranges to 1800 microns are available and many different configurations from single axis to 6-axis systems are offered.
For high stability, pre-positioning, and as a stable basis for the fast piezo scanners, self-locking ultrasonic motor stages with long travel ranges to 200 mm are also available.
About PI
PI is a leading manufacturer of piezo stages, piezo linear motors and precision motion-control equipment for microscopy, photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 40 years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+. PI USA designs and manufactures piezo products at the company’s US headquarters in Auburn, MA.
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Nanion’s Patchliner exceptionally well received by academic ion channel core facilities
Munich, Germany, March 4th, 2011 - The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to academic institutions intended for advanced ion channel research and screening projects, and are soon to be followed by the first SyncroPatch 96 shipment and installation.
The Patchliner, a highly versatile patch clamp screening platform for increased throughput, has been on the market since 2006. Patchliner customers are evenly distributed over pharmaceutical industry, contract research organizations and academic institutions because of the flexibility and increased throughput of the platform.
Again highlighted by the recent sales, the Patchliner is a much appreciated tool for academic research, mainly because of the high data quality obtained with the platform, and its vast experimental freedom.
Together with three additional Principal Investigators, Dr. Todd Scheuer and Dr. William Catterall invested in both the Patchliner and the Port-a-Patch to form a core facility for ion channel screening and research at the University of Washington, Seattle, USA.
Dr. Todd Scheuer, Research Professor at the Department of Pharmacology, University of Washington, Seattle, says:
“We invested in the Patchliner because of its great experimental flexibility. The diversity of our research projects requires a platform capable of high performance with a multitude of ion channels and cells, as well as experimental possibilities such as action potential- or primary cell recordings.”
In the southern hemisphere, Dr. Steven Petrou, Associate Director at the Florey Neuroscience Institute, and Associate Professor at the Centre for Neuroscience, The University of Melbourne, Australia, invested in multiple Patchliners for the ion channel core facility there.
Dr. Steven Petrou, says:
“We recently bought several Patchliners to cover the needs of our neuroscience research projects and to establish an ion channel core facility for the wider ion channel research community. Indeed, the Patchliner has unique experimental features including temperature control, internal perfusion and fast solution exchange. This in combination with supporting giga-Ohm seals and having a throughput corresponding to 100 dose responses per day convinced us that Patchliner will be of great use in our current, but also future research projects.”
Dr. Niels Fertig, CEO of Nanion says:
“We are of course very pleased with this year’s sales trend, which reflects the customers’ appreciation of our high fidelity patch clamp platform and the strong scientific background of our support team. As a consequence, we have expanded the US-office to match the demand for demonstration and to cover possible assay support. Further, the installation of another six Patchliners in top-notch academic laboratories confirms its strength and unparalleled experimental features.”
About Nanion:
Nanion Technologies GmbH is a German Private Limited Company and was founded in 2002 as a spin-off from the Center for Nanoscience (CeNS) of the University of Munich. Nanion’s team has developed and globally established two highly successful automated patch clamp instruments as enabling tools for sophisticated and high throughput applications for ion channel research and drug discovery. Nanion's instruments use planar patch clamp chips which replace the traditional glass pipette used in the technique of patch clamping. Nanion was nominated in 2007 for Germany's most prestigious innovation award the Deutscher Zukunftspreis (German Future Prize, Federal President's Award for Technology and Innovation).
National Science Center of Greece selects
nano-research technology from Vistec
Vistec Lithography Inc. (http://www.vistec-semi.com/), a leading supplier of electron-beam lithography systems, received a major order from Greece. The National Center for Scientific Research (NCSR Demokritos) has bought an EBPG5000plusES system for one of its associated Institutes. Installed at the Institute of Microelectronics (IMEL), the system will be the first 100kV lithography system in Greece and assure multidisciplinary cutting-edge nano-research.
IMEL is one of Europe?s leading Research Institutes in the field of Silicon technologies that performs multidisciplinary research. Professor Dimitris Tsoukalas, Director of IMEL, explains: "Due to the different fields of research carried out at the IMEL we had very special demands for the new patterning system. It not only had to be capable of a multi user environment but also had to provide high class and efficient nano-lithography in all
areas of our activities spanning from nanoelectronic devices to sensors and MEMS/NEMS. The EBPG5000plusES is the perfect match to these requirements and it will allow IMEL to further improve its position at the nanotechnology forefront."
The Vistec EBPG5000plusES is a high-performance lithography tool based on reliable and well-proven system architecture. Due to its electron-optical column the system can expose various substrate types. The system provides a spot size down to <2.2nm, which allows the routinely generation of nano-dimensional features below 8nm. The system incorporates an interactive graphical user interface (GUI) that provides ease of use for diverse "multi-user environments".
Due to its expertise and infrastructure IMEL is the key institution for top-down nano-research in Greece. Rainer Schmid, General Manager at Vistec Lithography comments the order: "We are honoured to have received an order from an institute with such a reputation. The EBPG5000plusES will be the first 100kV system in Greece. That will not only enable the institute to maintain its leading role in national nano-research but also to participate in European research projects, networks of excellence, and technology
platforms at the highest level."
The Spain Area awarded at nano tech 2011 nanotechnology
exhibition (Tokyo, Japan) Madrid
(Spain): March 01, 2011 The Phantoms Foundation and the Spanish Institute for Foreign Trade (ICEX), in cooperation with the Embassy of Spain (Economic and Commercial Office) in Tokyo brought a nanoscience and nanotechnology Spain Area at nano tech 2011, world's largest annual international nanotechnology exhibition, held from February 16 to 18, 2011 at Tokyo Big Sight (Tokyo,
- The Spain Area was distinguished with the “Special Award”. The reason of the award, as mentioned during the nanotech award 2011 ceremony:
- twelve organizations, including seven private companies and national research institutions, exhibiting in the area
- four organizations already have offices for distribution,
- state of the art of nanotechnology development in Spain, actively promoted for commercialization in Japan.
At the Spain Area, nanoscience and nanotechnology companies, science and technology research centers and industry associations presented innovative technologies uses, advances in nanotechnology and projects from Spain under “Spanish Nanoscience and Technological Offer” in order to better integrate the Spanish Science-Technology-Company-Society in Japan and the Global Market.
The Spain Area promoted the “Spanish Nanoscience and Technological Offer", representing the scientific, technological and innovative agents of the country as a whole, to foster relationships with other nano tech 2011 participants, to promote country culture of innovation, to better integrate the Spanish “Science-Technology-Company-Society” system in Japan, to generate and to develop scientific and technological knowledge, to improve competitiveness and to contribute to the economic and social development of Spain.
The Spanish participation grouped Companies and Research Centres providing an outlook of the most innovative projects and products in various fields of Nanoscience & Nanotechnology.
Participating companies/institutions within the Spain Area:
- Phantoms Foundation - www.phantomsnet.net (Coordinator)/ICEX - www.icex.es
- AITEX - www.aitex.es AlphaSIP - www.alphasip.es
- CIBER-BBN - www.ciber-bbn.es
- CSIC -SPANISH NATIONAL RESEARCH COUNCIL - www.csic.es
- GRAnPH Nanotech - www.granphnanotech.com
- Institute of Nanoscience of Aragon (INA) - http://ina.unizar.es/index.php
- Nanobiomatters Industries S.L. - www.nanobiomatters.com
- NANOGAP SUB-NM-POWDER S.A. - www.nanogap.es
- Neoker,S.L. - www.neoker.org
- TECNAN / L´urederra Technological Centre - www.tecnan-nanomat.es
España Technology for life: http://www.spainbusiness.com
Spain Business (Japan): http://www.spainbusiness.jp
Nano tech 2011: http://www.nanotechexpo.jp/en, http://www.phantomsnet.net/Nanotech2011/
Konarka's Alessandro Zedda to Speak on Organic Photovoltaic (OPV) Technology at PV EXPO 2011 – March 3, 2011 – Tokyo, Japan
Lowell, Mass. - Feb. 28, 2011 - Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to energy, today announced that Alessandro Zedda, vice president of materials development at Konarka, is speaking at the Exhibitors' Technology Seminar at PV EXPO 2011 on Thursday, March 3, 2011 in Tokyo, Japan. PV EXPO is one of seven exhibitions at Japan Renewable Energy Week, the world's largest renewable energy event. Konarka will also be exhibiting at PV EXPO, Tuesday, March 2 – Thursday, March 4, booth # E33-27.
WHAT: Konarka OPV Presentation at Exhibitors' Technology Seminar, PV EXPO 2011
WHO: Alessandro Zedda, Vice President of Materials Development, Konarka Technologies
WHEN: Thursday, March 3, 2011, 3:00 p.m. to 4:00 p.m.
WHERE: Venue C, Inside East Hall 4, Tokyo Big Sight, Japan
Alessandro will be presenting an introduction to OPV technology, how it works and some applications that are unique to OPV. Alessandro leads Konarka's materials and device research as well as partnerships to develop higher performing OPV modules. Prior to Konarka, he worked for a decade in various roles at Ciba Basel, a global producer of high-value effects for a wide range of products and now part of BASF. He started his career as a scientist at the Advanced Fluorine Chemistry Research at Ausimont in Milan, Italy and holds 30 patents and publications worldwide.
A world leader in OPV technology, Konarka has achieved a record breaking 8.3% efficiency as certified by the National Energy Renewable Laboratory (NREL), the highest performance recorded by NREL for an organic photovoltaic single junction solar cell. The company's organic photovoltaic film is lightweight, flexible and versatile, offering various large and small scale applications including curtain walls, components within windows and other BIVP and BAPV categories.
At PV EXPO 2011, 900 photovoltaic specialized exhibitors from over 60 countries and regions will gather to demonstrate cutting-edge technologies related to the manufacturing of solar cells. For more information on the event, visit: http://www.pvexpo.jp/en/
About Konarka Technologies, Inc.
Konarka Technologies develops and manufactures solar plastic films that convert light to energy – anywhere. As the leading developer of polymer-based, organic photovoltaic (OPV) technology that provides a source of renewable power in a variety of form factors, Konarka has a broad portfolio of patents, technology licenses and an accomplished technical, scientific and manufacturing team. Manufactured at low cost and low energy consumption, the company's Konarka Power Plastic® technology is lightweight, flexible, scalable and adaptable for use in a variety of commercial, industrial, government and consumer applications. Konarka Technologies is headquartered in Lowell, Mass., U.S.A. and has a full scale production manufacturing facility in New Bedford, Mass. U.S.A., with European headquarters in Nurnberg, Germany, business development offices in Asia and a research and development facility in Austria. For additional information, visit http://www.konarka.com
AFFIRIS ANNOUNCES AN EXTENSION OF ITS EXISTING ALZHEIMER´S DISEASE VACCINE DEVELOPMENT COLLABORATION WITH GLAXOSMITHKLINE
Vienna (Austria), 28 February 2011 - AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
AFFiRiS announced today the successful completion of preclinical work packages and related payments of EUR 3.5 million from GSK to AFFiRiS. The two companies have been working together for more than two years on an active vaccination approach for the treatment of Alzheimer´s disease. The collaboration is based on a license and option agreement announced in October 2008. The deal has a total potential value of up to EUR 430 million plus royalties. EUR 36 million have already been paid within the framework of this collaboration.
The co-founder and CEO of AFFiRiS, Dr. Walter Schmidt comments: "Our Alzheimer's vaccination programme is progressing very positively. Two vaccine candidates, AD01 and AD02, demonstrated satisfactory safety and tolerability profiles in phase I clinical trials and AD02 has already been moved forward into clinical phase II for efficacy testing. Now we have opened the pathway to alternative vaccine candidates such as AD03 and we are delighted that GSK awarded this achievement by exercising its related option. We welcome the opportunity to extend and further strengthen the collaboration between the two companies."
All three of AFFiRiS´s Alzheimer's vaccine candidates are designed to induce antibodies targeting the beta-amyloid peptide that is believed to contribute significantly to the pathology of Alzheimer's. With AD03, the third of the candidates, AFFiRiS additionally targets modified beta-amyloid peptides with their putatively different toxicity profiles in humans.
On top of its diversified activities in the Alzheimer´s field, AFFiRiS possesses a strong product pipeline including vaccine canditates for the treatment of Parkinson, Atherosclerosis, Hypertension and various other diseases. Remarkably, AFFiRiS recently announced that its preclinical program for the development of a Parkinson vaccine has been awarded with substantial funding by the US-based Michael J. Fox Foundation.
PIPELINE WITH CASH-FLOW
The co-founder and CSO of AFFiRiS Dr. Frank Mattner comments on this early and successful establishment of the strong development pipeline: "Many biotech companies strive to establish a pipeline in order to minimise risk. Sometimes their endeavours fail due to technical reasons sometimes because of financial constraints. Our AFFITOME®-Technology allows us to avoid technical challenges that are relevant to our approach. This technology also delivers a whole pool of product candidates for each of our targets rather than a single entity thereby significantly increasing our likelihood of success."
About AFFiRiS AG (date February 2011):
On the basis of the company's own patent positions AFFiRiS develops tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, Hypertension and several other conditions with unmet medical need and attractive market sizes. Alzheimer's is the current lead indication. For the Alzheimer's vaccine program, a license and option agreement with GlaxoSmithKline was closed in October 2008, triggering an upfront payment of EUR 22.5 million. The contract envisages (milestone-dependent) payments of up to EUR 430 million. A first milestone payment of EUR 10 million was made in October 2009 followed by Euro 3.5 million as announced today. AFFiRiS currently employs 80 highly-qualified staff at the Campus Vienna Biocenter in Vienna, Austria (www.affiris.com).
NanoBusiness Alliance Interview with Mihail Roco
Written by Vincent Caprio
February 20, 2011
This month, the NanoBusiness Alliance's Steve Waite talked to Mihail (”Mike”) Roco. Dr. Roco proposed the National Nanotechnology Initiative (NNI) on March 11, 1999, at the White House, and is a key architect of the NNI. He is Senior Advisor for Nanotechnology to the National Science Foundation (NSF), and the founding chair of the U.S. National Science and Technology Council’s Subcommittee on Nanoscale Science, Engineering and Technology (NSTC/NSET).
Dr. Roco has been an international leader of nanotechnology development and of converging new technologies and initiated the first U.S. federal government program that focused on nanoscale science and engineering at NSF in 1991. In 2007, he was recognized with the National Materials Advancement Award from the Federation of Materials Societies “as the individual most responsible for support and investment in nanotechnology by government, industry, and academia worldwide.”
In this interview, Mike notes that nanotechnology is recognized today along with information technology and biotechnology as a megatrend in science and engineering. He points out that nanotechnology has provided solutions for about half of the new projects on energy conversion, energy storage, and carbon encapsulation in the last decade. In the coming decade, Mike expects nanotech commercialization to become a powerful driver of innovation, job and wealth creation in the global economy.
The full interview is posted at:
ETH Zurich choose Vistec EBPG5200 for new Nanotechnology Center
Vistec Lithography, Inc., a leading provider of advanced electron-beam lithography equipment today announced that it received an order from the ETH Zurich (Swiss Federal Institute of Technology), a world-renowned research university, for one of its Vistec EBPG5200 systems. The Vistec EBPG5200 (http://www.vistec-semi.com/) will be installed in the new Nanotechnology Center, which is a unique, public private partnership between IBM Research - Zurich and ETH Zurich.
ETH Zurich will focus on exploratory research aiming at nanotechnology applications as MEMS/NEMS, nanowires, Carbon-based devices, functional materials, optical interconnects, photonics and directed self-assembly, just to indicate the most prominent. According to the evaluation team, the primary reason the Nanotechnology Center selected the Vistec system is the advanced technology capabilities it offers. "Our multiple research
applications require a high performance nano-patterning tool of superior flexibility, which is essential for extending our advanced R&D efforts", said the speaker of the evaluation team. "The Vistec EBPG5200 allows us to further expanding our ability to pursue both near-term and long-term projects."
The Vistec EBPG5200 is the latest version of the highly successive and field-proven EBPG electron-beam lithography tool series. The EBPG5200 system can be operated with 20, 50 and 100kV accelerating voltage and is equipped with a 50MHz pattern generator and full 20bit address technology. Thanks to further enhancements in resolution, noise reduction and beam stability, the Vistec EBPG5200 is set to routinely generate structures less than 8nm on varying substrates sizes from piece parts of a few millimetres to full patterning across a 200mm diameter. The system incorporates an interactive graphical user interface (GUI) that provides ease of use for diverse "multi user environments".
"This order from an excellent research university such as ETH Zurich is the result of our ongoing efforts to further enhance the performance of our electron-beam lithography systems," said Rainer Schmid, General Manager at Vistec Lithography, Inc. "We are always committed to our customers and their challenging research tasks."
FutureCarbon with electrically heated coating
for temperatures up to 500°C at nano tech 2011 show
Bayreuth/Germany, February 17.02.2011: FutureCarbon has developed a new variant of its Carbo e-Therm electrically heated coating — Carbo e-Therm UHT can be heated by low voltage to temperatures as high as 500°C. The company is presenting it for the first time to the international public at this year's nano tech show in Tokyo, Japan from 16 through 18 February.
FutureCarbon is again attending nano tech 2011, the world's biggest nanotechnology show. Included in its exhibits is the electrically heated coating Carbo e-Therm UHT, an innovation for heating solutions using temperatures up to 500°C. The big attraction with this high-temperature heating system is that the coating can be applied by the simplest techniques such as squeegeeing or brushing. A non-hazardous low voltage - 12 or 24 V for example - is enough to directly heat lab flasks, machine parts, vessels or samples without creating hot spots.
This heated coating shows the way to entirely new industrial applications calling for very high process temperatures.
FutureCarbon is exhibiting at booth E12 at the nano tech 2011 show, and looks forward to seeing you there. If you would like to spend more time talking to us about something of interest, you can arrange a time and date in advance: phone +49-(921)-507388-40 or e-mail sales@future-carbon.de.
About FutureCarbon
FutureCarbon specializes in the development and manufacture of carbon nanomaterials and their refinement to create what are called carbon super-composites, primary products for further industrial processing. Carbon super-composites are combinations of materials that unfold the special characteristics of carbon nanomaterials in the macroscopic world of real applications. All of our materials are manufactured on an industrial scale.
Nanostart AG invests in Singapore-based cleantech company MINT
Frankfurt / Singapore – February 17, 2011 – Nanostart AG, the leading nanotechnology venture capital company, has taken an investment position in Membrane Instruments and Technology (MINT) Pte Ltd, a cleantech company based in Singapore. MINT, founded in 2009 as a spin-off from the country’s renowned Nanyang Technological University, is a producer of next-generation technology for monitoring and controlling water quality in filtration-based water treatment plants. The core of the new technology lies in the proprietary, nanotech-based sensors developed by the company. These highly sensitive sensors automatically monitor the efficiency and proper functioning of filter membranes by continuously measuring key output parameters. The system from MINT thus enables the ongoing performance monitoring of water treatment plants in real time so that, in case of filter degradation or failure, corrective measures can be immediately introduced.
The investment was made by way of the Nanostart Singapore Early Stage Venture Fund, which is managed by Nanostart Asia, a 100% subsidiary of Nanostart AG. The fund now holds an 18% share in MINT.
Operators of water treatment plans are subject to stringent regulations which aim to ensure water quality standards. Modern water treatment systems are constructed of thousands of micro- and ultrafiltration membranes. If even just a few of these are not functioning properly, the quality of drinking water output can deteriorate quickly and significantly.
The fully automated sensor system from MINT enables the function of each individual filter membrane to be directly and continuously monitored in real time, marking an enormous step forward from conventional monitoring methods which involve manual sampling and laboratory tests. The new technology from MINT provides not only major savings in the cost and time associated with water treatment monitoring but also enables immediate reaction in case of malfunction. Until now, identifying and exchanging defective filter membranes has been an expensive and complicated process involving lengthy service disruptions. In contrast, the sensors from MINT enable these membranes to be identified and exchanged with unprecedented speed and ease. There are no other systems on the market today which enable real-time monitoring and control while offering such efficiency and cost effectiveness in water treatment as the new systems from MINT. Its proprietary nanotech-based sensor technology puts the company in a uniquely strong competitive position.
The global market for filtration membranes which MINT aims to serve is currently estimated at roughly USD 9 billion annually. The market specifically for water analysis and testing, currently estimated at some USD 500 million, is expected to grow at a rate of six to eight percent per year. This transaction marks the third investment position taken by the Nanostart Singapore Early Stage Venture Fund.
“The breakthrough technology from MINT has already proved itself in the first operating applications, and we see enormous market potential ahead,” said Andreas Kröll, managing director of Nanostart Asia. “We are delighted about this superb addition to our investment portfolio.”
“Nanostart is exactly the right partner for us,” added Prof. A.G. Fane, Chairman of the Board of MINT. “It brings extensive know-how in commercialization as well as a proven track record in cleantech. I am confident that this experience will be of significant benefit to MINT.”
MINT is the second Nanostart portfolio company to address the world’s increasingly problematic thirst for clean water. ItN Nanovation AG, the other of these two companies, in which Nanostart has held an investment position since 2005, has developed a patented technology for highly efficient and compact water filtration based on nanoceramics.
Over large areas of the planet, water is a scarce and valuable resource. Cities and entire nations face enormous challenges not only in efficiently using these limited resources but also in finding more affordable and reliable ways to produce clean drinking water. Developing countries, in particular, are investing enormous sums into water supply projects to create the infrastructure which their populations need. At the same time, standards for water quality are being raised in much of the world.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de
About MINT:
Membrane Instruments and Technology Pte. Ltd. (MINT) is a spin-off from the Nanyang Technological University (NTU) of Singapore, with the aim of becoming a leader in membrane instrumentation and optimization technology for the water treatment industry. Membrane processes are set to be the next standard for water and wastewater treatment. MINT designs and develops automated control systems which receive signals from nanotechnology-enabled sensors, predict the performance of the plant and implement the correct control strategies, resulting in significant cost savings. MINT’s flagship product has been validated by Singapore’s national water agency. For further information please visit www.mintmembranes.com
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the Canada, Australia or Japan.
OPTOELECTRONICS RESEARCH CENTRE AT UNIVERSITY OF
SOUTHAMPTON PURCHASES NANOINK’S DPN 5000 SYSTEM
The DPN 5000 enhances the Optoelectronics Research Centre’s world class nanoscale research in the areas of applied photonics and nanotechnology
CHICAGO – February 9, 2011 – NanoInk’s® NanoFabrication Systems Division is pleased to announce that the Optoelectronics Research Centre (ORC) at the University of Southampton, U.K., purchased a DPN® 5000 System to be used for the fabrication of nanostructured photonic metamaterials, nanophotonics and sensors. NanoInk’s DPN 5000 System is a full-featured, dedicatedn instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision.
With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling the tip movements during the writing process.
“NanoInk’s DPN 5000 system provides unique advantages in terms of materials deposition capability and scalability and we believe that many exciting research and commercial opportunities will develop from this technology,” said Dr. Kevin MacDonald, Senior Research Fellow at the ORC. “It will be particularly important in the development of our research on nanophotonics, metamaterials and optical sensors.”
“The DPN 5000 enhances the Optoelectronics Research Centre’s world class nanoscale research in the areas of applied photonics and nanotechnology. It has the ability to deliver unique capabilities in new areas of research, including nanobiology applications,” said Robert Marchmont, General Manager of Europe, the Middle East and Africa for NanoInk. “We look forward to being active collaboration partners with this internationally renowned centre.”
NanoInk’s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable setting. It provides the ability to design and create custom engineered and functionalized surfaces with nanometer scale precision and sub-cellular resolution, which enables cutting edge nanofabrication, nanoengineering and nanobiological applications.
More information is available on its new Web site at: www.nanoink.net/divisions.html#NanoFabrication
The Optoelectronics Research Centre is one of the world’s leading institutes for photonics research based at the University of Southampton. It comprises more than 30 groups working in areas from optical materials discovery and fundamental photonics to light generation and advanced optical fibre technologies. The groups have a strong history of contributing significantly to the remarkable growth of the photonics industry, including the optical telecommunications technology that underpins the Internet as well as many solutions in medicine, biosciences sensing, security and manufacturing. The Optoelectronics Research Centre at the University of Southampton Purchases a DPN 5000 is housed in the university’s new, state-of-the-art Mountbatten Building cleanroom and
laboratory complex. More information is available at: www.orc.soton.ac.uk
KACST-INTEL CENA kicks off research at imec
Leuven, Belgium – King Abdulaziz City of Science and Technology (KACST) signed agreement today with imec, a world-leading nanoelectronics research center headquartered in Belgium, to host researchers from KACST-INTEL consortium Center of Excellence in Nano-manufacturing Applications (CENA) at imec facilities in Belgium starting September 2011 for a period of three years. CENA focuses on leading-edge research on advanced nano-processing and fabrication technology, and aims at supporting the growth of Saudi Arabia's knowledge-based economy and at boosting its competitiveness on both regional and international levels.
Commenting after signing the agreement, H.E. Dr. Mohammed Ibrahim Al-Suwaiyel, President of KACST said: “Imec is a world-leading research center which provides an environment that will enrich the experience of CENA students/researchers and offer significant and relevant experience in applied nanotechnology research”. Dr. Al-Suwaiyel further emphasized CENA’s role in fostering collaboration between KACST as the leading research establishment in the Kingdom of Saudi Arabia, Intel Corporation and academic institutions across the Arab World and Turkey. “CENA is considered an important step towards growing Saudi Arabia's knowledge-based economy and boosting its competitiveness on both regional and international levels;” added Dr. Al-Suwaiyel.
Dr. Luc Van den hove, President and CEO of imec, praised the agreement as the first collaboration opportunity between KACST and imec and added: “We are pleased about the CENA hosting arrangement and are committed to continue to explore with KACST collaborations in other research areas relevant to both organizations.”
H.H. Prince Dr. Turki S. Al-Saud, KACST Vice President for Research Institutes, said: “The focus of CENA is to conduct leading-edge research on advanced nano-processing and fabrication technology, including MEMS/NEMS, nano-sensors and networks, nano-devices, and synthesis and deposition of nano-structures.” H.H. Dr. Turki Al-Saud pointed out: “Establishing CENA is considered an important step reflective of KACST’s effort, in particular, and the Kingdom of Saudi Arabia, in general, in enhancing graduate education, promoting advanced technology research and creating an environment of innovation for researchers in the Kingdom and Arab world & Turkey.”
In addition to its international reputation as a leading research center in nano-electronics and nano-technology, the shared vision, emphasis on industry-driven research, and alignment in research areas between CENA and imec were keys during the selection process.
“The choice of imec reflects the close relationship between Intel and imec that spans more than two decades covering various areas of research in the field of semiconductor processing and advanced lithography;” said Dr. Makarem Hussein, CENA Director. “This hosting agreement further underscores KACST continued effort in building the human resources needed for strong nanotech research in the Kingdom of Saudi Arabia. It is also a step towards making reality its vision for turning Saudi Arabia into a regional hub for science and research;” added Dr. Hussein.
CENA is planning the launch of “CENA DAY” events during March 2011 to engage imec researchers with eligible students and researchers in the region. Scholarships will be granted to selected students pursuing doctorate and master degree in various disciplines of engineering and science who are registered at universities affiliated with CENA through a joint research and academic advising agreement with CENA in the Kingdom of Saudi Arabia and throughout the Arab world, and Turkey.
Sabanci University in Istanbul orders electron-beam lithography system from Vistec
Vistec Lithography Inc.(http://www.vistec-semi.com) is pleased to announce that is has received an order from Turkey for one of its electron-beam lithography systems. The global supplier of advanced electron-beam lithography systems will deliver an EBPG5000plusES to the newly formed Nanotechnology and Application Center (SUNAC) of the Sabanci University based in Istanbul. The Gaussian Beam system fulfils the challenging requirements of the institute which will collaborate in the field of nanotechnology research with other institutions.
"The EBPG5000plusES is a 100kV high performance system, which is state of the art. It will enable us to address the nanotechnology development needs of natural sciences, applied sciences and engineering programs", says Dr. Volkan Özgüz, Director of the Nanotechnology and Application Center. "Due to its flexibility and advantages, the EBPG5000plusES is a perfect investment for the future and will help to establish SUNAC as one of Turkeys leading nanotechnology institution."
Vistec's EBPG5000plusES are dedicated electron-beam lithography systems, which have been developed to meet the diverse requirements for advanced nano-lithography applications in direct write for both R&D and production of GaAs devices. It enables a rapid exposure with a 25MHz rate and a minimum feature size of less than 8nm. The EBPG5000plusES system is capable to expose various substrate types including masks and dimensions up to 150mm
size.
Vistec is pleased to have received its first order from a Turkish university. "Due to their flexibility and the multi user environment, our systems are a perfect match to the needs of universities or industry research institutions. After selling a number electron-beam lithography systems to international well-known institutes in the last year, we are highly motivated to continue this positive development in the upcoming year", says Rainer Schmid, General Manager at Vistec Lithography Inc.
About Sabanci University
Sabanci University is a private university with a state of the art campus spread over 1,260,000 m2 and located 40 km from Istanbul?s city center, in Turkey. Sabanci University has adopted the motto of "creating and developing together". This vision is reflected throughout the entire University, from its interdisciplinary academic programs, its state-of-the-art technology and infrastructure and its research and development projects in industry. Through the implementation of its inventive faculty programs and the
establishment of close links with the State, business community, NGOs and other institutions of higher learning, Sabanci University has fostered an environment conducive to research. It has the distinction of being the first university in Turkey accepted for membership in the European Foundation for Quality Management (EFQM). www.sabanciuniv.edu
INSTITUTE OF PHOTONICS AT UNIVERSITY OF STRATHCLYDE
PURCHASES NANOINK’S NLP 2000 DESKTOP NANOFABRICATION SYSTEM
Plans to use the NLP 2000 for the deposition of soft materials to existing structures
to generate optical effects, color conversion and for laser fabrication
CHICAGO, Ill. – January 18, 2011 – NanoInk’s® NanoFabrication Systems Division is pleased to announce that the Institute of Photonics at the University of Strathclyde, Glasgow, U.K., purchased an NLP 2000 to be used for applied photonics and nanophotonics. NanoInk’s NLP 2000 System is a desktop nanofabrication system that allows researchers to rapidly design and create custom engineered and functionalized surfaces on the micro and nanoscale, using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area. The Institute of Photonics plans to use the NLP 2000 specifically for the deposition of soft materials to existing structures to generate optical effects, color conversion and for laser fabrication.
“We are excited by our initial results using the NLP 2000 in the deposition of optical materials and polymers. The patterning of soft materials using tip-based lithography builds strongly on our existing expertise and capabilities in microLED arrays. As an applications-focused research unit, we believe that many exciting research opportunities will stem from this technology,” said Simon Andrews, business development manager for the Institute of Photonics. “We are also very encouraged by NanoInk’s focus on supporting application development with a view towards future commercial exploitation.”
“The ability of the NLP 2000 to generate patterns of optical materials on scales wavelength or subwavelength dimensions is clearly aligned with the strategy and capability of the Institute of Photonics,” said Robert Marchmont, general manager of Europe, the Middle East and Africa, NanoInk. “With three of NanoInk’s DPN systems installed in close proximity, and the strong collaboration between Professors Martin Dawson, Peter Skabara and Duncan Graham, the University of Strathclyde has developed into a key center of excellence for DPN in optical nanoscience.”
NanoInk’s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable setting. More information is available at: www.nanoink.net/divisions.html#NanoFabrication
The Institute of Photonics, established in 1996, is a commercially-oriented research unit, part of the University of Strathclyde. The Institute’s key objective is to bridge the gap between academic research and industrial applications and development in the area of photonics. The University of Strathclyde is a leading university, meeting the needs of students, employers, industry and the wider community through its teaching, research, consultancy and knowledge transfer. Strathclyde is located in the heart of Institute of Photonics Purchases NanoInk's NLP 2000 Glasgow, and is Scotland 's third largest University. More information is available at: www.photonics.ac.uk
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN , NanoGuardian and NanoProfessor are trademarks or registered trademarks of NanoInk, Inc.
One Step Closer to Commercial Spaceflight
SpaceX launched its Dragon spacecraft into low-Earth orbit atop a Falcon 9 rocket at 10:43 AM EST on December 8, 2010 from Launch Complex 40 at the Air Force Station at Cape Canaveral.
The Dragon spacecraft orbited the Earth at speeds greater than 17,000 miles per hour, reentered the Earth’s atmosphere, and landed in the Pacific Ocean shortly after 2:00 PM EST.
This marks the first time a commercial company has successfully recovered a spacecraft reentering from low-Earth orbit. It is a feat performed by only six nations or government agencies: the United States, Russia, China, Japan, India, and the European Space Agency.
It is also the first flight under NASA’s COTS program to develop commercial supply services to the International Space Station. After the Space Shuttle retires, SpaceX will fly at least 12 missions to carry cargo to and from the International Space Station as part of the Commercial Resupply Services contract for NASA. The Falcon 9 rocket and Dragon spacecraft were designed to one day carry astronauts; both the COTS and CRS missions will yield valuable flight experience toward this goal.
View the press kit: www.spacex.com/downlaods/cots1-201012.pdf
About SpaceX
SpaceX is developing a family of launch vehicles and spacecraft that will increase reliability and performance of space transportation, while ultimately reducing costs by a factor of ten. With the Falcon 1 and Falcon 9 rockets, SpaceX has a diverse manifest of launches to deliver commercial satellites to orbit. After the Space Shuttle retires, the Falcon 9 and SpaceX’s Dragon spacecraft will start carrying cargo, including live plants and animals, to and from the International Space Station for NASA. Falcon 9 and Dragon were developed to one day
carry astronauts.
Founded in 2002, SpaceX is a private company owned by management and employees, with minority investments from Founders Fund, Draper Fisher Jurvetson, and Valor Equity Partners. The company has over 1,100 employees in California, Texas and Florida.
For more information, and to watch the video of the first Falcon 9 launch, visit:
http://spacex.com/multimedia/videos.php?id=57
View all videos at:
http://www.spacex.com/multimedia/videos.php
Crossing Automation Enters Carbon Nanotube Market with ExpressConnect Vacuum Wafer Handling System Design Win
Brings Wafer-Level Automation to New, High Growth Market
Fremont, Calif.—December 14, 2010—Extending its reach into related adjacent markets, Crossing Automation, Inc. (www.crossinginc.com), a leading supplier of efficient, cost-effective automation solutions and engineering services, today announced a design win for its ExpressConnectTM vacuum wafer handling system by a carbon nanotube (CNT) original equipment manufacturer (OEM). The Shuttle-LockTM and vacuum cassette elevator configuration will be integrated into the OEM’s process tool to automate wafer handling. ExpressConnect was selected because it offered a compact, low-cost solution that met the customer’s requirements for its R&D and pilot production environment.
“This order marks our entry into yet another emerging market with significant growth potential and highlights the opportunities available for automation in semiconductor-related markets including CNTs, photovoltaics, LEDs and MEMS,” said May Su, vice president of marketing for Crossing Automation. “Our ability to deliver a wide variety of cost-competitive automation building blocks that can be designed to accommodate very specific process requirements provides significant growth opportunities for us as a company.”
Crossing’s ExpressConnect vacuum wafer handling solutions are well suited to emerging technologies that are in the process of migrating from smaller wafer sizes used in R&D to production-scale 200 and 300 mm, which offer an ideal insertion point for automation technologies. CNTs, MEMS and LEDs are examples of markets that are currently in transition to higher levels of automation in order to meet yield and productivity enhancements.
ABOUT CROSSING AUTOMATION:
Crossing Automation is a leading supplier of efficient, cost-effective vacuum and atmospheric automation solutions, materials tracking and engineering services to high volume semiconductor equipment manufacturers, IC, LED and solar manufacturers and other adjacent markets. The company’s unique approach to automation solutions enables its customers to shorten time to market, lower development costs and reduce total costs. Through its front-end and back-end automation solutions, Crossing achieves critical manufacturing flexibility for OEMs and manufacturers alike.
Baolab wins R&D award in prestigious 2010 Elektra Awards
Expands to meet demand for its NanoEMS technology
Barcelona, Spain - 14 December 2010. Baolab has won the prestigious Elektra European Electronics Industry Awards 2010 in the R&D category for its innovative NanoEMS technology. The established annual highpoint of the electronics industry, the Elektra Awards gives the industry the opportunity to recognise the achievements of individuals and companies across Europe. They are designed to promote best practice in key areas including innovation, sales growth and employee motivation. The winners were announced at the Elektra Awards Dinner and Christmas Party which took place last week at the Lancaster London Hotel. http://www.elektraawards.co.uk
Speaking on behalf of the Electra 2010 panel of judges, host Hugh Dennis stated, "The range of research presented to us this year was exceptional, but it was the long-term potential of the winning research in a technology area of real importance which impressed the judges."
Neil Dickins, director of IC Group, presented the R&D Award to Baolab's CEO, Dave Doyle and CTO, Josep Montanyà i Silvestre. "Our NanoEMS technology is the breakthrough that MEMS customers have been waiting for," explained Dave Doyle. "We are perfecting the techniques for being able to create MEMS within the existing metal layers of the CMOS wafer using standard, high volume production techniques. As a result, they are an order of magnitude smaller and significantly less expensive compared with traditional MEMS techniques. This cost breakthrough is really exciting customers, especially as we can create several structures, which can be the same or different, simultaneously on one multi-sensor device to deliver even greater cost savings. Being shortlisted for this year's Elektra Awards has really raised our profile in the global electronics community, bringing in new enquiries from all over the world. Winning is a huge thrill for us and I'm sure will raise our profile even further."
As a result of being shortlisted, the company is now expanding its recruitment of new staff. Three new members of staff have recently been added to the team bringing the total up to twelve: -- Daniel Fernandez, ASIC design Engineer; Adolfo de la Calle, Digital Design Engineer; and Nigel Drew, Technical Marketing Manager. In addition, Joan Majo, former Spanish Minister of Industry, has been appointed Chairman.
Baolab is a private Spanish company that has received significant funding from Highgrowth Partners, a Spanish Venture Capital firm based in Barcelona that specialises in high technology investments. www.baolab.com
NanoEMS is a trademarks of Baolab Microsystems, S.L.
Nanostart-held ItN Nanovation: Water treatment technology among winners of '365 Landmarks in the Land of Ideas'
Frankfurt / Saarbrücken – The highly compact next-generation water treatment technology, developed by Nanostart (OTCQX: NASRY)-held ItN Nanovation AG, called Nanovation, has been selected as one of the winning innovations of “365 Landmarks in the Land of Ideas,” a competition sponsored by the German federal government. The technology is based on the company’s proprietary nanoceramic flat filter membrane system.
The award presentation noted that “Nanovation is revolutionizing water treatment and is a superb example of inventiveness, creativity and the richness of ideas within Germany. With this pioneering idea of using nanoparticles for filtration, an entirely new outlook has been opened for providing clean water to all mankind.”
“We are extremely proud to be one of the selected ‘Landmarks’ in the Land of Ideas competition,” said Lutz Bungeroth, CEO of ItN Nanovation. “We are pleased that our mobile, containerized water treatment modules were selected from a large number of innovations from throughout Germany. We have put a lot of effort into implementing the results of intensive research and German engineering into a next-generation product solution which opens new opportunities for utilizing our limited water resources in a clean and highly efficient way.”
The innovation from ItN Nanovation lies in the unique nanoceramic coating used in its filter membranes. Compared to conventional filtration solutions, the new technology from ItN Nanovation offers significantly superior performance and durability. The highly compact water treatment modules in standard container format are portable and can be used wherever needed. Installation requires no major building work and minimal lead time. Particularly in the arid regions of the world, ItN Nanovation sees tremendous growth potential for this next-generation water treatment technology.
For further information about the company, please visit www.itn-nanovation.de
Nanostart Asia launches independent website at nanostart-asia.com
Frankfurt / Singapore – December 14, 2010 – Nanostart subsidiary Nanostart Asia Pte Ltd now has its own web presence. The new independent website reflects the expanding business of this Nanostart subsidiary.
Virtually every target group can find relevant information within only a few clicks of the homepage. Users have the opportunity to learn about the structure of the Nanostart Singapore Early Stage Venture Fund, which is managed by Nanostart Asia. Shareholdings held by the fund are also profiled. Nanotechnology companies that are seeking capital can examine Nanostart investment criteria and utilize a checklist to evaluate their chances for cooperation. The website also features profiles of Nanostart Asia contact persons, who are available to answer questions. The design of the new Nanostart Asia website reflects the relationship with Nanostart AG, while simultaneously demonstrating the independence of the Asian location. The site serves primarily as a source of information for users in Asia. All content is therefore available only in English.
Nanostart Asia was launched in 2008. Shareholdings in three companies are currently held through the Singapore Early Stage Venture Fund, which is managed by Nanostart Asia.
Andreas Kröll, managing director of Nanostart Asia, explained that the decision to invest in nanotechnology in Singapore is due to the outstanding research landscape and the excellent support of the government, as the shared financing of the fund with the National Research Foundation demonstrates. Singapore is the basis for Nanostart’s business in Asia.
Users may visit the Nanostart Asia website at www.nanostart-asia.com
SUSS MicroTec and Rolith Cooperate on Development of New Nanolithography Technology
“Combined with our flexible equipment solutions the novel optical nanolithography technology by Rolith has the potential to bring high volume nanoimprint technology to market by fundamentally changing the cost structure compared to current technologies.”
Frank Averdung, President and CEO, SUSS MicroTec
Garching, GERMANY and Dublin, CA, USA, December 2, 2010 - SUSS MicroTec, a leading supplier of equipment and process solution for the semiconductor industry and related markets, today announced that it has entered into a joint development and exclusive license agreement with Rolith, Inc. to develop and build nanostructuring equipment employing a disruptive nanolithography method developed by Rolith. Availability of a high throughput cost effective technique for nanostructuring over large areas of substrate materials brings new possibilities to renewable energy and green building markets.
Rolith’s patent pending nanolithography technology is based on a proprietary implementation of near-field optical lithography using cylindrically shaped rolling masks. Sub-wavelength resolution is achieved by phase-shift interference effect or plasmonic enhancement printing structures. Continuous mode of operation will allow high throughput and low cost production.
anticipate the technology will enable the next generation of advanced products, such as high efficiency 3D solar cells, building-integrated PVs, smart glass and superior quality coatings with anti-reflective, anti-glare, self-cleaning and anti-fog qualities”, said Dr. Boris Kobrin, CEO/President of Rolith, Inc. “We are delighted to partner up with SUSS MicroTec who is known for their world class designs and excellent customer service. With their 60 years of experience with optical lithography systems SUSS MicroTec has the necessary expertise and network to help Rolith to bring this much needed technology to market.”
“Our recent achievements with nanoimprint lithography systems have made us a leading expert for structuring substrates in MEMS and nano applications”, stated Frank Averdung, President and CEO, SUSS MicroTec AG. “Combined with our flexible equipment solutions the novel optical nanolithography technology by Rolith has the potential to bring high volume nanoimprint technology to market by fundamentally changing the cost structure compared to current technologies.”
Swiss Expertise in Green Building Highlighted at
Ecobuild America Conference
Washington, December 1 - Six Swiss firms with specific expertise in green building practices will display products and services at booth 425 during the Ecobuild America conference at the Washington Convention Center on December 8 and 9, reports Markus Walther, Washington Representative of Cleantech Switzerland, the export platform dedicated to the Swiss cleantech sector.
Companies represented are:
- Intep, a consultancy for strategic projects in commercial real estate. www.intep.com
- Design*21, a design practice that provides full design, interior design, product and furniture design services.www.godesign21.com
- Zehnder, a supplier of energy-efficient systems for heating, cooling and fresh air.
www.zehnderamerica.com
- Krapf, manufactures high-end windows with excellent insulation values. www.krapfag.ch
- Schöb, which offers top-notch timber solutions. http://schoeb-ag.ch/en/schoeb.html
- Konvekta, a leading manufacturer of high efficiency run-around energy recovery systems for large building HVAC. http://www.konvekta.ch/index.php?id=151
"Making buildings more energy-efficient plays a key role in mitigating climate change," Mr. Walther said, "This is one of the primary objectives of Cleantech Switzerland. The country's technology leadership in sustainable building is exemplified by the MINERGIE® building standard for new and refurbished buildings, a voluntary code that enjoys such a good reputation in the construction sector that it is on its path to become standard practice. The program is supported by the Swiss Confederation, the Swiss Cantons along with Trade and Industry and is registered in Switzerland and around the world." www.minergie.com/home_en.html
NANOINK LAUNCHES NEW APPLICATION FOR
SINGLE CELL ARRAYS AT ASCB ANNUAL MEETING
NanoFabrication Systems Division to present groundbreaking
poster and exhibit regarding live single cell arrays
SKOKIE, Ill. – November 30, 2010 – NanoInk’s NanoFabrication Systems Division is pleased to announce the launch of a new application for single cell studies that enables micropatterning of proteins and polyethylene glycol (PEG)-based hydrogel at sub cellular scales. The new application note will be available on NanoInk's Web site in the coming weeks. The NanoFabrication Systems Division will also be presenting a poster and exhibiting at the ASCB (American Society for Cell Biology) 50th Annual Meeting, from Sunday, December 12 through Wednesday, December 15, at the Pennsylvania Convention Center in Philadelphia, Pa.
“The new application demonstrates successful use of the NLP 2000 System to investigate cell response to its microenvironment at single cell levels,” said Tom Warwick, general manager, NanoInk’s NanoFabrication Systems Division. “We envision that this will enable studies in live single cell arrays, nanotoxicology, developmental biology, tissue engineering, cell physiology, chemotaxis, migration, and mechanotransduction.”
Launched in 2009 as a tool for bioscience research, NanoInk’s NLP 2000 System is a simple, userfriendly desktop nanolithography platform. The system leverages patented Dip Pen Nanolithography® (DPN®) technology to deposit sub-cellular-scale features of a wide variety of materials with nanoscale registry, all under ambient conditions. With the addition of the new capability to its portfolio of biological research support materials, NanoInk continues to serve as a true partner to the life science community.
NanoInk has successfully demonstrated the patterning of single cells on protein arrays constructed using NanoInk’s NLP 2000. Multi-component arrays at sub cellular scales patterned with nanoscale registry have been used to investigate the cellular response at single cell levels. Cell binding areas are constructed using ECM proteins and PEG-based hydrogels are used for targeted delivery of materials to single cells.
ASCB 2010
John M. Collins, Ph.D., NanoInk, will be presenting a poster entitled, “Direct Protein Deposition for Single Cell Analysis” that will show how cells bind to an ECM protein and ‘anchor’ it over the top of a PEG hydrogel. It will be presented on Tuesday, December 14, from 11:30 a.m. to 1 p.m. at exhibit halls A/B/C of the Pennsylvania Convention Center. It is program #3144 and board #L381. NanoInk will NanoInk Launches New Application for Single Cell Arrays at ASCB also be exhibiting at booth #625 where its NLP 2000 System desktop nanolithography platform will be available for demonstrations.
Please visit www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale
manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute
of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
Divisions of NanoInk:
The NanoFabrication Systems Division provides core desktop instrumentation and application
expertise for current and future applications of DPN.
The Nano BioDiscovery Division provides instruments, assay kits, and contract services for nanoscale protein detection using DPN technology.
The NanoStem™ Cell Division aims to revolutionize the utility of stem cells through the application of DPN nanopatterning.
The NanoProfessor™ Division provides a complete nanotechnology educational solution including a suite of instruments, interdisciplinary-based curriculum, cutting-edge labs, and comprehensive educator and program support developed to extend hands-on nanotechnology education to the undergraduate classroom.
The NanoGuardian™ Division uses NanoEncryption™ technology to offer pharmaceutical customers a state-of-the-art on-dose brand security solution to fight counterfeiting and illegal diversion.
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, NanoEncryption, NanoGuardian,
NanoProfessor, NanoStem are trademarks or registered trademarks of NanoInk, Inc.
Sigma-Aldrich and Nanosys Enter into Distribution Agreement to Supply Materials to the Research Community
Global Availability of Silicon Nanowires via Aldrich(R) Materials Science Paves Way for Innovation and Application Development Across Areas Such as Bio-Informatics, Electronics and Clean Energy
ST. LOUIS, MO. - November 29, 2010 - Sigma-Aldrich (Nasdaq: SIAL) today announced a distribution agreement with Nanosys, Inc., an advanced materials architect. Under the agreement, Sigma-Aldrich, through its Aldrich Materials Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new applications in technologies such as solid-state lighting, electronics and energy storage.
"As Aldrich Materials Science continues to expand its nanomaterials offer, we are pleased to introduce an innovative line of silicon nanowires that includes undoped silicon nanowires as well as the higher conductivity, boron-doped nanowires," said Dr. Kaushik Patel, Product Manager, Aldrich Materials Science. "The applications of these nanowires are, we believe, truly innovative and revolutionary. The fabrication of nanowires is challenging; therefore, a consistent and high-quality supply of these materials from Aldrich Materials Science is expected to enable scientists to accelerate their research to further develop a variety of new high-technology applications that can continue to open up exciting end product markets. In all aspects of the Aldrich Materials Science business, from manufacturing and custom R&D to distribution of materials from leading-edge technology companies such as Nanosys, we strive to fulfill our mission of focusing on materials so that our research customers can focus on results."
"Architected and synthesized at the atomic level, our materials deliver exponential improvements in efficiency and performance," added Jason Hartlove, CEO of Nanosys. "This new distribution agreement with Sigma-Aldrich puts our technology directly into the hands of researchers who are doing exciting work in labs around the world, driving the use of architected material solutions in a new generation of markets and applications."
Nanosys silicon nanowires, which demonstrate semiconductor properties, are comprised of single crystal silicon grown using the vapor liquid solid (VLS) process to a diameter of 150 nm and a length of 20 ?m. The materials are available undoped or as activated boron-doped p-type silicon nanowires with 1?1019 /cm3 doping at ends and a 3 ?m intrinsic region in the center of the wire. Polydispersed silicon nanowires of various lengths that are designed for use in energy research are also expected to be available beginning January 2011.
Across an increasingly diverse range of applications, silicon nanowires can deliver tangible benefits and significant advances. Examples include:
- Electronics applications - sensors can be constructed from nanowire arrays that act as a highly sensitive 'e-skin' which could be used to restore the sense of touch to patients with prosthetic limbs or to enable robotic systems to 'sense' pressure.
- Solar cells - Research conducted earlier in 2010 found that fabricating thin films from ordered arrays of vertical silicon nanowires significantly increased the light-trapping properties in solar cells, compared to conventional silicon thin film photovoltaics.
- Batteries - Nanowire technology is enabling the production of batteries that are more economical, longer lasting, smaller and more environmentally friendly. Nanowires are used to increase the surface area for electrolyte reaction, thereby enabling greater power in a smaller overall footprint.
To learn more about Aldrich Materials Science, silicon nanowires and other new nanomaterials, please visit http://www.sigma-aldrich.com/newnano
Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "is expected to enable," "can continue to open," "are also expected to be available," "can deliver" or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that silicon nanowires will achieve any particular levels of revenue in the future. In particular, management's expectations regarding silicon nanowires could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company committed to Enabling Science to Improve the Quality of Life. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,700 employees providing excellent service worldwide. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com
About Nanosys, Inc.: Nanosys, Inc. is an advanced material architect, harnessing the fundamental properties of inorganic materials into process ready systems that can integrate into existing manufacturing to produce vastly superior products in lighting, electronic displays and energy storage. In 2010, Nanosys commercialized its quantum dot technology with the QuantumRailTM, a process-ready component that improves LED backlit display color gamut and efficiency, signing partnerships with LG Innotek and Samsung. Nanosys is currently working with major battery manufacturers to improve lithium-ion battery capacity using its SiNANOdeTM silicon composite additive that, when added to the anode side, improves capacity by 40 percent. SiNANOdeTM -enhanced batteries are expected to be available in 2011.
For more information, visit www.nanosysinc.com
Aldrich and Sigma-Aldrich are trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. QuantumRail and SiNANOde are trademarks of Nanosys, Inc.
Konarka's Power Plastic Achieves World Record 8.3% Efficiency Certification from National Energy Renewable Laboratory (NREL)
Large Area Single-Junction Solar Cell Obtains Unparalleled NREL Efficiency Rating
Lowell, Mass. - Nov. 29, 2010 - Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to energy, today announced that the National Energy Renewable Laboratory (NREL) has certified that Konarka’s organic based photovoltaic (OPV) solar cells have demonstrated a record breaking 8.3% efficiency. This is the highest performance recorded by NREL for an organic photovoltaic solar cell.
"The progress Konarka has achieved this year with regard to solar cell efficiency is unprecedented, representing a significant milestone for the industry," commented Howard Berke, chairman, CEO and co-founder of Konarka. "This unsurpassed NREL certification opens new doors for the commercial production of cost-effective, efficient electricity for numerous large scale applications."
Konarka Power Plastic is a patent-protected thin film solar material that converts light to energy. The unique material is lightweight and flexible, lending itself to a wide range of applications where traditional photovoltaics are not effective.
The latest certification results are for Konarka’s large area single-junction solar cell with a surface area of 1 square centimeter. This efficiency rating far exceeds previous single-junction organic photovoltaic cell measurement on that surface area and represents the world record for OPV efficiency.
About NREL
NREL is the U.S. Department of Energy's primary national laboratory for renewable energy and energy efficiency research and development. NREL is operated for DOE by The Alliance for Sustainable Energy, LLC. More about NREL’s photovoltaic research can be found at http://www.nrel.gov
About Konarka Technologies, Inc.
Konarka Technologies develops and manufactures solar plastic films that convert light to energy - anywhere. As the leading developer of polymer-based, organic photovoltaic (OPV) technology that provides a source of renewable power in a variety of form factors, Konarka has a broad portfolio of patents, technology licenses and an accomplished technical, scientific and manufacturing team. Manufactured at low cost and low energy consumption, the company's Konarka Power Plastic® technology is lightweight, flexible, scalable and adaptable for use in a variety of commercial, industrial, government and consumer applications. Konarka Technologies is headquartered in Lowell, Mass., U.S.A. and has a full scale production manufacturing facility in New Bedford, Mass. U.S.A., with European headquarters in Nurnberg, Germany, business development offices in Asia and a research and development facility in Austria. For additional information, visit http://www.konarka.com
All trademarks recognized.
Nanostart-held BioMers launches new
flagship product SimpliClear Full
Frankfurt / Singapore – November 29, 2010 – BioMers Pte Ltd, a portfolio company of Nanostart AG, has announced the initial market launch of its new flagship product line, the SimpliClear™ Full orthodontic system. These completely translucent dental braces may be used to treat patients even with severe misalignment of teeth which has, until now, only been possible with unsightly metal braces.
“Earlier this year, we launched SimpliClear™ Express, which was suitable for limited cases, such as orthodontic relapses or mild misalignments involving the front anterior teeth. Now we are launching SimpliClear™ Full, which is the only translucent orthodontic system in the world that can treat the full range of teeth misalignments. We are seeing much excitement from the orthodontic community with the SimpliClearTM Full solution,” said Dr. Mervyn Fathianathan, CEO of BioMers.
The SimpliClear™ Full braces solution is based on the same principles as metal braces, a proven treatment procedure, and can thus be used the full range of orthodontic treatments, from mild to severe cases. The unique benefit lies in the translucency of the proprietary materials used by BioMers, which makes SimpliClear™ braces practically invisible. Within the global orthodontics market, BioMers is the only provider to offer clear archwires.
“I am very impressed with the effectiveness of SimpliClear™ Full. The results that I have seen so far on the pioneering batch of patients have been excellent, in terms of the speed of treatment and effectiveness of results. Furthermore, the patients are very happy with the aesthetic appeal and feel of the braces. I expect that this orthodontic treatment option will be received well by the Singapore community,” said Dr. Kenneth Lew, an orthodontist with Tanglin Dental Surgeons, Singapore.
Having launched SimpliClear™ Full in Singapore, BioMers now plans to bring the new product line to other Asian countries, Europe and the U.S.
The target market for SimpliClear™ Full dental braces includes not only the countless patients around the world who are dissatisfied with the unsightly nature of traditional metal braces but also individual cases where patients cannot tolerate metallic braces because of allergies or other conditions.
The SimpliClear™ orthodontic solution from BioMers is based on composite polymer wires made extremely strong through the use of groundbreaking nanotechnology. This patented technology gives SimpliClear™ braces mechanical properties similar to traditional metal braces, with the added benefits of high biocompatibility and non-allergenic characteristics. The polymer composite is formed into translucent archwires, which have the tensile strength needed to move teeth into their correct positions.
About Nanostart:
Nanostart AG (OTCQX: NASRY), headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information, please visit www.nanostart.de.
About BioMers:
BioMers is a medical device company that has developed novel polymer composite products for numerous biomedical applications. The company’s flagship product is the SimpliClear™ braces system, which is the world’s first and only aesthetic solution for all types of orthodontic treatments. This translucent, almost invisible braces system is customized to each patient, providing faster and better results. Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. BioMers has received seed funding from NUS Enterprise, venture capital funding from the Nanostart Singapore Early Stage Venture Fund, and grants from government agencies, including SPRING Singapore and the Economic Development Board. For more information, visit www.biomersbraces.com
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.
Coatema Wins JEC Composites Innovation Award
November 9, 2010 - Dormagen, Germany - Coatema Coating Machinery GmbH was awarded the
JEC Composites Innovation Award for 2010 for Impregnating, Laminating and Calendering with
maximum flexibility and process versatility in the patented Coatema Click&Coat machinery concept.
The prestigious prize was presented by Prof. Klaus Drechsler, of the University of Stuttgart, to Andrea Glawe, Deputy Sales Director of Coatema, during the annual JEC Composites 2010 event in Singapore.
When asked about the differences between the Click&Coat concept and conventional technologies Frau Glawe said, "The innovation in this concept is our modular approach designed for flexibility and future expansion." Glawe explained that this not only includes quick change coating heads but also many critical process components which can be moved into position by a simple "click" and connected to a recently developed master control system.
Combinations of 40 different modules for various processes are possible without expensive and time consuming mechanical and electronic alternations.
Adjustable floor rollers on each module, the unique Click&Coat connector system and minimum cabling requirements make changes and expansions very user friendly.
This versatility provides for a maximum of process variants for coating, drying, curing, cleaning, calendaring and other critical process technologies.
Combined with Coatema´s well-known changeable modular coating and printing systems the Click&Coat technology cannot be matched for flexibility and as such is well-deserved of the JEC Innovation Award 2010 in the “Process” category.
"It makes it possible to react to technology change requirement in a time, cost and space saving way," concluded Glawe.
Coatema reports that the first Click&Coat prepreg line, with a working width of 800 mm, is currently being installed. It will be capable of implementing 5 different coating methods for direct or indirect coating on paper, rovings and other typical composite substrates.
The JEC Composites Show 2011 will take place in Paris from the 29th to the 31st of March 2011. The prepreg specialists at Coatema are looking forward to meeting you at the exhibition on booth V71.
About Coatema:
Coatema Coating Machinery offers mechanical engineering and R&D for coating, printing and
laminating plants for R2R and S2S applications. For more than 35 years Coatema has been delivering solutions to a wide range of markets including prepreg, flexible electronics, renewable energy, converting, technical textiles, paper, medical, and membrane
casting. Coatema offers lab units, pilot plants and entire turn-key production solutions for coating, printing and laminating of flexible or rigid substrates. Another key service of Coatema is custom made machinery for scale-up processes. Furthermore Coatema offers a company owned R&D center in Dormagen with 11 different lab and pilot lines and a production line with a working width of 2000 mm for research, process development or even
toll coating purposes. An annual international coating symposium completes Coatema´s manifold range of services. Current Information: www.coatema.com
Nanostart subsidiary MagForce receives renowned business award
Frankfurt / Berlin – November 17, 2010 – Nanostart subsidiary MagForce Nanotechnologies AG (FSE:MF6), a leader in the area of nanotechnology-based cancer treatment, has been selected as the 2010 recipient of the STEP award in the category “product/technology”. “We are honored to receive the prestigious STEP award in recognition of MagForce’s novel therapy for the treatment of brain tumors. Our innovative therapeutic approach uses nanoparticles, which are activated through the application of a magnetic field to produce heat within the tumor,” said Dr. Peter Heinrich, CEO of MagForce. “Following our recent EU approval, we are focusing on building the commercial structures needed to launch our Nano-Cancer-therapy at leading German cancer centers in early 2011. Our transformation from a research and development company to a commercial business also signifies a new therapy option for patients diagnosed with brain tumors.”
“We congratulate our majority-owned portfolio company MagForce Nanotechnologies on its achievement, particularly against such a field of outstanding nominees,” commented Marco Beckmann, CEO of Nanostart AG. “This vote of confidence by the selection committee, comprised of experts from both science and industry, underscores the promising outlook for Nano-Cancer® therapy in the oncology market.”
The STEP award, initiated by Infraserv Höchst and F.A.Z. Institute along with leading industry sponsors, was awarded for the fifth time this year. More than 100 companies competed in this year’s STEP award. Small and mid-sized growth companies in innovative fields ranging from pharmaceuticals, chemicals, life science, biotechnology, and nanotechnology to medical and green technology are eligible to take part in the annual competition.
FutureCarbon goes to Swisstech 2010 in Basle to show innovative super-composites with new electrical and thermal characteristics
FutureCarbon is exhibiting in the Nano Village of this year's Swisstech staged from 16 through 19 November in Basle. The Bayreuth-based company is presenting super-composite materials with new electrical and thermal characteristics.
At Swisstech, the central exhibition of Europe's subcontractor industry, FutureCarbon is showing super-composites based on carbon nanomaterials for further industrial processing:
Carbo e-Therm is an electrically highly conductive coating system – suitable for temperatures as high as 500°C – for a variety of heating purposes. This high conductivity makes it ideal in applications working on non-hazardous low voltage (e.g. 12 V). Carbo e-Therm can be applied direct to very different surface geometries and materials, and is both very robust mechanically as well as extremely stable chemically. A further bonus is that Carbo e-Therm heated coatings produce absolutely homogeneous heat distribution avoiding hot spots.
In CarboImpreg FutureCarbon presents a new member from its family of heating products. Electrically conductive, CarboImpreg will soak into rough or absorptive surfaces of very different materials such as real leather or textiles. Surfaces impregnated in this way can be electrically heated by applying a non-hazardous low voltage of 12 or 24 V for example.
CarboShield is a highly effective means of shielding based on carbon nanomaterials, a very thin coating of which is able to suppress electromagnetic radiation. CarboShield was developed both to safeguard humans, animals and technical installations against exposure to high-frequency electromagnetic fields, and to maintain information security by creating bug-proof facilities for instance.
FutureCarbon specializes in the development and manufacture of carbon nanomaterials and their refinement to create what are called carbon super-composites, primary products for further industrial processing. Carbon super-composites are combinations of materials that unfold the special characteristics of carbon nanomaterials in the macroscopic world of real applications. All of our materials are manufactured on an industrial scale.
RECAM®: a new and innovative approach for wastewater
and groundwater treatment
Sa Envitech is an Italian company which focuses on the research, development and industrialization of nanotechnologies and nanostructured materials for wastewater treatment. The company launched a new wastewater treatment technology with RECAM®.
This innovative nanostructured material has particular properties in terms of contaminants removal such as PAH, boron, COD, MTBE, chlorinated solvents, arsenic, phenols, chromium VI, and it is particular effective from wastewater and groundwater remediation.
RECAM® is inert, has no negative impacts on the environment and has passed all the tests from the Italian Ministry of the Environment.
SA Envitech built water treatment plants in Italy which provide excellent results and is now looking to widespread its technologies on an international level.
We are interested to test processes with RECAM® with international partners, in order to witness the efficiency and feasibility of this new material and discuss possible cooperation.
For any additional technical information, case studies and certifications, please visit our website: www.sa-envitech.com
Konarka and Nu Energy Announce Partnership
Konarka and Nu Energy Commercial Alliance to Initiate Deployment of Konarka Power Plastic into Australian Commercial and Residential Solar Market
Lowell, Mass. – Nov. 8, 2010 – Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to energy, today announced a commercial alliance with Nu Energy, a partnership that is expected to initiate deployment of its organic photovoltaic technology into the Australian market for both commercial and residential applications. The leader in the renewable solutions industry in Australia, Nu Energy has installed more than 18,000 solar systems throughout Australia in households, large industrial sites and government applications.
“We are delighted Nu Energy has selected Konarka’s Power Plastic to deliver solar technology to their customers throughout the region,” commented Howard Berke, executive chairman and co-founder of Konarka. “This relationship enables us to continue our go-to-market strategy of partnering with leading companies across the globe in a variety of emerging photovoltaic integrated applications.”
The thin, light-weight and flexible characteristics of Konarka’s Power Plastic makes it particularly conducive to a wide range of uses. Power Plastic captures both indoor and outdoor light and converts it into direct current (DC) electrical energy. Manufacturers can easily integrate the material into their products for both commercial and residential uses, creating energy producing products.
“This partnership gives Nu Energy additional solutions for its residential and commercial customers, adding value to their properties and reducing energy bills even further,” commented Simon Schauble, chief executive officer of Nu Energy. “We are proud to partner with Konarka and introduce their rapidly developing solar technology into Australia.”
About Nu Energy
Nu Energy is an Australian-owned solar company. It has provided renewable energy solutions for Australia’s commercial and residential sectors for more than 20 years. Nu Energy is a fully accredited member of the Clean Energy Council and has installed more than 18,000 solar systems throughout Australia in households, large industrial sites and government departments through to local corner stores. More information is available at: www.nuenergy.com.au
About Konarka Technologies, Inc.
Konarka develops and manufactures solar plastic films that convert light to energy – anywhere. As the leading developer of polymer-based, organic photovoltaic (OPV) technology that provides a source of renewable power in a variety of form factors, Konarka has a broad portfolio of patents, technology licenses and an accomplished technical, scientific and manufacturing team. Manufactured at low cost and low energy consumption, the company's Konarka Power Plastic® technology is lightweight, flexible, scalable and adaptable for use in a variety of commercial, industrial, government and consumer applications. Konarka Technologies is headquartered in Lowell, Mass., U.S.A. and has a full scale production manufacturing facility in New Bedford, Mass. U.S.A., with European headquarters in Nurnberg, Germany, business development offices in Asia and a research and development facility in Austria. For additional information, visit http://www.konarka.com
All trademarks recognized.
Piezo Mechanisms Catalog
Piezo Actuators, Piezo Motors, Piezo Stages, Drivers
PI (Physik Instrumente) L.P. -- a leading manufacturer of piezo ceramic actuators and precision motion-control equipment for semiconductor, bio-medical and nanotechnology applications -- has released a new catalog on Piezo Mechanisms.
The 400-page catalog presents PI’s complete spectrum of piezomechanic components and motion systems, from simple, direct actuators, to long-travel ceramic linear motors and complex multi-axis flexure guided nanopositioning stages. A separate section lists the latest digital control electronics.
The catalog also includes a tutorial on piezo design for positioning applications.
The catalog can be downloaded at:
http://www.piezo.ws/pdf/Piezo_Mechanism_Cat10.pdf
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Switzerland Announces Winners of
Significant Investment Projects for 2009
Edwards Lifesciences Corporation, Pall Corporation, Disney Research, and Measurement Specialties received 'Tell Awards' from Switzerland's Ambassador to the U.S. Manuel Sager.
WASHINGTON, November 3 - Edwards Lifesciences Corporation, Pall Corporation, Disney Research, and Measurement Specialties will receive 'Tell Awards' for Switzerland?s most significant inward investment projects by North American firms in 2009, reports Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion. The awards are named for the legendary Swiss hero William Tell and was presented on November 8 by Switzerland's newly arrived Ambassador to the U.S. Manuel Sager.
"The Tell Awards date from 2004 in a program originally recognizing projects by North American firms," Mr. Brossi said. Since then, Tell Awards have also been made in Brazil and Mexico. The program has grown in terms of interest expressed in Switzerland and abroad. Awards are sponsored by the Swiss Embassy, Switzerland Trade and Investment Promotion, and the American - Swiss Business Council based in Washington.
The most significant expansion project award for 2009 goes to Edwards Lifesciences Corporation. It recognizes Edwards for its new regional headquarters in Nyon, which serves the company's growing EMEA operations from a central location. Edwards also maintains a manufacturing facility in Horw.
The most significant headquarters project award for 2009 goes to Pall Corporation, which inaugurated its new European HQ in Fribourg to initially house the company's life sciences business in Europe, but with plans to integrate the industrial business in Europe by 2011.
The award for the most significant innovative technology investment in 2009 goes to Disney Research Zurich (DRZ), a joint venture between Disney and the Federal Institute of Technology Zurich (ETHZ). The only one of its kind in Europe, DRZ research projects are aimed at Walt Disney's animation studios and Disney's theme parks. One of the labs key areas is animation and modelling of human faces.
Measurement Specialties will receive the award for the most significant manufacturing investment in 2009 recognizing its purchase of Intersema Sensoric SA, located in Bevaix. Intersema designs and manufactures high precision MEMS-based pressure sensors for consumer, industrial and medical applications.
Previous award winners are Baxter International, Yahoo!, Alcon Corporation, AGCO, Medtronic, CSL Behring, Merck & Company, Albany International, Intuitive Surgical, Johnson & Johnson, Autodesk, CEMEX, Electronic Arts, Kyphon, Microsoft, Amgen, IBM, Stryker, VeriSign, Celgene, eBay, Google and P&G. Please see our website at www.locationswitzerland.com for copies of previous releases.
"Switzerland continues to be an attractive FDI destination in terms of new and expanded investments," Mr. Brossi commented. "For example, A. D. Little?s November 2009 study ?Global and Regional Headquarters in Switzerland? states that between 2003 and 2009, 269 headquarters transferred to Switzerland. Of these 54% are from the U.S., 29% from Europe, and the balance from Asia and elsewhere."
The report states that reasons for choosing Switzerland as an HQ location include economic competitiveness, an attractive tax system, highly qualified labor, a central location with excellent infrastructure, quality of life and support from administrative authorities.
Surveys also rank Swiss companies as the most innovative in Europe, dispelling the myth that the country's ideas often fail to find commercial success at home, according to an article in SwissInfo. Switzerland climbed one place to top the European Innovation Scoreboard issued by the European Union in March 2009. And research by the KOF Swiss Economic Institute reveals that innovation really does translate into cash.
“Swiss Technology Award 2010”: The Joint Venture of CSEM and SUI, SenseCore AG (Sense) is named among the three finalists for the most prestigious award for technology in Switzerland.
Neuchâtel, 27 October – On the occasion of the 5th “Swiss Innovation Forum” which will take place on 4th November at the Novartis campus in Basel, the 23rd “Swiss Technology Award” will be announced. In designating Sense as one of the finalists, the “Swiss Technology Award” highlights on the Swiss and international stage the physiological signal monitoring technology developed by CSEM and its Swiss partners, such as AdNovum (Zurich) or Eschler Textil (St. Gallen). This achievement also offers the young company a unique opportunity to demonstrate its innovative talents.
By honoring innovation in the service of excellence, Sense – a joint venture of CSEM and Sports Unit of Innovation (SUI) – was able to stand out from among many other candidates in the start-up category. The LTMS (Long Term Monitoring System) technology, originally developed by CSEM for the European Space Agency (ESA), was designed for non-intrusive and comfortable monitoring of astronauts’ health. Currently, this portable system enables continuous and simultaneous measurement of the main physiological signals such as electrocardiogram, respiration, blood–oxygen saturation, or body temperature.
Biomedical applications are mainly aimed at professional and amateur sportspersons, as well as at medical patients. Cooperations with famous racing teams have already been agreed, and well-known football teams have confirmed their interest for this product. This concept which includes intelligent and multipurpose wireless sensors in T-shirts will enable athletes to efficiently manage their training and to significantly improve their performances. Large-scale pilot projects will be officially launched from the end of 2010 with the support of internationally renowned sport teams and federations.
Alexandros Giannakis:
“It’s an exceptional recognition for us and our partners to be shortlisted among the three finalists for the “Swiss Technology Award” in the start-up category. We are honored to represent Sense today, and whatever the final outcome, we will show ourselves to be worthy of the confidence we have been granted. We would like to take this opportunity to thank CSEM and the SUI, without whom this technology and this product would never have been developed.”
About CSEM – an innovation center
CSEM, Centre Suisse d’ Electronique et de Microtechnique (Swiss Center for Electronics and Microtechnology), founded in 1984, is a private research and development center specializing in microtechnology, nanotechnology, microelectronics, system engineering and communications technologies. It offers its customers and industry partners custom-made innovative solutions based on its knowledge of the market and technological expertise derived from applied research. Having founded several start-ups, it contributes to developing Switzerland as an industrial location. To date, a total of 29 such enterprises, with more than 500 employees, have been launched by CSEM. Approximately 400 highly qualified and specialized employees from various scientific and technical disciplines work for CSEM in Neuchâtel, Zurich, Basel, Alpnach and Landquart. They represent more than 30 nationalities and constitute the basis of the company’s creativity, dynamism and potential for innovation.
Further information is available at www.csem.ch
About SenseCore AG (Sense)
Sense is a joint venture created in October 2008 by CSEM and the SUI. Specialized in the sector of biomedical monitoring, the young start-up aims to transform the market of continuous and simultaneous measurement of the main physiological signals thanks to a concept of wireless sensors adapted to the needs of professional athletes as well as clinics or rehabilitation centers.
Further information is available at www.sense-core.com
About the “Swiss Technology Award”
Since 1987, the “Swiss Technology Award” promotes and rewards Swiss innovative technologies internationally. It is currently considered as one of the most prestigious awards for technology in Switzerland.
Further information is available at www.swiss-innovation.com
Nanostart-held ItN Nanovation achieves key milestone in international expansion
Frankfurt / Saarbrücken – October 27, 2010 – ItN Nanovation AG (ISIN DE000A0JL461), a portfolio company of Nanostart AG, has announced a key milestone in the international expansion of its ceramic flat filter membrane technology, called CFM Systems®, for water treatment applications. The company has now agreed the terms and conditions for establishing a joint venture in Saudi Arabia with a Saudi Arabian investor from Jeddah and a consortium of German industrial investors. ItN Nanovation will initially hold a 17.5 percent share in the joint venture, which will later be increased to 40 percent. This rise has already been stipulated in the term sheet and must be implemented by 2014.
The parties are likely to sign binding agreements regarding the joint venture by the end of November.
According to the signed term sheet, ItN Nanovation will receive around USD 2.35 million (approximately EUR 1.75 million) up front for providing a limited amount of locally delimited usage rights for the patented CFM nanotechnology systems. ItN Nanovation will use around two thirds of this sum for acquiring its share in the joint venture. The company is likely to recognise this amount as other operating income for the current financial year. Apart from this one-off payment, ItN Nanovation will also receive additional royalties that will be recognised in income. Due to the company’s share in the joint venture, it will also participate in the profits and losses as well as value creation of the joint venture on a pro-rata basis.
The joint venture will operate under the name of Saudi Water Nanovation and produce and sell CFM Systems and accessories for flat filter membrane solutions at its own premises in Saudi Arabia. Plans are for the joint venture to construct a plant that will have three times the capacity available to ItN Nanovation AG at present once it reaches the last construction phase (probably in 2013). The joint venture may be able to start up production as early as 2011.
ItN Nanovation’s ceramic flat filter membranes are a brand new solution for filtering systems in the water recycling, drinking water supply and surface water processing sectors. The need for such solutions is particularly high in Saudi Arabia and neighbouring Arabian countries.
Apart from the positive effect on group income, the joint venture has model character for ItN Nanovation in terms of developing the company’s international business in conjunction with local partners, and other joint ventures are already in the pipeline.
The ItN Nanovation management board will be holding a telephone conference (in german language) for investors, analysts and media representatives on Thursday, 28 October 2010 at 10:00 a.m. CET. They will explain this cooperation in detail and provide information on the company’s outlook for the coming quarters. If you wish to participate in the telephone conference, please contact Diane Selge, edicto GmbH on +49 69 905505-53 or at dselge@edicto.de for the log-in data.
Nanostart-held Lumiphore announces cooperation agreement with leading oncology company
Frankfurt, Germany / Richmond, Calif. – October 26, 2010 – Lumiphore Inc., a portfolio company of Nanostart AG, has signed a global cooperation with Algeta ASA (Oslo Stock Exchange, ticker: ALGETA), a leading company specializing in innovative radiopharmaceutical therapies to treat cancer patients. The agreement enables the integration of Lumiphore’s Lumi4® complexes into the targeted radiotherapeutics and companion diagnostics from Algeta. This also marks the fourth significant partnership for Lumiphore in just four years.
The highly targeted form of radiotherapy works by using a new class of radiation-emitting pharmaceuticals, called “alpha-pharmaceuticals”. These act through molecular binding to cancer cells, where they can then emit alpha particles in precisely the right location to treat the tumor.
The agreement provides Algeta with an option to the exclusive rights to incorporate the Lumi4® isophthalamide chelation technology from Lumiphore into these targeted radiopharmaceutical therapeutics for cancer.
The Lumi4® complex functions by binding to a radioactive metal ion, which is the radiation source that emits the alpha particles which in turn destroy the tumor. At the same time, another portion of the complex binds to the pharmaceutical substance which is required to identify the tumor cells.
Under the terms of the agreement, Algeta obtains an exclusive 12-month option to an exclusive license for the use of Lumiphore's Lumi4® chelator technology within the field of therapeutic radiopharmaceuticals. The license will also give Algeta the right to use this technology in companion diagnostics, which are radiopharmaceuticals for determining either the suitability of patients for treatment and/or the effectiveness of treatment. Algeta will pay Lumiphore a fee on signing the option agreement and will make further payments should it exercise the option and take up the license.
Alpha radiation is of particular interest in fighting cancer because, provided it can be delivered to the tumor site, it has the potential to effectively destroy cancer cells while at the same time limiting delivery to the local area and thus sparing the surrounding healthy tissue. This greatly reduces side effects, making the therapy an attractive alternative.
“Lumiphore’s goal is to bring the benefits of bifunctional metal-chelation technology to therapeutic markets that use targeted radiopharmaceuticals to treat cancer. The ability to chelate radioactive metal isotopes and covalently attach them to therapeutic antibodies, peptides, proteins, or other receptor targeting molecules will benefit targeted delivery to cancer sites and has the potential to make current therapeutic antibodies more effective,” said Dr. Ken Raymond, President and CEO of Lumiphore.
Algeta holds a proprietary technology involving the use of thorium-227, an isotope that emits high-energy alpha particles, to target and destroy cancer cells. Such isotopes are of considerable interest in the treatment of cancer as they are potent at killing tumor cells but have a highly localized effect. By linking thorium-227 to tumor-targeting molecules such as monoclonal antibodies, Algeta has the potential to create a pipeline of new generation alpha-pharmaceuticals designed to specifically seek and destroy cancers while minimizing damage to surrounding healthy tissues.
“Using Lumi4® bifunctional chelates could create a new class of radioimmunotherapeutics,” explained Thomas Ramdahl, Chief Technology Officer of Algeta. “By linking thorium-227 to selected tumor targeting antibodies using existing non-proprietary chelates, Algeta has already demonstrated in vivo the potential of its proprietary technology for enhancing the performance of radio-immunotherapies based on existing clinical antibodies. We believe that the new chelators will provide even better results.”
Algeta is a world leader in the medical application of alpha emitters and in the development of the alpha-pharmaceuticals, an entirely new class of cancer treatment pharmaceuticals which incorporate these, using drug-coupled alpha emitters to target and destroy cancer cells.
Lumiphore has other existing partnerships with Thermo Fisher Scientific Specialty Diagnostics for certain diagnostic tests in both laboratory and point-of-care formats, such as for Downs Syndrome; with CisBio International, for the drug discovery research market; and with Biophor Diagnostics Inc. for diagnostic tests for drugs of abuse.
NANOINK’S NANOFABRICATION SYSTEMS DIVISION
OFFERS FREE NANOTECHNOLOGY WORKSHOPS
AT GEORGIA TECH AND PRINCETON UNIVERSITY
Workshops will focus on Tip-Based Patterning for Bio and Nano Engineering
SKOKIE, Ill. – October 18, 2010 – NanoInk, Inc.®, a global leader in nanotechnology, announced today that its NanoFabrication Systems Division will present free workshops focusing on tip-based patterning for bio and nano engineering at Georgia Tech on Monday, October 25, and at Princeton University on Tuesday, November 2. The workshops will feature technical talks, discussions and product demonstrations and will highlight the most recent applications and protocols related to deposition of biomaterials using NanoInk’s NLP 2000 System, a desktop nanolithography platform.
The workshop at the Georgia Tech Nanotechnology Research Center will take place on Monday
October 25, from 10 a.m. to 3 p.m. In addition to the technical talks, discussions and product demonstrations, the workshop will also feature a presentation by professor Khalid Salaita, of Emory University. Professor Salaita‘s presentation is titled, “Nano-mechanical and spatial regulations within cell junctions,” and will begin at 10:15 a.m. The workshop will be held in the conference room at the Marcus Nanotechnology Building, located at 345 Ferst Drive NW, Atlanta, Ga. More information, including registration and directions, is available at http://tiny.cc/Nanoink-GeorgiaTech.
The workshop at the Princeton Institute for the Science and Technology of Materials (PRISM) will take place on Tuesday, November 2, from 10 a.m. to 3 p.m. It will be held in the Bowen Hall Auditorium (Room 222), located at 70 Prospect Ave., Princeton, N.J. More information, including registration and directions, is available at http://tiny.cc/Nanoink-Princeton.
During the workshops, participants will have access to NanoInk’s NLP 2000 System, which is an easy to use and affordable desktop nanolithography platform in which patterns of nano to micron-sized features can be created with a wide variety of materials from metal nanoparticles to biomolecules. With the NLP 2000 System, researchers can rapidly design and create custom engineered surfaces over large areas, using NanoInk’s proven technique of Dip Pen Nanolithography® (DPN®).
More information about the workshop topics are as follows:
Biomaterials Deposition: Demonstrations will show how to directly pattern hydrogels, both pure and functionalized, in arbitrary sizes and patterns over large areas (40 mm x 40 mm). The NLP 2000 System gives researchers the ability to pattern multiple biocompatible polymers at sub-cellular features sizes with nanoscale precision.
Biosensor Functionalization: The NLP 2000 System can be used to write directly to existing structures, opening up the possibility to functionalize microscale sensor devices with multiple materials.
Parallel and Multiplexed Depositions: Using NanoInk’s multiple tip arrays; demonstrations will show how to pattern complex multi-component protein arrays with sub-cellular feature sizes for use in cell adhesion, cell migration, and cell differentiation studies.
Rapid Prototyping: The generation of new patterns requires a simple change in the pattern entered into the software. This direct write technique can be used to rapidly prototype arbitrary patterns without having to create a new master stamp or mask for each pattern.
Please visit www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
TriQuint names VIPER RF as design resource
SUNDERLAND, UK: 24 September 2010 — VIPER RF, a specialist in microwave and RF IC design and development, has announced that it has entered into a co-marketing agreement with TriQuint, a leading RF product manufacturer and foundry services provider. Under the agreement VIPER RF will offer design support and specialised RF expertise to help customers develop chips using TriQuint's process technologies and design tools.
VIPER RF is a UK microwave and RF consultancy and product-based company that addresses a range of markets including defence and security, communications and wireless applications, covering frequencies in the range DC – 100GHz.
The TriQuint foundry offers a range of process technologies including GaAs FETs (pHEMT and MESFET), InGaP HBT, BiHEMT and GaN, on 3-inch, 100mm and 150mm wafers. Its customers include OEMs, fabless semiconductor and wireless startups. VIPER RF joins an established network of design resources worldwide that each has the experience and tools to assist TriQuint’s customers in realising their RF and microwave IC design goals.
“Third party design expertise, such as that provided by VIPER RF, is invaluable to customers with limited design resources, and this type of co-marketing agreement provides tangible benefits to the entire RF ecosystem,” commented Mike Peters, Director of Marketing for Commercial Foundry at. TriQuint. “VIPER RF’s experience in GaAs MMIC and RFIC design, as well as its market focus, is a very good match to the application areas we address.”
“TriQuint is one of the world’s leading providers of GaAs and GaN foundry technologies, and it is a great honour for us to have been named as one of their co-marketing design resource companies,” added Jim Mayock, CEO of VIPER RF. “We look forward to a long and mutually rewarding relationship helping customers to use TriQuint’s foundry services profitably.”
About VIPER RF
VIPER RF Ltd. is a microwave and RF consultancy and product-based company with a design office situated in Sunderland, North East of England. The privately-funded company was established in 2008 with the aim of developing innovative products as well as offering design services and consultancy.
The company has considerable expertise in the design and development of sophisticated RF components and subsystems from concept through to product release, and prides itself on developing close long-term partnerships with its clients.
VIPER RF addresses a range of markets including defence and security, communications and wireless applications, covering frequencies in the range DC – 100GHz. The company has specialist knowledge in a range of technical areas including GaAs MMIC and RFIC design, RF and microwave subsystem and module development and packaging technologies.
For further details please see www.viper-rf.com
New series of “Nanotechnology for E&P” webinars
on Tuesday 28th September!
Extending equipment life and operating envelopes using nano-scale coatings.
Sign up now at www.epnanonet.com
The webinar will feature presentations and Q&A sessions with leading experts in this field who have identified the potential market for nano coatings in the oil & gas sector:
Dr Diane Hickey – Advanced Diamond
Dore Rosenblum – Sub-One
Andrew Sherman – Mesocoat
To participate in EPNanoNet webinars, you will need to be a member of EPNanoNet.
Membership in the network offers:
· Free access to all EPNanoNet webinars
· Preferential invitations to EPNanoNet summits
· Free access to the online discussion forum
· Free access to the online library (including the “Industry roadmap” for nanotechnology in E&P)
· And the opportunity to network with leading nanotechnology providers, the world’s largest oil and gas companies, equipment suppliers to the oil and gas sector, investors and researchers!
Nanostart-owned MagForce publishes study results of Nano-Cancer® therapy in leading medical journal
Berlin / Frankfurt – September 21, 2010 – The internationally renowned Journal of Neuro-Oncology has published the results of a clinical study by MagForce Nanotechnologies AG (Frankfurt Stock Exchange:MF6), a majority-owned portfolio company of Nanostart AG, demonstrating the effectiveness of its Nano-Cancer® therapy in the treatment of patients with recurrent glioblastoma. These clinical trials served as the basis for EU regulatory approval, received in June 2010, of this revolutionary new approach to treating solid tumors.
The Journal of Neuro-Oncology is an international multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research.
With this publication in the Journal of Neuro-Oncology, the detailed results of clinical trials demonstrating the effectiveness of Nano-Cancer® therapy have now for the first time been shared with the international scientific and medical community.
According to statements made by Dr. Peter Heinrich, CEO of MagForce Nanotechnologies, the company is currently planning further strategic steps. Product introduction, starting with the German market, is schedule to commence in the first quarter of 2011. Sale and marketing teams for product commercialization, as well as the needed infrastructure, are currently being put in place. In addition, other clinical trials will be initiated, and the company will be structured to optimally serve the international market.
The full journal article, entitled “Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme,” may be found at http://www.springerlink.com/content/u27ll42612302123/ or http://www.ncbi.nlm.nih.gov/pubmed/20845061.
The study reported on the treatment of 59 cancer patients suffering from recurrent glioblastoma, a particularly aggressive form of brain tumor. Using Nano-Cancer® therapy in conjunction with radiotherapy, the median survival time of the patient group was 13.4 months, compared to 6.2 months using existing conventional therapies in a control study. The median survival time was thus more than doubled, a significant increase. In addition, the new therapy offers the advantage of minimal side effects and reduced patient discomfort compared to existing therapeutic alternatives.
Nanostart AG announces record numbers for the first half of 2010
Transparency report in accordance with §17 Section 2 of the general terms
and conditions for open markets
Frankfurt, Germany – September 21, 2010 – Frankfurt-based nanotechnology company Nanostart AG is reporting the best first-half results since the company was founded for the first six months of 2010. In accordance with commercial code, semi-annual net profit totaled EUR 923,000 (previous year EUR -1.4 million). Earlier in the year, Swiss company and global market leader Roche Diagnostics purchased the main product line of American Nanostart holding BioMicro Systems, Inc. Revenues from this transaction are however not included in semi-annual numbers, as the cash transfer took place after the June 30, 2010 reporting date.
In addition to positive earnings results, Nanostart achieved a net asset value of nearly EUR 144 million as of the reporting date. This is approximately EUR 29 million more than at the same point last year. In the conservative calculation of net asset value, shares of unlisted shareholdings – about 80 percent of the current portfolio – are attributed to acquisition costs in the calculations. Only existing shareholdings in Nanostart AG companies that are listed on the stock exchange are entered at market value.
The company continues to pursue international expansion. Acquisition of additional holdings is anticipated this year, especially in Singapore, where Nanostart is investing as a government partner.
Semi-annual numbers are now archived at the Nanostart website in the Investor Relations area. The 2010 semi-annual report will be available September 27 in the company reports section.
About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan. If there is any inconsistency between the German and the English versions of this document, the German version will prevail.
AMO GmbH decided in favour of the Vistec's Electron-Beam Lithography System EBPG5200
Vistec Lithography, Inc., a leading supplier of advanced electron-beam lithography systems, announced today that AMO GmbH, a research service provider for nanotechnology located in Aachen (Germany), has placed an order for Vistec's electron-beam lithography system EBPG5200.
AMO (Gesellschaft für Angewandte Mikro- und Optoelektronik mbH) as a research service provider holds designated competencies in several areas of nanotechnology as nanofabrication, nanoelectronics, nanophotonics and biotechnology. Beside research & development capacity AMO is able to offer the entire infrastructure required for nanotechnology, in which electron-beam lithography plays a decisive role. With the new Vistec EBPG5200 a highly flexible and reliable patterning system will be available
for nanofabrication services.
The Vistec EBPG5200 is the latest version of the highly successive and field-proven EBPG electron-beam lithography tool series. The EBPG5200 system can be operated with 20, 50 and 100kV accelerating voltage and is equipped with a 50MHz pattern generator and full 20bit address technology. With the EBPG5200 Vistec offers true 100kV/ 1mm performance under regular electron-optical conditions.
Thanks to further enhancements in resolution, noise reduction and beam stability, the Vistec EBPG5200 is set to routinely generate structures less than 8nm on varying substrates sizes from piece parts of a few millimetres to full patterning across a 200mm diameter. The system incorporates an interactive graphical user interface (GUI) that provides ease of use for diverse 'multi user environments'.
Dr. Christian Moormann, Managing Director of AMO GmbH, stated: "High end electron beam lithography is the basic technology for all our activities in nanophotonics, electronics and nanoimprint. We decided to base our flexible nanotechnology R&D services again upon a Vistec electron beam lithography system because performance and service were convincing. We believe in the high quality of EPBG5200 even in rugged environmental situations and enlarge our capabilities significantly with the new system."
Commenting on today's announcement, Rainer Schmid, General Manager at Vistec Lithography, Inc. noted: "With the EBPG5200 at AMO a long lasting and fruitful collaboration between the two companies further continues. Customers like AMO help us to supply systems, which fit best to the challenging requirements of nanopatterning today and in future."
EXSOR NAMED EXCLUSIVE DISTRIBUTOR FOR NANOINK IN BRAZIL
Exsor to distribute NanoInk’s nanofabrication equipment and the
NanoProfessor Nanoscience Education Program
CHICAGO, Ill. – September 14, 2010 – NanoInk, Inc.®, a global leader in nanotechnology,
announced today that it has reached an agreement with Exsor Com. e Imp. de Equipamentos de
Precisão Ltda. to serve as NanoInk’s exclusive distributor in Brazil for the company’s desktop nanofabrication equipment including the NLP 2000 System, the DPN 5000 System and the NanoProfessor™ Nanoscience Education Program. Founded in 2006, Exsor provides nanotechnology and optics products and equipment to companies and universities in Brazil.
James Hussey, chief executive officer for NanoInk said, “We are extremely pleased to expand our reach into Brazil with Exsor, which has demonstrated its strong commitment to nanotechnology as a distributor of this rapidly developing technology.”
“We are thrilled to be named the authorized distributor for NanoInk in Brazil,” said Ute Labitzke, general manager, of Exsor. “We feel there is a tremendous market for NanoInk’s nanofabrication equipment which brings sophisticated nanofabrication equipment to the laboratory desktop. Additionally, the NanoProfessor Program offers innovative technology in the area of nanoscience and we look forward to offering this program to community colleges, technical institutes, and undergraduate universities throughout Brazil.”
NanoInk’s NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable setting. NanoInk’s NLP 2000 System is a desktop nanofabrication system that allows researchers to rapidly design and create custom engineered and functionalized surfaces, using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area.
The DPN 5000 System is a full-featured, dedicated instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision. With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling the tip movements during the writing process.
The NanoProfessor Nanoscience Education Program aims to expand hands-on nanotechnology
education from the cleanrooms of research-based universities to undergraduate classrooms and is especially well-suited to nanotechnology educational initiatives. The program alternates between classroom lectures and hands-on lab work and includes a 275-page textbook authored by leading nanotechnology experts covering the topics of Nanotechnology Basics, NanoPhysics, NanoChemistry, NanoBiology and Environmental, Health, and Safety perspectives on nanotechnology.
To place an order through Exsor for NanoInk’s desktop nanofabrication equipment or the
NanoProfessor Program, please call +55-11-4612 1312 or email exsor@exsor.com.br.
More information about NanoInk’s NanoFabrication Systems Division is available on its new Web site at: www.nanoink.net.
For more information on how the NanoProfessor Nanoscience Education Program can be implemented at your community college, technical institute, high school or university, please call (847) 679-NANO (6266) or visit www.NanoProfessor.net.
NANOINK RELEASES TWO NEW NANOSCALE APPLICATIONS
IN BIOLOGY FOR THE NLP 2000 SYSTEM
CHICAGO -- September 7, 2010 -- NanoInk, Inc.®, a global leader in nanolithography, announced that it expanded the range of nanoscale applications for biology with the recent launch of two new Application Notes. NanoInk’s NanoFabrication Systems Division instruments, most notably the NLP 2000 System, have now been proven to enable applications related to micropatterning of polyethylene glycol (PEG)-based hydrogel and UV-curable polymer. These new capabilities broaden even further the applicability of the NLP 2000 System for biological sciences. Earlier Application Notes described the benefits of using NanoInk’s platform to functionalize biosensors, pattern functional hydrogels and print
multiplexed protein arrays.
Launched in 2009 as a tool for bioscience research, the NLP 2000 System is a simple, user-friendly desktop nanolithography platform. The system leverages patented Dip Pen Nanolithography® (DPN®) technology to deposit sub-cellular-scale features of a wide variety of materials with nanoscale registry, all under ambient conditions. With the addition of two new Application Notes to its portfolio of biological research support materials, NanoInk continues to serve as a true partner to the life science community.
‘‘The first of the new Application Notes demonstrates successful use of the NLP 2000 System for micropatterning PEG-based hydrogels,’’ said Tom Warwick, NanoInk’s general manager of sales and marketing. ‘‘Hydrogels are three-dimensional cross-linked polymer networks that have physical characteristics similar to those of natural tissues. The versatility of PEG chemistry and the excellent biocompatibility of PEG-based hydrogels have been instrumental in hydrogel advances related to controlled material release, directed cellular function, tissue engineering, and regenerative medicine applications. NanoInk has developed a consistent and reproducible methodology for directly depositing
hydrogel precursors at defined locations on a surface and subsequently polymerizing these precursors to form PEG-based hydrogels.’’
The second new bioscience Application Note validates the utility of the NLP 2000 System for printing UV-curable polymers. Features generated by the NLP 2000 System have sub-cellular dimensions, so polymer arrays can be used to study cell/substrate interactions at the single cell level. Micro-patterned polymers are also useful in tissue engineering, lab-on-a-chip, flexible circuit and microlens applications.
With DPN’s ability to generate arrays that cover millimeter-scale areas with nanometer resolution and precision, the NLP 2000 System has been proven to print homogeneous and highly reliable polymer patterns onto smooth substrates like glass and silicon wafers.
NanoInk Releases Two Nanoscale Application Notes for the NLP 2000 NanoInk is dedicated to developing and supporting a wide range of biological applications for the NLP2000 System. The latest two Application Notes further confirm this commitment. A full list of
applications notes is available at: www.nanoink.net/biomaterials/literature.html#notes.
Please visit NanoInk’s new Web site at www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
FutureCarbon at Composites Europe 2010
– look into high-tech super-composites live
At this year's Composites Europe show from September 14 through 16 in Essen FutureCarbon GmbH, the leading producer of super-composite materials, is presenting its latest solutions for heating systems in hall 10-11 on booth G36.
CarboImpreg is a brand-new product from FutureCarbon based on carbon nanomaterials. It belongs to a family of products grouped around Carbo e-Therm, a high-efficiency electrically heated coating that will operate on non-hazardous low voltage. CarboImpreg will enable impregnation of rough or absorptive surfaces of materials such as leather to make these surfaces conduct. What's special about CarboImpreg is that it soaks into the material surface and will allow even warming of this surface by application of a suitable voltage (e.g. 12 or 24 volts).
Nor are the processing properties of the material altered – direct further processing is quite straightforward such as adhesion to plastic molded parts.
Interested companies and journalists are invited to arrange a meeting or interview. Just phone or e-mail FutureCarbon.
FutureCarbon specializes in the development and manufacture of carbon nanomaterials and their refinement into so called carbon supercomposites as primary products for industrial further processing. Carbon supercomposites are composite materials that evolve the special properties of carbon nanomaterials in the macroscopic world of real applications. All of our materials are manufactured on an industrial scale.
In addition to the electrically heated Carbo e-Therm and CarboImpreg coatings, the FutureCarbon portfolio includes a variety of materials with functionality specialized for electrical and mechanical characteristics.
Among them are:
CarboGran, a dry and dustfree granulate of carbon nanotubes with excellent dispersing characteristics that make it suitable for follow-up standard industrial processes without the effort of predispersion.
CarboFlex is a silicone resin characterized by superior elasticity plus high electric conductivity.
CarboCond is an electrically conductive epoxy resin that exhibits substantially improved mechanical properties through a special additive of carbon nanoparticles. It is suitable for all purposes calling for very high electric conductivity and mechanical ruggedness: antistatic flooring, coatings, ESD protective components, etc.
For more information visit: www.future-carbon.de
INL Selects Vistec's Electron-Beam Lithography System EBPG5200 for
Nanotechnology Research
Braga, Portugal / Watervliet, USA - Vistec Lithography, a leading supplier of advanced electron-beam lithography systems has announced today that the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal has placed an order for Vistec's
electron-beam lithography system EBPG5200. The Portuguese Laboratory is the first fully international research organization in Europe in the field of nanoscience and nanotechnology.
The INL, which was established by Portugal and Spain some years ago, has now moved into the equipping phase of its new research facility, where the lithography equipment will play an important role. With the Vistec EBPG5200 series and its unique and flexible nanoscale patterning capabilities, the INL has acquired one of the most advanced electron-beam lithography systems for nanotechnology research and development. Furthermore, this will be the first installation of an EBPG5200 system at the Iberian Peninsula.
The Vistec EBPG5200 is the latest version of the highly successive and field-proven EBPG electron-beam lithography tool series. The EBPG5200 system can be operated with both 50 and 100kV accelerating voltage and is equipped with a 50MHz pattern generator and full 20bit address technology. Thanks to further enhancements in resolution, noise reduction and beam stability, the Vistec EBPG5200 is set to generate structures to less than 8nm on varying substrates sizes from piece parts of a few millimetres to full patterning
across a 200mm diameter. However, what makes Vistec?s electron beam lithography of superior standards so unique and actually possible, is the perfect match of the various system components such as the electron-optical column, the hardware platform, the data processor and the exposure engine working together in a flexible and user friendly system. The system incorporates an interactive graphical user interface (GUI) that provides
ease of use for diverse "multi user environments".
"Nanotechnology has the potential to profoundly impact our future life in all aspects. The EBPG5200 opens up the opportunity to maintain highest flexibility and to keep our research activities on track with the challenging requirements of the future", said Prof. Paulo Freitas, Deputy Director General at INL.
Commenting on today's announcement, Rainer Schmid, General Manager at Vistec Lithography, Inc. noted: "At Vistec, we believe that it is essential toalign with leading research organizations in the encouraging field of nanoscience and nanotechnology. That?s why we feel honored by INL's choice to decide in favor of an EBPG5200."
International Iberian Nanotechnology Laboratory (INL)
INL is an international research organization in the field of nanosciences and nanotechnology, building a major research effort in the area of nanomedicine (nanotechnology applied to the medical area), and applications of nanotechnology to food and environment quality control. These activities will be supported by transversal research in nanoelectronics and single molecule based devices. INL is presently equipping its central laboratory facilities and is recruiting research personnel worldwide (www.inl.int).
Vistec Electron Beam Lithography Group
The Vistec Electron Beam Lithography Group is a global manufacturer and supplier of electron-beam lithography systems with applications ranging from nano and bio-technology to photonics and industrial environments like mask making or direct writing for fast prototype development and design evaluation. The Vistec Electron Beam Lithography Group combines Vistec Electron Beam and Vistec Lithography.
Vistec Lithography
Vistec Lithography develops, manufactures, and sells electron-beam lithography equipment based on Gaussian Beam technology. Their electron-beam systems are world-wide accepted in advanced research laboratories and universities. The company is located in Watervliet, NY (USA), within the Capital Region of New York.
Vistec Electron Beam
Vistec Electron Beam is providing electron-beam lithography equipment based on Shaped Beam technology, which is used by leading semiconductor manufacturers and many research institutes around the world. Their innovative electron-beam systems are used for microchip production and integrated optics as well as for scientific and commercial research. The
company is located in Jena (Germany).
NANOINK LAUNCHES NEW WEB SITE
CHICAGO, Ill. – August 31, 2010 – NanoInk, Inc.®, a global leader in nanotechnology, announced today that it launched a new corporate Web site, www.nanoink.net, which includes the latest information on its five operating divisions: NanoFabrication Systems; Nano BioDiscovery; NanoGuardian™; NanoProfessor™; and NanoStem™ Cell. The new Web site clearly delineates between the different divisions and commercial applications, so that visitors can more easily find the information they need. The Web site also contains updated product information, the very latest application notes and proof of performance data.
“Over the last several years, NanoInk has grown to incorporate five distinct operating divisions,” said James Hussey, chief executive officer for NanoInk. “Our new Web site reflects the transition from a technology company to a provider of commercial applications including core desktop Nanolithography instrumentation, anti-counterfeiting for the pharmaceutical industry and nanotechnology curriculum and education.”
NanoInk’s divisions include:
• The NanoFabrication Systems Division provides core desktop instrumentation and application expertise for current and future applications of DPN®. More information is available at: http://nanoink.net/divisions.html#NanoFabrication
• The Nano BioDiscovery Division provides instruments, assay kits, and contract services for nanoscale protein detection using Dip Pen Nanolithography® (DPN) technology. More
information is available at: http://nanoink.net/divisions.html#NanoBioDiscovery
• The NanoGuardian Division uses NanoEncryption™ technology to offer pharmaceutical
customers a state-of-the-art on-dose brand security solution to fight counterfeiting and illegal diversion. More information is available at: www.nanoguardian.net
• The NanoProfessor Division provides a complete nanotechnology educational solution including a suite of instruments, interdisciplinary-based curriculum, cutting-edge labs, and comprehensive educator and program support developed to extend hands-on nanotechnology education to the undergraduate classroom. More information is available at: www.nanoprofessor.net
• The NanoStem Cell Division aims to revolutionize the utility of stem cells through the application of DPN nanopatterning. More information is available at:
http://nanoink.net/divisions.html#NanoStemCell
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale
manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net
Nanostart holding ItN Nanovation AG successfully fulfills large order for drinking water purification equipment
Frankfurt / Saarbrücken, August 31, 2010 – Nanostart portfolio company ItN Nanovation AG (ISIN DE000A0JL461) has successfully fulfilled on schedule the first large order for a customer in Saudi Arabia. The order for CFM Systems ceramic flat-filter membrane technology was announced in May 2010.
Delivery of the nanoceramic filtration units to the customer has now been completed. Order volume totaled nearly USD 500,000.00, and ItN Nanovation has received all resulting payments except for the standard 10 percent guarantee deposit. ItN Nanovation nanoceramics are used as a pre-filter for reverse osmosis membranes. Discussions about additional large-volume orders for the same drinking water treatment plant are nearing finalization.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de
About ItN Nanovation:
ItN Nanovation AG, founded in 2000, is one of the leading nanotechnology companies in the world, developing innovative ceramic products, such as filtration systems and coatings, for large industrial customers. The nanoscale powder needed for those products is manufactured by the company itself. The filtration products from ItN Nanovation can be used for drinking water purification, waste water treatment, as beverage filters and for the separation of oil and water. Ceramic coatings based on nanotechnology are used in a variety of ways as protective and catalytic coatings in various industries: from baking ovens to aluminum foundries to coal-fired power plants. The company's success is founded on an extensive product portfolio, combined with comprehensive development and application know-how. For further information about the company, please visit www.itn-nanovation.de
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan
SwissINSO is on the Move
LAUSANNE, Switzerland, August 25, 2010 /PRNewswire/ --
- SwissINSO, a major innovator in the application of solar-power to water purification/desalination and heating/cooling of buildings, announces its move to Switzerland's prestigious EPFL Science Park, joining an exclusive club of world-class players.
SwissINSO SA is proud to announce its move to the prestigious R&D Science Park at EPFL (Ecole Polytechnique Federale de Lausanne), the Swiss Silicon Valley. The move to this renowned technology hub reflects the success of the company's significant product developments and rapid business growth.
SwissINSO will work within the scientific community of 300 laboratories, 4000 researchers and 7000 students. This further strengthens the company's commitment to bringing advanced, 100%-green solar technology to the marketplace.
SwissINSO is in good company as it joins the roster of 80+ companies, ranging from start-ups to some of the world's most prominent high-tech names.
A Long-Standing Research Partnership
"This move was a natural outgrowth of the partnership we developed with LESO, the solar applied research laboratory of EPFL", said Dr. Yves Ducommun, CEO of SwissINSO and a PhD from EPFL. "SwissINSO is proud to have financed two new positions at LESO, a post-doctoral scientist and a doctorate student, as part of its commitment to practical applications of advanced solar energy technology.
We believe that these knowledge-sharing initiatives and technological partnerships will help accelerate the technical and commercial development of new green products for which we have a distinct competitive edge", he added.
About SwissINSO: SwissINSO utilizes its proprietary intellectual property assets to provide environmentally friendly, innovative solar-energy solutions and related technologies to meet growing global needs. The company's goal is to become a world leader in turn-key solutions using renewable energy for the purification and desalination of water and the air cooling and heating of buildings. (http://www.swissinso.com)
SwissINSO currently has two core businesses:
- KRYSTALL (TM) is the world's first 100% solar-powered turnkey water purification system enclosed within standard 20-ft (6,1m) or 40-ft. (12,2m) containers. Easily transportable, Krystall uses patented reverse-osmosis technology to purify 100,000 litres of contaminated water or to desalinate 50,000 litres of seawater per day into high-quality water for drinking or agriculture, with low operating and maintenance costs.
Krystall is perfectly suited for servicing remote towns and villages, hotels, humanitarian and relief situations, and turnkey camps.
- KLYMAA (TM) uses state-of-the-art nano-composite solar coating technology, developed exclusively with EPFL, to heat and cool buildings via solar-collector glass facade panels. These colored, glazed thermal "curtain walls" are opaque to the eye but transparent to sunlight, allowing as much transmission of the sun's energy as clear glass. Available in a wide variety of colors and treatments, these solar panels now offer architects and engineers design possibilities previously unthinkable.
About EPFL: Ecole Polytechnique Federale de Lausanne (EPFL), is one of the premier academic institutions in Switzerland and Europe. Charged with three missions -- education, research and technology transfer at the highest international level, EPFL is associated with several specialized research institutes. Together with its sister institution in Zurich, the school is among the pre-eminent educational and applied research establishments in the world. EPFL is dedicated to pursuing innovative projects that combine fundamental and applied research to the advancement of science.
http://www.epfl.ch/index.en.html
Safe Harbor Statement: A number of statements contained in this press release are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including our ability to raise capital when needed and on acceptable terms and conditions, the intensity of competition and general economic factors. The actual results SwissINSO, recently acquired by Pashminadepot.com, may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. SwissINSO Holding Inc encourages the public to read the information provided here in conjunction with its most recent filings, which may be viewed at http://www.sec.gov
Coatema at K 2010 in Düsseldorf
Thomas Kolbusch, Vice President
The world’s biggest trade fair for plastics and rubber “K 2010” will take place in Düsseldorf from 27th October till 3rd November 2010. More than 3.000 international exhibitors have signed up to present their latest developments at the show.
Coatema Coating Machinery is going to present a new development for small-scale, cost-efficient and multifunctional R&D roll to roll equipment: the new unit called Smartcoater.
This unit with a working width of 100 mm, includes a 5in1 application system and offers knife system, micro roller, engraved roller slot die and foulard for different
coating and printing operations.
Coatema´s Smartcoater is equipped with a 350 mm hot air dryer in EEx-layout and a laminating device. Reproducibility is possible without any compromises. The multifunctional unit is equipped with 3-4 motors, load cells and a backward running operation mode.
Those features make small sample production an easy operation. The whole unit is enclosed and can also be offered for glove box operations.
As Dr. Andreas Giessmann - owner of Coatema Coating Machinery - stated “the Smartcoater is only one highlight of new equipment in 2010”, Coatema is ramping up a new range of lab and pilot coaters this year to support the ongoing success of the lab solutions programme of Coatema.
Another highlight that will be shown during the exhibition is called Thin Film Coater with different coating and printing systems and a high precision gap control for discontinuous coating and printing.
The scale-up specialists at Coatema are looking forward to meet you at an exciting exhibition in Düsseldorf. Do not miss the opportunity to meet us at booth 4A60 to
discuss your coating, printing and laminating projects in the field of plastics and rubber.
All units can be tested and rented for coating and printing trials in the Coatema R&D centre - with 11 pilot coaters, 1 production line and 1 cklick&coatsystem - one of the biggest centres worldwide.
About Coatema:
The company Coatema Coating Machinery offers mechanical engineering for coating, printing and laminating plants for R2R and S2S applications. For more than 35 years now, Coatema has been developing solutions for the most different markets like prepreg, flexible flectronic, renewable energies, converting, technical textiles, paper, medical, membrane, etc. Coatema offers lab plants, pilot plants as well as entire turn-key production solutions for coating, printing and laminating of flexible or rigid substrates.
Furthermore Coatema offers a company-owned R&D centre in Dormagen with 11 different pilot lines and a production line with a working width of 2.000 mm for research, process development or even toll coating purposes. An annual international coating symposium completes Coatema´s manifold range of services. Another key service of Coatema is mechanical engineering for scale-up processes especially in the area of new technologies, like e.g. solar or nano coatings. For further information please visit www.coatema.com!
Lux Research Water: Profiting from Waste: Finding the Value Embodied in Wastewater
Join us for a Webinar on September 14
Space is limited
Reserve your Webinar seat now at:
http://www2.luxresearchinc.com/e/3562/egister-661784107/155G0/10617902
Municipalities, agriculture, industry, and mining use prodigious quantities of water that result in equally large volumes of wastewater that is laden with nitrate and phosphorous nutrients, organic matter, hydrocarbons, and various dissolved and suspended minerals. All too often the wastewater is simply disposed and even when properly treated – at great cost – it only mollifies the most harmful environmental effects. Even with available modern treatment, runoff accounts for algal blooms, dead zones, damaged aquifers and harms the receiving bodies of water, soil, air, and human health. However, that same waste represents a vast store of wealth that can provide nearly 6% of the globe’s energy, extend dwindling metal and mineral supplies, and reduce the need for chemical fertilizers. Fortunately, there are many forward looking firms accessing the vast wastewater resource.
Join us to learn about:
• The value of the energy, minerals, and nutrients embodied in wastewater that is globally generated
• The adverse environmental and economic costs associated with present disposal paradigms
• The technologies and companies set to tap the potential value stream in wastewater
Title: Lux Research Water: Profiting from Waste: Finding the Value Embodied in Wastewater
Date: Tuesday, September 14, 2010
Time: 11:00 AM - 12:00 PM EDT
After registering you will receive a confirmation email containing information about joining the Webinar.
System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer
Nanostart holding ItN Nanovation: results improve by more than 600,000 euros in the first half of 2010
Saarbrücken / Frankfurt – August 24, 2010 – Nanostart portfolio company ItN Nanovation AG (ISIN DE000A0JL461) has further improved its financial results. The numbers published yesterday in the semi-annual report show an increase of 626,000 euros over the same period last year. In the first half of the year, the company managed to create conditions for achieving overall objectives for fiscal 2010.
Reorganization and restructuring measures are making a significant impact. On the cost side, the company has been able to achieve additional substantial reductions. In total, personnel costs and other operational expenses have been reduced by 25 percent.
The company obtained a gross cash influx of nearly 1.3 million euros through a capital increase in April 2010. The placement of shares with reputable industrial investors at an issue price very close to the market value was successful. Funds were procured in particular to prepare for anticipated bulk filtration orders. Despite capital increase measures, the financial situation remains tight.
Ceramic flat filter CFM Systems® are developing as planned into a major sales item and margin enhancer. The primary area of application in 2010 is pre-filtration of reverse osmosis systems for drinking water extraction. This is a large market segment in the Arabian region. ItN Nanovation achieved access to this market by successfully fulfilling an initial order in July that was placed in early May. Concrete orders from Saudi Arabia with considerable volume are already emerging for the third and fourth quarters of the current year. The objective of achieving the highest revenues in company history in 2010 is within reach.
Together with a Maltese partner, the first highly integrated MBBR (Moving Bed Bio Reactor) container purification plant was developed and presented to the public as a series in June 2010. This globally unique system will make a sustainable contribution to the future business success of ItN Nanovation. The first systems are scheduled for delivery from Malta in November/December of the current year. In addition, entry into the Indian market with a simplified version of this container system is planned.
ItN Nanovation is now entering the final phase of a multistage reorganization and restructuring concept, in which the company is significantly improving sales in terms of profit ratio. The company anticipates a considerable increase in sales in the second half of 2010 and expects positive overall numbers for the year thanks to results-improving effects created by the formation of joint ventures and subsidiaries.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About ItN Nanovation:
ItN Nanovation AG, founded in 2000, is one of the leading nanotechnology companies in the world, developing innovative ceramic products, such as filtration systems and coatings, for large industrial customers. The nanoscale powder needed for those products is manufactured by the company itself. The filtration products from ItN Nanovation can be used for drinking water purification, waste water treatment, as beverage filters and for the separation of oil and water. Ceramic coatings based on nanotechnology are used in a variety of ways as protective and catalytic coatings in various industries: from baking ovens to aluminum foundries to coal-fired power plants. The company's success is founded on an extensive product portfolio, combined with comprehensive development and application know-how. For further information about the company, please visit www.itn-nanovation.de.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
U.S. Risks Losing Global Leadership in Nanotech
While the U.S. still leads the world in nanotech innovation by virtue of its size, Japan, Germany and South Korea are doing a better job of bringing technology to market, says Lux Research.
In terms of sheer volume, the U.S. dominated the rest of the world in nanotech funding and new patents last year, as U.S. government funding, corporate spending, and VC investment in nanotech collectively reached $6.4 billion in 2009. But according to a new report from Lux Research, countries such as China and Russia launched new challenges to U.S. dominance in 2009, while smaller players such as Japan, Germany and South Korea surpassed the United States in terms of commercializing nanotechnology and products.
The report, titled “Ranking the Nations on Nanotech: Hidden Havens and False Threats,” compares nanotech innovation and technology development in 19 countries in order to provide government policymakers, corporate leaders and investors a detailed map of the nanotech’s international development landscape. Overall, the report found global investment in nanotech held steady through the recent financial crisis, drawing $17.6 billion from governments, corporations and investors in 2009, a 1% increase over 2008’s $17.5 billion. Only venture capitalists dialed back their support, cutting investments by 43% relative to 2008.
“Part of what motivated our research was the emerging possibility that ambitious new government funding in Russia and China represented a threat to U.S. dominance in nanotech innovation,” said David Hwang, an Analyst at Lux Research, and the report’s lead author. “But while the field certainly gained momentum in both countries as a result of the increased funding, both countries have economic and intellectual property protection issues that prevent them from being real threats just yet.”
To uncover the most fertile environments for technology developers, buyers, and investors, Lux Research mapped the nanotech ecosystems of select nations, building on earlier reports published from 2005 through 2008. In addition to tracking fundamentals, such as the number of nanotech publications and patents issued, the report also inventoried direct and indirect spending on nanotech from government, corporate and venture sources. Among its key observations:
The U.S. continues to dominate in nanotech development… for now. Last year saw the U.S. lead all other countries in terms of government funding, corporate spending, VC investment, and patent issuances. But its capacity to commercialize those technologies and leverage them to grow the economy is comparatively mediocre. U.S. competitiveness in long-term innovation is also at risk, as the relative number of science and engineering graduates in its population is significantly lower than it is in other countries.
Other countries stand to get more bang for their nanotech buck. Japan, Germany, and South Korea continued their impressive trajectories from 2008, earning top spots in publications, patents, government funding, and corporate spending. Compared to the U.S., all three also remain more focused on nanotech and appear more adept at commercializing new technology. The relative magnitude of the technology manufacturing sectors in these three countries are the world’s highest, meaning their economies stand to benefit the most from nanotech commercialization.
Russian and Chinese investment in nanotech yields slow progress. While both governments launched generous nanotech investment programs last year, the technology hasn’t gained momentum in either country’s private sector, both of which have a history of skimping on R&D. The relative lack of momentum was further underscored by the abysmal number of new nanotech patents for either country last year.
“Ranking the Nations on Nanotech: Hidden Havens and False Threats,” is part of the Lux Nanomaterials Intelligence service. Clients subscribing to this service receive ongoing research on market and technology trends, continuous technology scouting reports and proprietary data points in the weekly Lux Research Nanomaterials Journal, and on-demand inquiry with Lux Research analysts.
About Lux Research
Lux Research provides strategic advice and on-going intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients. Visit www.luxresearchinc.com for more information.
Nanostart increases shareholding in Singapore
medical technology company BioMers
Frankfurt / Singapore – August 12, 2010 – Nanostart AG has increased its ownership share in Singapore-based BioMers Pte Ltd. The proceeds from this current round of financing are to be used to expand the company’s global sales network, especially in Europe and the USA. In particular, the company plans to hire new staff as well as to invest in wide-ranging sales and marketing activities. A further investment objective is to automate the company’s production, which takes place in its Singapore headquarters.
BioMers produces innovative polymer composite wires based on nanotechnology. Its first successful commercial application has been in orthodontic wires used for braces and retainers. Until now, these wires had to be made of metal in order to have the needed physical properties. With its revolutionary technology, BioMers is now the world’s only company able to produce these from clear or colored translucent plastic and thus to make braces and retainers which are aesthetically pleasing. This breakthrough provides the company with a decisive competitive advantage, giving it the potential to fundamentally transform the global market for orthodontic devices. BioMers offers a complete set of products for aesthetic orthodontic treatment.
“BioMers has a truly unique product portfolio in the field of orthodontics which fits very well with the current market trend,” remarked Andreas Kröll, managing director of Singapore-based Nanostart subsidiary Nanostart Asia Pte Ltd. “The global market for braces is becoming much more oriented toward aesthetics, and this market – as well as the return potential for investors – is enormous.”
Nanostart holds its position in BioMers as lead investor through its Nanostart Singapore Early Stage Venture Fund. With this transaction, the fund’s shareholding in BioMers rises from 16 to about 25 percent.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About BioMers:
BioMers Pte Ltd is a spin-off of the world-renowned National University of Singapore (NUS). Using the company’s proprietary technology, originally developed at NUS, extremely strong nanofiber-reinforced polymer composites can be produced for various biomedical applications. These first of these revolutionary innovations to be brought to market are the company’s aesthetic products for orthodontic applications, including translucent wires for braces and translucent retainers. Further information may be found at www.biomersbraces.com.
Disclaimer
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Nanostart-held Nanosys: Major investment from Samsung Electronics
Palo Alto / Seoul / Frankfurt – August 11, 2010 – Samsung Electronics Co., Ltd. (GDR:SSNGY), a global leader in semiconductor, telecommunication, and digital technologies, is making a significant investment in Silicon Valley-based Nanosys, Inc., a portfolio company owned in part by Nanostart AG. Under the strategic alliance, Samsung and Nanosys will work together to create a new generation of cost effective, higher-efficiency products in the fields of solar, LED, memory, semiconductor, and display technology. In addition, the cooperation arrangement will accelerate the development of commercial applications of nano-architected materials for the electronics and thin film solar.
Under the terms of the deal, Samsung Electronics will contribute USD 15 million of new equity capital to Nanosys, along with additional funding and resources to co-develop products using Nanosys technologies. Samsung will also acquire licensing rights to the globally unparalleled nanotechnology portfolio from Nanosys. Existing investors will contribute a further USD 10 million in new equity.
“We believe that working closely with Nanosys will help us to develop exciting new products for our customers that will address needs in the world’s largest markets across a number of technologies,” said Seungho Ahn, senior vice president of the Intellectual Property Center, Samsung Electronics.
“Samsung is a clear leader in the electronics and solar sectors,” said Jason Hartlove, CEO of Nanosys. “Not only does Samsung bring deep knowledge of solar, memory and display technologies and markets, they bring tremendous experience in scaling up new technologies, which will help us accelerate the development, production and market introduction of devices enabled by our nano-architected materials.”
Marco Beckmann, CEO of Nanostart, added: “We are extremely pleased at the decision by Samsung to make this commitment to Nanosys. It demonstrates once again the enormous interest from major global corporations in our U.S. portfolio holdings.”
Nanostart recently announced the acquisition of another of its U.S. portfolio companies, NanoGram Corporation, by Teijin Ltd. of Japan. Earlier this year, Swiss pharmaceutical and diagnostic giant Roche bought the primary product line of a third Nanostart U.S. holding, BioMicro Systems, Inc., in an asset sale transaction.
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About Nanosys:
Nanosys, Inc. is a leader in the development of nanotechnology-enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with more than 800 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products in the areas of lighting, electronic displays, solar power and energy storage. More company information can be found at www.nanosysinc.com.
About Samsung Electronics:
Samsung Electronics Co., Ltd. is a global leader in semiconductor, telecommunication, digital media and digital convergence technologies with 2009 consolidated sales of USD 116.8 billion. Employing approximately 188,000 people in 185 offices across 65 countries, the company consists of eight independently operated business units: Visual Display, Mobile Communications, Telecommunication Systems, Digital Appliances, IT Solutions, Digital Imaging, Semiconductor and LCD. Recognized as one of the fastest growing global brands, Samsung Electronics is a leading producer of digital TVs, memory chips, mobile phones and TFT-LCDs. For more information, please visit www.samsung.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Dow Expands in Switzerland with new Microbial Control Customer Applications Center
New York, August 10 - Dow Chemical Company, which established its European Headquarters in Horgen, near Zurich, Switzerland, in the mid 1950's, recently opened an updated customer application center and a fully upgraded Research and Development (R&D) Center of Excellence in Buchs, canton St. Gallen, reports Mario Brossi, North American Senior Advisor to Switzerland Trade and Investment Promotion.
Mark Henning, general manager, Dow Microbial Control, said the company's customer application centers, now numbering 10 worldwide, are designed around applying world-class science and technology on a local and regional basis in order to solve significant microbial control problems related to disease transmission.
"The Buchs facility, part of Dow?s acquisition of Rohm & Haas, has undergone substantial upgrades, which along with the R&D Center of Excellence makes it one of the premier microbiology labs in the European region," Mr. Henning said.
Rick Strittmatter, global R&D director, Dow Microbial Control, commented "This facility also benefits the microbial control industry worldwide by providing customers with access to the latest microbiology technologies and tools, including our TAUNOVATE high throughput testing."
Mario Brossi said, "It is always pleasing to see a significant expansion by one of the original wave of American investors in Switzerland. Dow is one of the Fortune 50 that early on established a substantial presence in our country. To see them now add to their European HQ presence in the Zurich area with the opening of this cutting edge R&D Center in St. Gallen further validates the competitiveness of Switzerland as an investment location and leading research destination."
New Director Business Development & Sales
Moritz Graf zu Eulenburg
Beginning with the 1st of July Moritz Graf zu Eulenburg will take over the position of the Director Business Development and Sales at InovisCoat GmbH.
Herewith InovisCoat consequently acknowledges its strong growth in the area of high-tech coating. InovisCoat, originally coming from the photo film and
-paper production, has increased its business in nanotechnologic areas like optical films, life science and barrier sheets.
Moritz Graf zu Eulenburg, formerly successful Director Sales at Coatema Coating Machinery GmbH, was caught by the enormous technological competence of InovisCoat. The extreme precision of the multilayer coating can achieve dry coating thicknesses between 500 nanometer and 100 micrometer. This is a unique feature of InovisCoat GmbH.
About InovisCoat GmbH:
InovisCoat GmbH stands as a spin-off from AGFA in the long-lasting tradition of high-tech functional coating. InovisCoat can offer its customer everything from chemical development, as well as paste preparation and the actual coating, to ensure a successful and quality wise exclusive production of high-tech products. InovisCoat understands itself not as a simple contract coater, but as a highly competent partner for the development of new products or new economical production processes.
Formerly specialized on photographic films and papers, InovisCoat broadened its business activities especially into the nano-technologic fields of optical films (e.g. OLEDs, display technology), pharmacy- or medical technologies (e.g. wound curing, hospital hygiene), security systems (eg. identification, copy protection) as well as energetic systems (e.g. barrier sheets). Here InovisCoat can support its customers through its profound experience as well as its high innovation potential to find ever new solutions.
The existing, quite complex production facilities fulfill highest requirements on precision and flexibility even for light-sensitive products. With a substrate width of up to 1.135 mm and a coating width of 1.100 mm different materials can be coated with up to 9 different layers at the same time. Naturally each individual layer can have its own functionality. Dry coating thicknesses of 500 nanometers up to 100 micrometers can be achieved. Due to the high flexibility of the different production plants InovisCoat can offer everything from r&d quantities, via pilot production up to bigger mass production.
Nanostart-held NanoGram to be fully acquired by major
Japanese chemical corporation
Milpitas / Osaka / Frankfurt – August 9, 2010 – NanoGram Corporation, a nanotechnology company based on California and partly owned by Nanostart AG, has been acquired in its entirety by Teijin Limited (Tokyo Stock Exchange: 3401). Teijin is one of Japan’s leading international chemical groups, with some 19,000 employees and consolidated revenues in the last fiscal year of 765 billion yen. Since 2009, Teijin and NanoGram have been working together to develop new applications for its technology in the high-growth market for printed electronics, meaning electronic components which are literally “printed.” Compared to conventionally produced components, the printed electronics produced using the NanoGram technology are cheaper and more flexible in application. NanoGram is a leading-edge pioneer not only in the production of printed electronics, but also in other areas and has been actively sought around the world as a valuable partner.
Its takeover of NanoGram assures Teijin of exclusive access to an innovative nanotechnology platform which is strongly protected with 107 U.S. and international patents as well as more than 80 additional U.S. patents pending. Under the terms of the agreement, neither party is permitted to disclose the purchase price.
Teijin is excited to couple its expertise with NanoGram's technology to capitalize on the expanding markets for flexible displays and printed semiconductor materials," said Ichiro Kobayashi from Teijin, and now the CEO of NanoGram.
"Our nanoparticle manufacturing technology, and the materials we have developed using the technology, have proven to have superior functionality in a variety of applications for solar, flexible displays and printed semiconductor applications," said Dave Corbin, the former CEO of NanoGram. "What NanoGram needs to take those materials to market is application expertise and the ability to scale quickly. Teijin recognized the potential in NanoGram and its technology. It will be the company that takes us to the next level."
Nanostart AG, the international nanotechnology venture capital company based in Frankfurt, made its initial investment in NanoGram in 2007. The proceeds from the sale of its stake to Teijin will be invested by Nanostart into new nanotechnology holdings. Particularly within the Asian market, Nanostart management currently sees extraordinarily promising investment opportunities in nanotechnology which are being aggressively pursued.
This trade sale of its shareholding in NanoGram to Teijin marks the second exit so far this year for Nanostart. Earlier this year, the Swiss pharmaceutical giant Roche Diagnostics acquired the primary product line of another U.S.-based Nanostart portfolio company, BioMicro Systems Inc., in an asset sale transaction.
Teijin Limited is a global technology-driven group. Teijin Limited is listed on the Tokyo and Osaka stock exchanges and has a market capitalization of USD 3.1 billion.
About Nanostart:
Nanostart AG, headquartered in Frankfurt, Germany, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About NanoGram:
NanoGram Corporation is a pioneer and leading cleantech solutions provider that enables customers and partners to realize product and system performance previously thought impossible. NanoGram develops, manufactures, and sells silicon-based photovoltaic as well as advanced nano materials, process technologies, and production tools for optical, printed electronic and energy products. NanoGram also offers complete licensing packages that include proven materials production processes, surface modification and dispersion technologies, process transfer expertise, and ongoing support. For more information, please visit www.nanogram.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Nanostart-held ItN Nanovation signs cooperation agreement with leading Italian builder of wastewater treatment facilities
Saarbrücken / Frankfurt – August 3, 2010 – ItN Nanovation AG (ISIN DE000A0JL461), a portfolio company of Nanostart AG, yesterday announced the signing of a major cooperation agreement with one of Italy’s leading builders of wastewater treatment facilities. Under the newly signed agreement, Ecologia Soluzione Ambiente S.p.a. has committed itself to exclusively use the CFM Systems® ceramic flat filter membrane technology from ItN Nanovation in the construction of its future wastewater treatment facilities.
With this new partnership, ItN Nanovation has made a significant inroad not only in the Italian market for wastewater treatment, which is the third largest in Europe, but also in the similarly important markets of France, Spain and the UK. The deal thus opens significant additional revenue potential to ItN. In addition to use within conventional wastewater solutions, the two partners also see the potential for use in new applications for water treatment.
Ecologia Soluzione Ambiente, founded in 1966, is a plant manufacturer, focused on cleantech solutions. In its water division, the innovative company is specialized in wastewater treatment, and rainwater treatment. The company has local offices to support its business activities in the UK, France and Spain.
“That a technology leader in wastewater treatment facilities like Ecologia Soluzione Ambiente has decided to exclusively use our ceramic flat filter membranes is yet another demonstration of the superb performance that CFM Systems® can uniquely provide,” said Lutz Bungeroth, CEO of ItN Nanovation. “We are currently negotiating further cooperation arrangements along these lines in other highly promising markets. There’s a lot of interest in what our technology can do.”
About Nanostart:
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
About ItN Nanovation:
ItN Nanovation AG, founded in 2000, is one of the leading nanotechnology companies in the world, developing innovative ceramic products, such as filtration systems and coatings, for large industrial customers. The nanoscale powder needed for those products is manufactured by the company itself. The filtration products from ItN Nanovation can be used for drinking water purification, waste water treatment, as beverage filters and for the separation of oil and water. Ceramic coatings based on nanotechnology are used in a variety of ways as protective and catalytic coatings in various industries: from baking ovens to aluminum foundries to coal-fired power plants. The company's success is founded on an extensive product portfolio, combined with comprehensive development and application know-how. For further information about the company, please visit www.itn-nanovation.de.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
New Website on Piezo Technology
July 29, 2010, PI Ceramic -- a leading manufacturer of piezo ceramic materials, piezo components and custom engineered piezo products -- has released a new website.
New Website with More Information on Piezo Technology
The new website provides more technical background information on general piezo technology, application notes, tips & tricks, and several tutorials on piezo actuators, piezo materials and piezo composite transducers (energy harvesting and structural health monitoring).
Contents is currently available in the following three languages:
English: www.piceramic.com
German: www.piceramic.de
Italian: www.piceramic.it
About PI Ceramic
PI Ceramic is a leading manufacturer of piezo ceramic components for sensors and actuator applications as well as engineered assemblies for OEM, Industrial and research customers in the following industries:
Lasers & photonics, precision machining, medical, bio-nanotechnology, aerospace and semiconductors. PI Ceramic is a member of the PI (Physik Instrumente) Group of companies and currently employs more than 160 staff. The company was founded in 1992 and was ISO 1994 certified in 1994. It holds a number of patents piezo manufacturing and ultra-reliable multilayer actuators.
Downloads:
Piezo Ceramic Materials, Parameters
www.piceramic.com/datasheet/Datasheet_piezo_ceramic_materials_PI_Ceramic.pdf
Piezo Actuators and Engineered Assemblies:
Paper on the Development and Lifetime Tests of Piezo Actuators
www.piezo.ws/pdf/Development_Highly_Reliable_Piezo_Actuators_white_Paper_PI_Ceramic.pdf
Coventor and MANCEF to Offer Four MEMS Design Scholarships
at COMS 2010
Winners to receive 1-year MEMS design software license of Coventor's CoventorWare Designer/ Analyzer package and a chance to publish research. The scholarships will be awarded at the COMS 2010 award ceremony in Santa Ana Pueblo, New Mexico on Wednesday Sept 1, 2010. Visit http://www.mancef.org/scholarships for complete details and application requirements.
Intel Milestone Confirms Light Beams Can Replace
Electronic Signals for Future Computers
Intel Creates World's First End-to-End Silicon Photonics Connection with Integrated Lasers; Could Revolutionize Computer Design, Dramatically Increase Performance, Save Energy
SANTA CLARA, Calif., July 27, 2010 – Intel Corporation today announced an important advance in the quest to use light beams to replace the use of electrons to carry data in and around computers. The company has developed a research prototype representing the world's first silicon-based optical data connection with integrated lasers. The link can move data over longer distances and many times faster than today's copper technology; up to 50 gigabits of data per second. This is the equivalent of an entire HD movie being transmitted each second.
Today computer components are connected to each other using copper cables or traces on circuit boards. Due to the signal degradation that comes with using metals such as copper to transmit data, these cables have a limited maximum length. This limits the design of computers, forcing processors, memory and other components to be placed just inches from each other. Today's research achievement is another step toward replacing these connections with extremely thin and light optical fibers that can transfer much more data over far longer distances, radically changing the way computers of the future are designed and altering the way the datacenter of tomorrow is architected.
Silicon photonics will have applications across the computing industry. For example, at these data rates one could imagine a wall-sized 3D display for home entertainment and videoconferencing with a resolution so high that the actors or family members appear to be in the room with you. Tomorrow's datacenter or supercomputer may see components spread throughout a building or even an entire campus, communicating with each other at high speed, as opposed to being confined by heavy copper cables with limited capacity and reach. This will allow datacenter users, such as a search engine company, cloud computing provider or financial datacenter, to increase performance, capabilities and save significant costs in space and energy, or help scientists build more powerful supercomputers to solve the world's biggest problems.
Justin Rattner, Intel chief technology officer and director of Intel Labs, demonstrated the Silicon Photonics Link at the Integrated Photonics Research conference in Monterey, Calif. The 50Gbps link is akin to a "concept vehicle" that allows Intel researchers to test new ideas and continue the company's quest to develop technologies that transmit data over optical fibers, using light beams from low cost and easy to make silicon, instead of costly and hard to make devices using exotic materials like gallium arsenide. While telecommunications and other applications already use lasers to transmit information, current technologies are too expensive and bulky to be used for PC applications.
"This achievement of the world's first 50Gbps silicon photonics link with integrated hybrid silicon lasers marks a significant achievement in our long term vision of ‘siliconizing' photonics and bringing high bandwidth, low cost optical communications in and around future PCs, servers, and consumer devices" Rattner said.
The 50Gbps Silicon Photonics Link prototype is the result of a multi-year silicon photonics research agenda, which included numerous "world firsts." It is composed of a silicon transmitter and a receiver chip, each integrating all the necessary building blocks from previous Intel breakthroughs including the first Hybrid Silicon Laser co-developed with the University of California at Santa Barbara in 2006 as well as high-speed optical modulators and photodetectors announced in 2007.
The transmitter chip is composed of four such lasers, whose light beams each travel into an optical modulator that encodes data onto them at 12.5Gbps. The four beams are then combined and output to a single optical fiber for a total data rate of 50Gbps. At the other end of the link, the receiver chip separates the four optical beams and directs them into photo detectors, which convert data back into electrical signals. Both chips are assembled using low-cost manufacturing techniques familiar to the semiconductor industry. Intel researchers are already working to increase the data rate by scaling the modulator speed as well as increase the number of lasers per chip, providing a path to future terabit/s optical links – rates fast enough to transfer a copy of the entire contents of a typical laptop in one second.
This research is separate from Intel's Light Peak technology, though both are components of Intel's overall I/O strategy. Light Peak is an effort to bring a multi-protocol 10Gbps optical connection to Intel client platforms for nearer-term applications. Silicon Photonics research aims to use silicon integration to bring dramatic cost reductions, reach tera-scale data rates, and bring optical communications to an even broader set of high-volume applications. Today's achievement brings Intel a significant step closer to that goal.
Intel, the world's largest chip maker, is also a leading manufacturer of computer, networking and communications products. Additional information about Intel is available at www.intel.com/pressroom.
Intel is a trademark of Intel Corporation in the United States and other countries.
* Other names and brands may be claimed as the property of others.
Emerging Technologies Battle to Fill Peak Electrical Demand
Electric utilities are exploring options to supplant natural gas plants as the dominant source of back-up generation during periods of peak electrical demand.
Every summer, thousands of people return home from work in the late afternoon and switch on their televisions, lights, and air conditioning. Their collective action temporarily increases demand for electricity, and drives up its price as utilities tap additional sources of electrical generation – typically natural-gas-fired power plants. Although this system has served well for decades, the high price of peak energy has attracted an array of new technologies – including demand response, solar power, and energy storage. All of them aim to challenge the dominance of costly natural gas “peaker” plants. But while each challenger shares a role in defraying peak demand, all must address challenges of their own before reaching their full potential, according to a new report from Lux Research.
The report, titled “Who Wins the Peak? The Battle of Solar, Storage and Smart Grid to Fill Peak Demand,” assesses the potential roles of demand response, solar and energy storage in satisfying peak demand. It also details the widely different costs and production profiles of each technology, and their comparative capacity factors, which is the ratio of actual power output over a given period versus total possible output during that period.
“As the cost of energy storage declines, it will help make wind, solar and other intermittent renewables more viable sources of cheap dispatchable power during peak periods,” said Ted Sullivan, a Senior Analyst with Lux Research and the report’s lead author. “Combined with demand response, these technologies could address the top third of the peak demand curve and reduce the need to keep gas-fired turbines on standby.”
The report focuses on four competing technologies: solar, demand response, thermal energy storage, and compressed air energy storage. To compare the viability of each solution against conventional gas plants, Lux Research built proprietary cash flow and levelized cost of electricity (LCOE) models for each technology. To ensure accuracy, it tested its assumptions through primary interviews with technology practitioners, and extensive secondary research. Among the report’s key observations:
Demand response is best positioned to displace natural gas during extreme peak periods. Demand response beat out all other technologies in terms of cost, given that it requires minimal capital expenditure compared to other forms of generation. However, practical supply limits it to a 1% capacity factor, meaning that demand response cannot address the entire peak alone.
Subsidized solar can outcompete natural gas, with caveats. Solar technologies present the next most attractive opportunity for peak reduction, thanks largely to subsidies. Typically mounted on rooftops in a fixed position, distributed generation solar systems have a capacity factor of roughly 23%. Ground-mounted systems equipped with tracking increase capacity factors to around 30% – maximizing their time of use revenue potential in the late afternoon peak.
Although best positioned to win the peak, immaturity cripples adoption of energy storage. Energy storage technologies will be increasingly necessary to bridge the intermittency of renewables so that solar and wind can credibly supplant dispatchable natural gas generation. However, the technology’s immaturity makes it a non-starter today on cost and bankability, meaning that natural gas will continue to win the peak for years to come.
“In order to supplant expensive natural gas peaker plants, policymakers need to better align subsidies for wind and solar with their actual cost to utilities,” said Sullivan. “Although subsidies help make solar plants more economically viable, there is little incentive for utilities to install and operate them. Once installed, solar plants help satisfy peak demand, but increase system-level costs to utilities – such as the need to maintain dispatchable natural gas peaker plants in addition to solar capacity.”
“Who Wins the Peak? The Battle of Solar, Storage and Smart Grid to Fill Peak Demand,” is part of the Lux Solar and the Lux Power Intelligence services. Clients subscribing to these services receive ongoing research on market and technology trends, continuous technology scouting reports and proprietary data points in the weekly Lux Research Solar or Power Journal, and on-demand inquiry with Lux Research analysts.
About Lux Research
Lux Research provides strategic advice and on-going intelligence for emerging technologies. Leaders in business, finance and government rely on us to help them make informed strategic decisions. Through our unique research approach focused on primary research and our extensive global network, we deliver insight, connections and competitive advantage to our clients. Visit http://www2.luxresearchinc.com/e/3562/2010-07-21/1IZR/3623462 for more information.
Webcast Describes Swiss Tax Regime's Influence
on Foreign Direct Investments
Already favorable rates continue to trend downward
New York, July 20 - During a recent webcast sponsored by Switzerland Trade & Investment Promotion (STIP) Sebastien Maury, Head Swiss Tax Center of Excellence, KPMG LLP described the Swiss tax regime and various options available for companies seeking to establish or expand their operations in Europe.
Webcast host Mario Brossi, North American senior advisor for STIP, said "the explanation is timely given that the country's favorable tax regime is frequently cited as a key reason why firms select Switzerland to base their regional or international operations." He noted that more than 7,000 foreign companies have a presence in Switzerland and of those over 1000 steer European or global activities from the alpine nation, including more than 680 North American firms which have operations there.
Swiss tax rates are set at the federal, cantonal (state) and local (communal) level. KPMG's Maury noted that these rates, already among the lowest in Europe, are trending downward. "As examples," he said, "the canton of Lucerne taxes will drop to 12% in 2012 from 16% this year and 18.4% in 2009. Canton Schwyz rates will be 11.7% in 2012 compared to 14.6% this year and 15.2% in 2009. These figures include the Federal tax rate of 7.8%," he said, "meaning that corporate taxes in Switzerland in 2009 ranged from 12.7% to 25.7% depending on location."
Certain privileged statutory tax structures are also in place, depending on the type of company being established. "Holding companies only pay the federal 7.8% rate," Maury said. "Domiciliary and mixed company taxes range from 7.8% to 11.8% and principal companies pay from 5% to 8%."
Mr. Brossi added, "Under the right circumstances, Cantonal and communal tax authorities are open to negotiating tax rates and holidays. These adjustments vary and are generally based on the type and location of the investment project and the number of people the venture is expected to employ."
The June webcast, including an overview of Switzerland, a session on effective business process planning for Europe and a testimonial from Kelly Services can be downloaded from http://www.locationswitzerland.com/internet/osec/en/home/invest/us/fairs_and_events/past_events.html
White Paper: Development of Highly Reliable
Multilayer Piezo Actuators
July, 2010, Auburn, MA –– Piezo technology specialist PI Ceramic has released a new white paper on the development and test of highly reliable multilayer piezo actuators.
Piezoelectric multilayer actuators are the driving force behind the most challenging motion control applications when it comes to speed and precision. They have found use in fields as different as injection valves for combustion engines (speed) and atomic force microscopy (precision). These types of actuators have been in use for about two decades and have reached maturity several years ago. Continuous improvements are based on long term tests and exact knowledge of the environmental operating conditions and failure modes allows to push the limits of this technology even further.
The paper describes the development and lifetime tests of ceramic encapsulated actuators under different operating conditions (DC and AC). The actuators are compared to polymer coated piezo ceramic actuators in long term tests. Equations and graphs for lifetime calculation under different operational and environmental conditions and special internal electrode designs for stress reduction are discussed.
Paper Download at:
http://piezo.ws/pdf/Development_Highly_Reliable_Piezo_Actuators_white_Paper_PI_Ceramic.pdf
Short link
About PI
PI is a leading manufacturer of hexapod systems, piezo stages, piezo linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Israeli company uses nanotechnology to develop paint that
makes planes disappear off radar
Ofer Petersburg
Imagine for a moment what the battlefield will look like in the future. Unmanned planes flying through the air; robots fighting on the ground; smart missiles hunting down targets. Now imagine that none of this can be detected on radar screens.
It may sound fictional, but it's happening. An Israeli company called Nanoflight is currently developing a special paint that makes drones, missiles, or war craft simply disappear. Or, to be more precise, they become very difficult to detect.
The critical stage in developing the paint, which was developed in a nanotechnology lab, has recently concluded, and a successful test run was conducted this week. For the test run, a thin layer of the material was painted on dummy missiles, and radar waves aimed at them had a difficult time registering them.
The paint particles don't make the missile's detection on the radar disappear completely, but make it exceedingly difficult to positively identify the object as a missile. In the future, this development will allow any missile or jet significantly decreased radar detection.
Even though they may not entirely disappear from radar screens, this technology is a considerably more cost-effective method to evade radar detection than purchasing an American stealth plane for $5 billion.
How does it work? In order to locate objects, the radar transmitter sends out electromagnetic waves. When these waves hit an object, they are scattered in all directions, with some of them being bounced back to the radar itself. Regular signal reception indicates the existence of an object.
The nanotechnology developed envelopes the object, absorbs the radio waves emitted by the radar, and releases them as heat energy scattered in space. In doing so, the material disguises the object, making it difficult to identify by radar.
"We are only at the beginning and are discovering new worlds everyday," said Eli Shaldag, a former senior Israel Air Force official who worked on the Arrow missile project. He currently is part of the military applications department of Nanoflight.
"This is a breakthrough with the potential to change the rules of the game in the battlefield," Shaldag said.
When will the material be ready for use on war craft?
"We have already completed the main development stage. We conducted a number of tests and discovered that the particles in their nanotechnology composition do significantly neutralize the ability to detect objects that have been painted with the material. We are entering the second stage, after which we will already be able to produce the material in larger quantities."
Will this material be applicable for additional uses in the future?
"Absolutely yes. Discovery of nanotechnology materials is still in its infancy, and we are decoding the secret of this technology's power every day. We are currently working on developing an application of the material that will work with infrared so that soldiers won't be detected on night-vision goggles."
According to company officials, the material can also be used for civilian purposes.
"Just like the nanotechnology material can prevent a radar from detecting a missile, it can also prevent radiation emitted by electrical transformers from reaching nursery schools," said Nanoflight CEO Ricardo Burstein.
Burstein also noted that the material can prevent pollution through its absorption and transformation properties.
"In the future, it could be painted on sidewalks and roads in order to decrease air pollution. We are currently conducting an experiment with the City of Ramat Gan in which we are painting guardrails with the material in order to purify pollution from cars," Burstein explained.
http://www.ynetnews.com/Ext/Comp/ArticleLayout/CdaArticlePrintPreview/1,2506,L-3919257,00.html
Brochure: Piezo Technology made Affordable
Flexure Actuators for Speed, Precision and Force
PI (Physik Instrumente) L.P. -- a leading manufacturer of piezo ceramic actuators and precision motion-control equipment for semiconductor, bio-medical and nanotechnology applications -- has released a new brochure on Lever Amplified Piezo Flexure Actuators.
The brochure presents a number of new applications along with a variety newly designed, low-cost flexure actuators for OEMs.
Traditional Piezo Systems Use
Piezo actuators and positioning systems are traditionally known for their extremely high precision in the sub-nanometer realm such as required in atomic force microscopy, nanotechnology and semiconductor applications. The extreme precision has given this cutting edge technology a reputation for high cost.
However…
Piezo actuators can do a lot more than “just“ nanometers. Their excellent dynamics and high force play a crucial role in many areas, where the (nanometer) precision is of lesser importance: e.g. for fast switching, vibration cancellation, or to adjust tools in machines. In these applications the piezo actuator is one – if not the only – solution and in the case of the new PiezoMove OEM actuators, a very affordable one.
PiezoMove actuators combine flexure guided motion with long travel ranges up to 1mm and affordability. They are very compact, easy to integrate, require no maintenance and provide service life of Billions of cyles. If nanometer precision is required, closed-loop versions are also available.
Application fields
- Microfluidics: Valves, pumps, microliter and nanoliter dosing
- Biotechnology: Cell manipulation, patch-clamp, microarrays, nanoliter dosing, dispensers, microstructuring with imprint processes
- Medical engineering: Diaphragm pumps, valves, dosing, injection, sample handling
- Mechatronics, machining, adaptronics: Active structures, vibration isolation, active tools, structure deformation
- Laser technology, metrology: Cavity tuning, beam control, control of optics or slit widths, sample positioning
Download: The brochure can be ordered by mail or downloaded at:
www.piezo.ws/pdf/2010_PI_PiezoMove_Affordable_Piezo_Flexure_Actuators.pdf
About PI
PI is a leading manufacturer of piezo stages, piezo linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Affordable Hexapod 6-Axis Positioning & Alignment System
Auburn, MA -- the F-206.S, Six-Axis Hexapod Alignment System from Nanopositioning Specialist PI (Physik Instrumente) L.P, is the most affordable precision positioning system of its kind. It provides 6D motion with 33 nanometer resolution and advanced alignment software for optics and photonics components.
Including a highly advanced parallel kinematics controller/driver featuring vectorized motion with arbitrary pivot point capability as well as an extensive software package,
the complete system is available from $33,900 in North America
http://store.pi-usa.us/ProductDetails.asp?ProductCode=F-206.S0
PI has 2 decades of hexapod design experience and world’s largest installed base of parallel-kinematic nanopositioning systems.
Datasheet & More Information: http://www.hexapods.net/F206-Hexapod.htm
Animation: http://www.hexapods.net/Hexapod_F-206_images/F206_Hexapod_Animation-300.JPG
How does is the F-206 Differ from other Positioning & Alignment Systems?
The "parallel-kinematics" design with a virtual pivot point and vector-based 6D motion-controller is what sets the F-206.S system apart from conventional "stacked multiaxis positioners". Due to the reduced moving mass (only one common lightweight platform for all 6 actuators) the system can respond and settle much faster. It is also considerably more compact and accurate than conventional multi-axis stage stacks (serial kinematics). Its parallel-kinematics design and advanced, digital 6D controller minimizes unwanted crosstalk motion.
Controller Handles Complex Nanopositioning Tasks
The F-206.S HexAlign system is of great value for any complex, high-accuracy positioning and alignment task where independent, high-precision motion in six degrees of freedom is required. Its flexibility is based on the virtual-pivot-point capability built into the controller. Since Hexapod motion is not determined by fixed bearings but real-time, 6-space control algorithms, this point can be chosen freely with a single software command, a prerequisite for fast and accurate alignment tasks.
Software for Automatic Optical Alignment:
The Hexapod comes with powerful control and alignment software, LabView™ drivers, DLLs, etc. and many programming examples. When equipped with an optional high-speed photometer card, the Hexapod aligns arrays, waveguides & collimators up to 10 times faster than conventional multiaxis positioning stages.
Application Examples
Precision positioning, alignment & testing of optics, photonics & MEMS components. Nanolithography, Micromanipulation, Microsurgery.
Features
- Compact, Affordable Six-Axis Parallel-Kinematics Nano-Alignment System
- Powerful 6D-Digital Controller with Alignment Routines & LabView™ Drivers
- Low Inertia, Fast Response & Settling
- 33 Nanometer Design Resolution
- PivotAnywhere Fully Virtualized Center of Rotation
- No Moving Cables: Reduced Friction, Improved Reliability, Easy Integration
About PI
PI is a leading manufacturer of hexapod systems, piezo stages, piezo linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+
PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
Nanostart subsidiary MagForce Nanotechnologies receives EU regulatory approval for its Nano-Cancer® therapy
Frankfurt / Berlin, June 28, 2010 – Following more than 20 years of research and development efforts, MagForce Nanotechnologies AG (Frankfurt Stock Exchange: MF6), a majority-owned subsidiary of Nanostart AG, has received regulatory approval for medical use of its Nano-Cancer® therapy throughout the European Union. This momentous event marks the world’s first nanoparticle-based cancer treatment to come to market.
Approval was granted not just for treating one particular type of brain tumor but rather, without limitation, for the treatment of all primary brain tumors. Furthermore, the therapy was approved as a primary therapy, meaning that it – like surgical resection, chemotherapy, and radiation – may be used as a first-line treatment for patients who have been newly diagnosed with brain tumors.
This novel therapy involves the instillation directly into the tumor of a fluid containing special iron oxide nanoparticles. These magnetic nanoparticles are then subjected to a controlled magnetic field so that they oscillate and generate heat. The elevated temperature within the tumor causes the cancer cells to be damaged or destroyed.
This approval follows successful completion of the conformity evaluation procedure of the company’s NanoTherm® magnetic fluid by Medcert GmbH and of its NanoActivator® magnetic field applicator by Berlin Cert GmbH. Both of these medical certification and testing companies are officially authorized centers for the conformity evaluation of medical devices.
“With regulatory approval now received, our company has entered a new phase. MagForce is transforming itself from a medical R&D company to a commercial provider of medical technology,” said Dr. Peter Heinrich, CEO of MagForce Nanotechnologies.
MagForce founder and CSO Dr. Andreas Jordan added, “After research and development efforts spanning more than 20 years, we now have regulatory approval in hand. This is a historic moment for us.”
This regulatory approval gives the green light for the company to proceed with its planned market launch of Nano-Cancer® therapy, which will commence in the coming weeks.
Nanostart CEO Marco Beckmann underscored that “regulatory approval was granted not just for glioblastoma but for the treatment of all primary brain tumors, thus opening enormous market potential for the new therapy. We congratulate the management team and entire staff at MagForce on this tremendous success.”
The regulatory approval was received based on the results of a clinical study in patients suffering from recurrent glioblastoma, a particularly aggressive and deadly form of brain tumor. In these clinical trials, the new therapy was able to demonstrate its remarkable effectiveness, with median patient survival time increased from 6.2 months using conventional therapies to 13.4 months using Nano-Cancer® therapy in combination with radiotherapy. Median patient survival following diagnosis of the recurrence was thus more than doubled. Furthermore, compared to existing conventional treatments, the side effects and patient discomfort associated with the new therapy are minimal.
About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de.
About MagForce Nanotechnologies:
MagForce Nanotechnologies AG is a world-leading company in the area of nanotechnology-based cancer treatment. The proprietary procedure which it has developed, Nano-Cancer® therapy, enables the targeted treatment of solid tumors through the intratumoral release of heat from magnetic nanoparticles. Its products used in the therapy, NanoTherm® and NanoActivator®, have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. For further information, visit www.magforce.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Rolex Learning Center Opens at Switzerland's
Federal Institute of Technology Lausanne
New York, June 23 - The newly opened Rolex Learning Center on the campus of the Swiss Federal Institute of Technology Lausanne (EPFL) is a dramatic example of Switzerland's focus on its scientific establishment, says Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion. The country's many institutes of higher education are often cited as among key FDI decision criteria companies consider when establishing a presence there.
Designed by Japanese architects Kazuyo Sejima and Ryue Nishizawa, the single story Rolex
Learning Center will function as a laboratory for learning, a library with 500,000 volumes and an international cultural hub for EPFL, open to both students and the public.
The center is spread over one single fluid space of 20,000 sq meters, providing a seamless network of services, libraries, information gathering, social spaces, study cubicles, restaurants, cafes and beautiful outdoor spaces. As described by the EPFL it is a highly innovative building, with gentle slopes and terraces, undulating around a series of internal patios, with almost invisible supports for its complex curving roof, which required completely new methods of construction.
Full details including downloadable files are available at www.rolexlearningcenter.ch
Vistec’s advanced EBPG5200 Electron Beam Lithography System Ordered by Penn State
June 1st, 2010 - University Park, Pennsylvania / Watervliet, New York - Vistec Lithography Inc., a world leader in electron beam lithography, announced a major order with the Pennsylvania State University, University Park, PA, for one of Vistec's EBPG5200 electron beam lithography systems. The instrument will become part of the National Science Foundation's National Nanotechnology Infrastructure Network to support advanced nanotechnology research across the nation.
The Vistec EBPG5200 will allow fabrication of a diverse set of devices supporting fundamental and applied research for emerging nanotechnology applications. With the acquisition of the lithography system and its unique nanoscale patterning capabilities, the Penn State Nanofabrication Laboratory will have one of the most advanced electron beam lithography systems for nanotechnology research and development. Through the National Nanotechnology Infrastructure Network (NNIN), the EBPG5200 will also be available to other academic institutes, industries and government entities desiring high performance electron beam lithography and nanotechnology fabrication services.
The EBPG5200 system will be installed in the University's new Millennium Science Complex and will be a cornerstone for current and future Penn State nanotechnology research. The system is a result of an NSF Major Research Instrumentation award under the American Recovery and Reinvestment Act of 2009. Additional funding comes from Penn State and the Commonwealth of Pennsylvania.
The Vistec EBPG5200 is the latest version of the highly successful EBPG5000plus electron beam lithography system technology. The EBPG52000 system with both 50 and 100 keV accelerating voltages, 50 MHZ pattern generator and full 20 bit address technology has the demonstrated ability to routinely pattern to 6-8 nm, address field sizes to 1mm, and accommodate varying substrates sizes from piece parts of a few millimeters to full patterning across a 200 millimeter diameter. The EBPG5200 electron optics and column design provides not only high resolution, but also delivers high beam currents resulting in very high throughput, high resolution patterning. Further, the EBPG5200 system that will be installed at Penn State has been designed with a unique z-axis feature allowing it to accommodate thick or curved substrates and making it ideal for emerging nanotechnology applications. Coupled with its extremely flexible Linux based software and associated GUI's, it is ideal for multiuser, university applications. The various features of EBPG series have made it a leader for university, research institute and industry environments where ease of use, high resolution, throughput and system reliability are required.
"The Vistec team is extremely proud to have been selected by Penn State and to be associated with the Materials Research Institute and the Penn State Nanofabrication Laboratory. We are looking forward to our relationship and to further advance the EBPG5200 system and its capabilities for Penn State's advanced nanotechnology research", said Rainer Schmid, General Manager of Vistec Lithography Inc., Watervliet, NY, where the system will be fabricated. "Vistec has been a partner with Penn State over many years. We welcome the opportunity to have Penn State as a customer and to be associated with its nanotechnoloy research, its faculty and students."
"We are very excited about our NSF Instrumentation award and the acquisition of the Vistec EBPG5200", said Theresa S. Mayer, Professor of electrical engineering and Director of the Penn State Nanofabrication Facility. "The instrument is the perfect match for our demanding and unique research needs. It will provide us with a flexible, user friendly, state-of-the-art patterning capability to explore many new avenues of nanotechnology research and development using electron beam lithography. We are very pleased to be partnering with Vistec and look forward to our continued interactions."
Switzerland Posts Biotech Gains in 2009
Employment hits 19,071, a 6% Increase over 2008; Turnover up 7% to CHF 9.3 billion
New York - Despite a less than favorable global economic environment the Swiss biotechnology industry performed rather well in 2009, reports Mario Brossi, North American senior advisor for Switzerland Trade and Investment Promotion. According to the Swiss Biotech Report 2010 employment in the sector grew 6% to 19,071 while turnover reached CHF 9.3 billion*, a 7% increase over the prior year.
"The report notes that while the financing environment was challenging, Swiss companies were able to raise CHF 370 million in new capital, led by NovImmune's CHF 60 million in venture capital," Mr. Brossi said. "BioMedInvest II raised CHF 100 million in new capital and Index Ventures EUR 350 million for early stage investment."
In other activity mondoBiotech floated its shares on the SWX Swiss Exchange, Evolva became public through a reverse merger with Arpida, and ESBATech in a transaction worth up to CHF 600 million was acquired by eye care leader Alcon.
"A measure of a country's ranking in a particular field is the number of patents filed per million of population," Mr. Brossi said. "The World Patent Index reports that for Switzerland the number of biotech patents registered under this criterion is about 250. This compares favorably with the US (70), Japan (65), Germany (45), and Great Britain (40). Much of the country's success in biotech is due to strong Federal support, its network of excellent research institutions and research-oriented industrial players."
According to the Swiss Biotech Report 2010 as of 2009 there were 327 biotech firms in the country, of which 65 are classified as suppliers to the industry.
Switzerland at BIO 2010
At the recently concluded BIO 2010 International Convention in Chicago Swiss biotech was represented by 18 companies in the Swiss Pavilion and 9 pavilion partners including cantonal and regional economic development agencies, Swiss biotech clusters, the SIX Swiss Exchange, and the country?s innovation promotion agency CTI. Swiss presentations during the technical sessions covered monoclonal antibodies and white (industrial) biotechnology. The Swiss Delegation was the 10th largest country delegation at BIO.
Further information at www.swissbiotechreport.ch
*1 Swiss Franc (CHF) = ~US $0.86
Successful introduction of the new Coatema-
Smartcoater during Printed Electronics Europe
For the first time Coatema introduced a new and revolutionary plant concept live during the Printed Electronics Europe 2010 in Dresden. The multifunctional Smartcoater includes 5 coating and printing systems, a 350 mm hot air dryer in EEx-layout and a lamination device. A small working width of 100 mm and compact dimensions allow a minimum use of substrates and chemistry.
More than 800 visitors came to get a first impression of the Smartcoater and an overview on the benefits of this multifunctional unit. The interest and requests for
quotes exceeded all expectations.
The Smartcoater is set-up in our R&D Centre in Dormagen. Here we have 11 different pilot lines and 1 production line with a working width of 2.000 mm available and you are cordially invited to visit us in Dormagen (near to Cologne and Düsseldorf).
The Smartcoater is equipped with a process control system with Siemens S7 and tension measurement rollers.
The Smartcoater - all around a successful concept which will be upgraded for the operation with hotmelts and in inert atmosphere.
Further information can be found at www.coatema.de
About Coatema:
The company Coatema Coating Machinery deals with the mechanical engineering for coating, laminating and printing plants for R2R applications. For more than 30 years now, Coatema has been developing solutions for the most different markets like textile, foil, paper and renewable energies. This can be lab plants, pilot plants as well as entire turn-key
production solutions for the coating and laminating of R2R substrates. One area of Coatema, the R&D Solutions, deals with the service for coating and laminating like e.g. Coatema´s coating lab with more than 11 pilot plants and on production plant with a working with of 2.000 mm. An annual international coating symposium completes Coatema´s large range of services. Another of Coatema´s specialties is the special mechanical engineering for scale-up processes in the area of new technologies, like e.g. fuel cells or nano
technologies.
PI Grows Sales Organization in Europe
New Locations for PI UK and PI France
Auburn, MA - Piezo Technology and Motion Control specialist Physik Instrumente (PI) GmbH & Co. KG, Karlsruhe, Germany has strengthened its European sales organization with new offices and people.
The new PI UK office at Trent House, Cranfield Technology Park, is strategically located close to Cranfield University and provides room for further growth of the company.
PI France recently also relocated into a new office in the suburbs of Paris, very close to the famous Boulevard Péripherique ring road.
The move allows PI to provide improved service with optimal customer proximity, and to focus more directly on the company’s core nanopositioning and piezo technology business.
About PI
PI is a leading manufacturer of nanopositioning and precision motion-control equipment for high-resolution microscopy, life sciences, semiconductor, optics, photonics and bio-nanotechnology applications. PI has been developing and manufacturing standard & custom precision products with piezoelectric and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500.
Fiberforge Establishes EMEA Headquarters in Switzerland
New York, May 4 - Composite materials specialist Fiberforge has opened its European subsidiary, Fiberforge GmbH in Switzerland to serve as its EMEA headquarters reports Mario Brossi, North American Senior Advisor for Switzerland Trade and Investment Promotion. The 1,000 square foot facility in Baar, canton Zug, will be managed Simon Jespersen, PhD, a technical expert in thermoplastic advanced composites and the Fiberforge manufacturing process, Mr. Brossi said.
Dr. Jespersen said Fiberforge GmbH will lead European sales and business development efforts, manage joint development projects with customers, and ensure timely and effective service for systems installed in Europe. "Other functions in Baar will include engineering, sales, marketing, finance, administration, and technical support," he said.
Commenting on the location, Dr. Jespersen noted that "Switzerland was the first and only choice as being the best single entry point for a small company looking to expand in Europe and for a large company (which we endeavor to be some day) needing favorable tax treatment. Other plusses include a motivated, well-educated multilingual workforce facilitating business across boundaries, excellent transportation and communications infrastructure, a business-friendly government and the country's own research and educational institutions."
Peter Müllhaupt of the Zug economic promotions office said "We are very pleased to welcome Fiberforge GmbH to the Canton of Zug. Our major objective is to provide a business-friendly mentality and environment because happy business owners are the best ambassadors for a prospering economy."
Nanostart-holding MagForce: US investment fund
commits EUR 20 million equity
Frankfurt / Berlin – May 04, 2010 – MagForce Nanotechnologies AG has signed a Standby Equity Distribution Agreement (“SEDA”) with YA Global Master SPV Ltd. (“YA Global”), an investment fund managed by Yorkville Advisors. Under this agreement, MagForce now has the option over the next 36 months to avail itself of a binding commitment by YA Global to subscribe to and purchase multiple tranches of newly issued shares from the company’s approved capital up to a total amount of EUR 20 million. MagForce will retain complete discretion over if and when it makes use of its rights over the life of the option.
Under the terms of the agreement, MagForce may offer these tranches from time-to-time, pursuant to the terms of the agreement. The purchase price of newly issued shares shall be determined by a formula based on the market price of MagForce’s stock. The commitment provides MagForce with flexible access to additional equity capital of up to EUR 20 million, thus ensuring that the company retains a sound basis of financial comfort as it enters the rapidly approaching commercialization phase and further expands its R&D pipeline.
“The signing of this agreement with YA Global will better enable MagForce to proceed with two very important investments,” explained Dr. Peter Heinrich, CEO of MagForce Nanotechnologies AG. “Firstly, it will provide us with additional resources for the European market launch of Nano-Cancer® therapy for the first indication expected to receive European regulatory approval, which is glioblastoma multiforme. Secondly, it will allow us to expand our clinical investigations to encompass even more kinds of solid tumors. With this additional capital now available, we will be able to accelerate our transformation from an essentially German R&D venture financed with German capital into a truly international commercial enterprise.”
“We are extremely pleased to be able to announce our investment in MagForce” said Dr. Michael J. Nowak, head of healthcare and managing director at Yorkville Advisors. MagForce is currently moving forward with the planned market launch of its first product in what is perhaps the most interesting phase of company development. Dr. Nowak added, “The innovative structure of our investment commitment, with its combination of both flexibility and financial security, is an ideal arrangement for the company at this stage.”
About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de
About MagForce Nanotechnologies AG:
MagForce Nanotechnologies AG is the world’s leading company in the area of nanotechnology-based cancer treatment. Its patented therapy allows the targeted destruction of tumors using magnetic nanoparticles. MagForce’s nanotechnology represents a revolutionary approach to the future successful treatment of solid tumors. For more information, please visit www.magforce.com
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
NANOMEDICINE WEBINAR SERIES DESIGNED FOR MEDICAL, INDUSTRY AND RESEARCH COMMUNITIES
CME Accredited Live and On-demand Sessions Now Available
SAN DIEGO – April 20, 2010 – NanoTecNexus (NTN), formerly NanoBioNexus, already acclaimed for its educational forums and nanobiotechnology expertise, announces the second installment of courses, seminars, and lectures to be delivered online with proven and easy to use webinar tools. Delivering online webinars is part of NTN’s strategy to reach broad geographically dispersed communities, leverage scientific, medical, and business experts worldwide, and deliver the highest caliber content in a costeffective manner.
Nanomedicine 2: New Strategies and Innovations to Understand, Treat and Monitor Disease is a continuation of the highly successful Nanomedicine 1 webinar series, a first of its kind Continuing Medical Education (CME) accredited webinar series sponsored by the UC San Diego School of Medicine and produced in partnership with the UC San Diego NanoTumor Center (NTC). The first of six Nanomedicine 2 sessions is scheduled for Tuesday, April 27, 2010, at 8:00AM Pacific. Brochure and details here.
The NanoTumor Center, a public-private consortium funded by the National Cancer Institute Alliance for Nanotechnology and led by UC San Diego, is dedicated to the translational application of nanotechnology in the fight against cancer. NanoTecNexus, a member of this consortium and lead for the NTC educational projects, led the planning committee in the design and organization of the webinar series to meet the accreditation standards and requirements.
“Education in the new field of cancer nanotechnology for the scientific and clinical communities as well as the general public is an integral part of our center,” said NTC Director Sadik Esener, PhD, Professor of Electrical and Computer Engineering at the UCSD Jacobs School of Engineering.
The Nanomedicine 2 webinar series also follows a Business and Technology Series designed for the research, industry, and investment communities worldwide as well as the general public interested in learning about progress made in nanotechnology development. The goal is to educate on the translational progress of applications using nanotechnology. “We are committed to fill an important void and place the attention on real progress, not just promise or hype,” said Adriana Vela, Founder and CEO of NanoTecNexus. “I am proud to say that, since our inception, we have not wavered from delivering quality content with top expert presenters.”
For a full schedule of upcoming Nanomedicine or Business and Technology series webinars, visit www.nanotecnexus.org.
About NanoTecNexus
NanoTecNexus (NTN), formerly known as NanoBioNexus, is a leading non-profit organization
headquartered in San Diego with offices in Tucson AZ, San Jose, CA and Vancouver, WA. NTN is dedicated to catalyzing collaboration and knowledge exchange in the nanotech field by connecting people, technology, industry and investment. NanoTecNexus enables constituents worldwide to keep up-to-date on the developments of cutting-edge nanotechnologies. Nanotechnology involves manipulating matter at the atomic or molecular scale smaller than 100 nanometers (1 nm=1 billionths of a meter) and taking advantage of properties that are present at that scale. Nanotechnology is used in thousands of applications in medicine
and health, energy and water, defense and many others. On the Net: www.nanotecnexus.org
About Moores UCSD Cancer Center
The Moores UCSD Cancer Center is one of the nation’s 41 National Cancer Institute designated Comprehensive Cancer Centers, combining research, clinical care and community outreach to advance the prevention, treatment and cure of cancer. For more information, visit www.cancer.ucsd.edu
About the NanoTumor Center
The NTC is a five-year, $20-million National Cancer Institute (NCI)-funded public-private
consortium and one of only eight such NCI-backed programs in the nation. UCSD physicians, engineers, chemists and biologists collaborate with colleagues at the Burnham Institute for Medical Research, in addition to various industry partners, to examine the potential uses of nanotechnology in cancer detection, imaging and treatment. For more information, visit http://ntc-ccne.org .
Lux Research Solar State of the Market: Solar’s Impending Shakeout
Join us for a Webinar on May 11
Space is limited.
Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/326527067
In 2010, the solar market will recover from a rocky 2009, as interest in solar power and cleantech reaches an all-time high. However, the overcapacity throughout the solar value chain that has plagued the industry will continue, despite demand from traditional markets in Europe and strong demand growth in China and the U.S. The intense competition among solar component suppliers will pressure incumbents to squeeze-out fractional manufacturing costs. Meanwhile, well-funded start-up firms face an ever-growing challenge to penetrate the solar market and reap return for their investors. The next few years will see supply and demand come violently back into parity through a mix of company failures, low utilization rates, and unexpected demand catalyzed by subsidies in export-oriented countries, particularly China. Join Lux Research as we present our findings, with this webinar addressing these questions and more:
• What markets will see strong growth in solar demand through 2015?
• When and where will solar supply and demand come back in balance?
• How will evolving cost structures impact technology selection and growth in the solar market?
• What is the outlook for investors in solar energy, and where will they focus new investments?
Title: Lux Research Solar State of the Market: Solar’s Impending Shakeout
Date: Tuesday, May 11, 2010
Time: 11:00 AM - 12:00 PM EDT
After registering you will receive a confirmation email containing information about joining the Webinar.
System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer
XYZ Piezo Flexure Stage for Micromanufacturing,
Microscopy & Nanomanipulation
PI’s P-563.3CD PIMars stage is a piezo flexure-guided scanning / nanomanipulation system. The unit enables precision motion control with resolution in the sub-nanometer realm and 340x340x340 µm travel in XYZ, significantly more than other capacitive-feedback equipped systems currently provide. Integrated, direct-measuring capacitance sensors and digital closed-loop control boost linearity by up to three orders of magnitude over conventional piezo stages.
Typical Applications: Micromanufacturing, Bio-Technology, Nanotechnology, Scanning Microscopy, Nano-Manipulation, Nano-Imprint, Semiconductor & Data-Storage Test Equipment.
An nanostructuring application note is available here:
www.tinyurl.com/Nano-Manufacturing-Stage
Drawings, Datasheet, more Information available at:
http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=201550
How do PIMars Stages Work?
PIMars stages incorporate high-force solid state piezo actuator drives, frictionless flexure guiding systems and absolute measuring capacitive position sensors. The high force of the solid state piezo actuators allows for fast response in the millisec range and high scanning frequencies.
How do PIMars Stages Differ from other Nanopositioning Stages?
PIMars™ stages are based on a different design principle than conventional scanning stages. The XYZ system consists of only one moving part, a single module rather than three individual stacked modules, as common in other XYZ systems. This “parallel-kinematics” mechanical design is complemented by a parallel direct- motion metrology feedback system.
With parallel direct-metrology, all non-contact sensors monitor the moving platform in reference it to ground “from the outside”. They can “see” off-axis and runout errors. The controller then eliminates unwanted motion in real-time. Conventional serial-metrology sensors (integrated in each axis) cannot detect off-axis errors.
Parallel motion metrology allows for significantly higher overall XYZ precision.
Features and Advantages
- 340 x 340 x 340 µm Travel Range
- 66 x 66 mm Clear Aperture
- Nanometer Resolution
- Millisecond Responsiveness
- Ultrahigh Vacuum Versions up to 10-9 hPa Available
- Invar, Super-Invar and Titanium Versions Available
Controllers
A variety of analog and digital controllers in bench-top, OEM-board, and rack-mount designs are available to drive the units.
About PI
PI is a leading manufacturer of piezo systems, piezo linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+
Superior innovations in composites
– FutureCarbon on show at Hanover 2010
At this year's Hanover Fair, FutureCarbon, a leading name in carbon supercomposites, is presenting its innovative products based on carbon nanomaterials. Included are Carbo e-Therm, an electrically heated coating, and CarboGran, a simply dispersed granulate.
FutureCarbon is exhibiting its products at the Hanover Fair in hall 6 at booth K14. One of the highlights is a vehicle door with a Carbo e-Therm electrical heating coating that can be operated on a non-hazardous small voltage of 12 volts. Carbo e-Therm is easily applied, manually or mechanically, to different shapes and forms, especially when it is a matter of heating complex surface geometries or guarding against frost. In the automobile industry Carbo e-Therm is now being used to electrically heat steering wheels, dashboards and doors. But this is not the only sector to profit from the advantages. The foodstuffs industry has discovered Carbo e-Therm for tempering production plant, and in other sectors it is used to protect particular kinds of piping against frost. Visitors have ample opportunity to gain an impression of all the surface heating possibilities offered by Carbo e-Therm.
FutureCarbon is also presenting a live demonstration of CarboGran, a simply dispersed granulate of carbon nanotubes suitable for direct use in very different manufacturing processes. Visitors can learn how easily CarboGran is dissolved in fluids and compare this to standard carbon nanomaterials. CarboGran dissolves immediately and the carbon nanotubes distribute evenly in the fluid.
CarboGran can be used to create electrical conductivity in materials. Dispersions of CarboGran are worked into fabrics and fleece to make them electrically conducting and suitable for producing special-purpose antistatic clothing. CarboGran is also used for varnish or paint formulations with carbon nanotubes, intended for the automobile industry or machine plant. Surfaces that charge electrically can then subsequently be given a discharging layer of paint.
Yet another application for CarboGran is in the manufacture of electrically conducting thermoplastic compounds. The powder is free flowing and not dusty, so it can go into standard compounding processes. Dispersibility in polymers such as polyamide is very good. The electrical conductivity of CNT compounds is high enough for a powder coating without subsequently degrading the mechanical properties of the polymer.
About FutureCarbon
FutureCarbon specializes in the development and manufacture of carbon nanomaterials and their refinement into so called carbon supercomposites as primary products for industrial further processing. Carbon supercomposites are composite materials that evolve the special properties of carbon nanomaterials in the macroscopic world of real applications. All of our materials are manufactured on an industrial scale. www.future-carbon.de
FutureCarbon expands distribution
with new sales partner in Germany and Austria
Chemicals trader CSC Jäklechemie is the new sales partner of FutureCarbon, the leading supplier of extra-high-grade semi-manufactured products of carbon nanomaterials for further industrial processing. CSC Jäklechemie will in future strengthen FutureCarbon's market presence in Germany and Austria.
Paul C. Kästlen, the CSC Jäklechemie director of the division for paint and varnish raw materials, says: "We're very pleased to have FutureCarbon onboard as a new supplier. Being one of Germany's leading chemicals traders, we're continuously looking for innovative solutions for our customers. And in FutureCarbon we've found a partner enabling us to offer our customers both sustainable and high-quality semi-finished products of carbon nanomaterials".
A major strength of Jäklechemie is its many years of experience in distribution and consulting. "Jäklechemie is a sales organization that's able to respond to special customer needs, and that's exactly what we need to distribute our products", reckons Dr Walter Schütz, founder and director of FutureCarbon. "Given its broad-based portfolio of products from raw materials in the paint industry through acids to specialized materials for surface treatment, this medium-sized enterprise is the ideal partner to expand FutureCarbon's potential for growth in German-speaking Europe", adds the FutureCarbon director Tomas Meinen.
About CSC Jäklechemie
For more than 100 years CSC Jäklechemie has been one of Germany's leading, medium-sized chemicals marketing enterprises. In addition to industrial chemicals, its portfolio includes many less well-known, specialized products for the paint, metal and electronics industries, water supply and management, protection of the environment and the foodstuffs and cosmetics industries. The company's flexibility shows in the diversity of its services, from applications consulting, disposal and recycling concepts through refilling, mixing and warehouse management to correct product-specific international transportation and single sourcing.
About FutureCarbon
FutureCarbon specializes in the development and manufacture of carbon nanomaterials and their refinement into so called carbon supercomposites as primary products for industrial further processing. Carbon supercomposites are composite materials that evolve the special properties of carbon nanomaterials in the macroscopic world of real applications. All of our materials are manufactured on an industrial scale.
Ultrasonic Motor Powers New Line of Linear Positioning Stages:
Fast, Cost-Effective, Low-Profile
Auburn, MA, piezo system specialist PI announces the M-692 series of low-profile, ultrasonic linear translation stages designed for high-speed positioning tasks with limited space.
Backlash-Free, with Linear Encoder
These stages are the lowest profile, closed-loop, linear motor-equipped, micropositioning systems in the industry. Two standard versions are available: M-692.1U4 with 20 mm stroke and M-692.2U4 providing 90 mm. Both versions are equipped with integrated linear encoders for backlash-free positioning. The stages can be arranged to form compact XY systems.
Video at: http://www.youtube.com/v/loAhRLFFPNk&autoplay=1&rel=0&start=111%27
Scalable Design, OEM Versions, Vacuum Compatible Versions
The M-692 design is scalable and can be varied to provide different travel ranges to 300 mm for OEM Quantities. Vacuum-compatible versions are also available on request.
Optimized Controller and Drive Electronics
For optimum performance, the highly specialized C-867 motion controller is available. This dedicated ultrasonic motor controller also integrates the drive electronics to generate the ultrasonic oscillations for the piezoceramic element. Furthermore, the controller features a number of special characteristics to address the requirements of ultrasonic motors such as continuous automatic drive frequency adjustment and dynamic parameter switching for optimized dynamics and settling behavior.
Advantages of PILine® Micro Positioning Systems
- Stable: Self-Locking at Rest, with no Energy Consumption
- Very Low Profile: 14 mm (0.6” Height)
- Closed Loop: Integrated Linear Encoder for Backlash-Free Positioning
- Fast: Ultrasonic Linear Motor provides Velocity to 350 mm/sec (14”/sec)
- Cost-Effective Design; Scalable for OEM Applications
- Compact XY Combinations Possible
- Non-Magnetic & Vacuum Compatible Versions
Application Examples
Biotechnology, Micromanipulation, Microscopy, Automation, R&D, Quality assurance testing
About PI
PI is a leading manufacturer of piezo systems, piezo linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 35+ years. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with eight subsidiaries and total staff of 500+
Follow PI on Twitter: http://twitter.com/PI_Physik_Inst
PI Blog: http://physik-instrumente.blogspot.com/
DuPont Expands in Switzerland with New Photovoltaic Facility
Collaborative Research Center Aims at Advances in Solar Module Designs
New York, April 6 - DuPont, with a presence in Switzerland since 1959, has opened its new Meyrin Photovoltaic Applications Laboratory at its European Technical Center near Geneva reports Mario Brossi, North American Senior Advisor for Switzerland Trade and Investment Promotion. ?DuPont says that the Lab will operate as an open center, enabling technological exchanges and research collaborations between the company and its customers, industrial partners, institutes and academia,? Mr. Brossi said.
Ian Hudson, president, DuPont Europe, Middle East and Africa, said that as well as the central location in the middle of Europe, one of the attractions that first drew the company to Switzerland (over 50 years ago!) is the country?s openness to collaborations between companies with similar interests. "This openness enables the creation of new products and processes very efficiently and is a factor in the number of innovations coming from our European Technical Center," he said. Other advantages noted include proximity to the Geneva International Airport, the local highly qualified universities and research institutes, a motivated specialized multilingual workforce, and pro-business a good relationship with local government agencies.
All told, DuPont has approximately 800 employees in Switzerland, the bulk of which are in the Geneva area, the site of its EMEA Headquarters.
Mr. Brossi noted that Switzerland has attracted several firms involved in alternative energy R&D and manufacturing. ?Recent examples include Vermont-based wind turbine manufacturer Northern Power Systems, which has opened its European headquarters in Zurich, and China-based integrated photovoltaic products manufacturer Trina Solar with its new European regional headquarters also in Zurich.? Native companies are represented by thin-film solar cell manufacturer Flisom, the Institute for Solar Technology, and solar module manufacturer 3S Solar Systems.
"Expansions are the greatest testimonial to a country?s attractiveness as an FDI destination," Mr. Brossi commented. "Over the years the ?Swiss experience? has resulted in expansions by many existing investors. In addition to DuPont's new laboratory recent examples include Baxter International, Bombardier, Edwards Life Sciences, McDonald?s Europe, Medtronic, Microsoft, RBC Capital Markets and Tyco Electronics."
NanoProfessor Announces Findings of Community College Nanotechnology Education Research Study
SKOKIE, IL -- 03/16/10 -- NanoProfessor™, a division of NanoInk, Inc. focused on nanotechnology education, is pleased to announce the findings of its nanotechnology education research study, which evaluated the impact nanotechnology-focused curriculum has in influencing students' selection of a community college or technical institute. NanoProfessor commissioned market research firm Synovate to survey more than 500 high school seniors and adults returning to school from across the U.S. who had an interest in a science-related curriculum and were considering attending a community college or technical school. Study participants surveyed had to live within 25 miles of two community colleges or technical institutes.
The key finding of the study revealed that approximately one-third of high school seniors and one-quarter of adults would be positively influenced in their school selection if a nanotechnology education curriculum was available. Those percentages rose to approximately 45 percent for both students and adults who saw the NanoProfessor Program as a unique offering.
"This study supports that there is a significant level of awareness and interest among high school students and adults on the benefits of a nanotechnology education," said Dean Hart, executive vice president for NanoProfessor. "Students are even more excited by curriculum that consists of actually building nanoscale structures and will choose those schools that can provide them with that hands-on training. The NanoProfessor Nanoscience Education Program provides community colleges, technical schools, and undergraduate university programs with a new resource to use in capturing this student demand, while preparing students for rewarding nanotech positions in a myriad of emerging high-tech industries."
Other key findings from the study include:
- When survey participants were asked how nanotechnology would impact
their career, the top 3 responses were: "Helpful/Beneficial";
"Broaden Knowledge"; and "Offer More Opportunities/Open More Doors."
- Price, curriculum offered, and expertise of professors are the top 3
factors influencing consideration of a community college and/or
technical institute.
- A school's Web site is the most popular resource used by high school
seniors and adults to gather information about prospective schools.
However, high school seniors are also likely to seek out
recommendations from other sources or references as part of their
decision-making process.
The NanoProfessor Nanoscience Education Program aims to expand hands-on nanotechnology education from the cleanrooms of research-based universities to the classrooms of undergraduate programs and is especially well-suited to educational initiatives at the community college, technical school, and undergraduate university level. The program alternates between classroom lectures and hands-on lab work and includes a timely 300-page textbook covering the topics of Nanotechnology Basics, NanoPhysics, NanoChemistry, NanoBiology, and Environmental, Health, and Safety perspectives on nanotechnology.
In the hands-on lab experiments, students learn the fundamentals for building custom-engineered, nanoscale structures while working with state-of-the-art instruments including NanoInk's NLP 2000 Desktop NanoFabrication System, a student-friendly atomic force microscope (AFM), an advanced fluorescence microscope, and various chemical and biological materials used today by nanotechnology experts.
For more information on how the NanoProfessor Nanoscience Education Program can be implemented at your community college, technical school, high school or university, please call (847) 679-NANO (6266) or visit www.NanoProfessor.net.
About the NanoProfessor™ Nanoscience Education Program
The NanoProfessor Nanoscience Education Program aims to advance the field of nanoscience and address the growing need for a skilled workforce of nanotechnologists. The NanoProfessor Program, including instruments, an expert-driven curriculum, and student/teacher support materials, is available for community colleges, technical schools, and universities worldwide. More information is available at www.NanoProfessor.net. You can also follow NanoProfessor on Facebook® at www.facebook.com/pages/NanoProfessorTM/367787368082.
About Synovate
Synovate, the market research arm of Aegis Group plc, generates insights that drive competitive marketing solutions. The network provides clients with cohesive global support and a comprehensive suite of research solutions. Synovate employs over 6,400 staff across 62 countries. For more information on Synovate visit www.synovate.com
Tethis PMCS, your nanostructured coatings factory
PMCS source represents Tethis solution for synthesis and integration into devices of nanostructured functional coatings. Pulsed Microplasma Cluster Source (PMCS) allows the production of high purity porous coatings starting from conductive materials and offers the following features:
- room temperature deposition, allowing the use of every kind of substrate (metals, ceramics, polymers, silicon membranes and generally micro-electro-mechanical systems)
- high collimation of the supersonic beam. Patterning with sub-micrometric lateral resolution achievable by simple non-contact stencil mask method, without any photo-lithographic techniques
- high-purity deposition conditions
- low energy impact on the substrate, generating low density nanoscale porous materials
Available also as full automated complete system, compatible with 8" wafer and connectable to clean room.
PMCS web page:
http://www.tethis-lab.com/products-coatings-scbd_pmcs.html
Visit our web site: www.tethis-lab.com
Nano-Scale Imaging / Fabrication Advances Driven by
Piezoelctric Active Vibration Control
Wes Wigglesworth, Technical Manufacturing Corporation
Scott Jordan, PI (Physik Instrumente) L.P.
Abstract
Engineers from TMC and PI have developed active vibration isolation technology based on piezo ceramic solid state actuators that has become an established solution in nano-lithography applications.
However, active vibration cancellation can also improve stability and resolution in super-resolution microscopy applications.
Left: STACIS actuators supporting a photolithography scanner’s isolation platform (TMC)
Center: Settling time in response to on-board disturbance: Piezoelectric Active (black) vs. Passive Air Isolator (red)
Right: The latest ceramic encapsulated piezo actuators can achieve 10 times longer lifetimes than standard actuators (PI)
Based on digital signal processing algorithms and responsive PI piezo technology with the latest ultra-reliability enhancements, patented[i] STACIS active isolators have proven their dependability in mission-critical fab deployment for over a decade. STACIS is now available in small form-factors ideal for emerging applications ranging from advanced microscopies to nanomanufacturing.
Vibration and Throughput: The Yield-Killers
The semiconductor industry is ruled by two unbreakable laws. Moore’s Law, Equation 1, describes the exponentiating density of integrated circuit elements with time.
Equation 1. Moore's Law observes a doubling of device density every 18 months.
Meanwhile, Equation 2, defines a term describing nanoscale processing in the face of the fundamental economic constraint of “time is money.”
Equation 2. The economic imperative of “time is money” necessitates more devices per cm2, larger area processing and faster cycle times.
Together, these describe a challenge for process engineers and researchers alike: the tractability of nanoscale processes worsens with relentlessly diminishing scale, yet the process must be economical. This pushes substrate sizes up and cycle times down, both of which are at cross purposes to the exponentiating resolutions required.
References
[1] U.S. Patent Nos.5660255 and 5823307 (STACIS)
For More Information read the White Paper at:
Nanostart-held Curiox Biosystems wins Emerging Company award
“Emerging Company of the Year in Asia Pacific” in biomedical sciences
“Curiox is a potential industry leader within 10 years”
Singapore / Frankfurt – March 15, 2010 – Curiox was awarded "Emerging Company of the Year 2010 in Asia Pacific", on 12th March, by BioSpectrum Asia. BioSpectrum Asia is a leading B2B media platform covering the life sciences industry in the Asia Pacific region.
Curiox and other Asia Pacific companies were assessed on the basis of their achievements and potential for future growth to determine companies that shall emerge as industry leaders, in the biomedical science and biotechnology sectors, in the coming decade. BioSpectrum’s team of industry experts evaluated all aspects of the organizations’ performance and public profile, prior to nominating Curiox as the winner of the award in the sector biomedical sciences. The award was given to five more companies from other sectors in life sciences and medical technologies.
Curiox’s "Emerging Company of the Year" award comes hot on the heels of Curiox’s LabAutomation2010 "Innovation AveNEW" award, earlier this year; as one of the industry’s most innovative laboratory automation technology. This magnitude of worldwide industry acceptance and excitement for is welcomed by the young Singaporean start-up Curiox; and comes at a crucial time as Curiox begins to expand its products to overseas markets.
“It is truly an honour to be selected with top companies in Asia who have been around much longer than Curiox. These awards demonstrate to our customers, partners and competitors that our DropArray™ technology is truly innovative, and is recognized by industry experts (on a global scale) to be beneficial and potentially disruptive to the laboratory automation industry,” comments Curiox’s CEO Dr Namyong Kim.
Curiox's patent-pending DropArray™ technology provides a next-generation “wall-less” microtiter platform, and complimentary washing instrument, to provide researchers with better quality of data, 10 - 50 times savings in sample and reagent consumption, and up to 60 % assay time reduction. Additionally, DropArray™ technology promotes integration with liquid handling systems by maintainaining reproducibility and compatibility with existing microtiter plate detection systems.
Curiox Biosystems intends to penetrate the United States, European and Japanese laboratory markets this year through strategic partnerships and distributors.
According to BioSpectrum Asia, it has a readership of over 150,000 (including print magazine, online-edition and website) of which a large majority represent key decision makers in the Pharma and Biotech industry.
The Nanostart Singapore Early Stage Venture Fund I holds almost 19% in Curiox Biosystems.
About Nanostart:
Nanostart AG is the world’s leading nanotechnology investment company. The Frankfurt-based company provides venture capital financing for nanotechnology companies in various growth phases. It also provides the benefits of its experience and expertise to developers of financial instruments and to investors in the nanotechnology sector. For further information about the company, please visit www.nanostart.de.
About Curiox Biosystems Pte Ltd:
Curiox Biosystems has a vision to accelerate the progress of life sciences and drug discovery through better miniaturization. Curiox is a bioinstrumentation company enabling the miniaturization of heterogeneous bioassay for researchers working in life sciences, drug discovery, and diagnostics. Curiox’s patented miniaturization platform, DropArray™, provides up to 1,000 times savings in sample and reagent consumption, and up to 10 times reduction in assay time. The company is located in Singapore, the biomedical hub of Southeast Asia. The company is a spin-off from Institute of Bioengineering and Nanotechnology (IBN) backed primarily by Nanostart and Exploit Technologies, the commercializing arm of Singapore’s Agency for Science, Technology and Research (A*STAR). For further information, please visit www.curiox.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan
Highly Flexible Coating Plants for the Coilcoating Industry
Dr. Andreas Giessmann - For the finishing of steel or aluminium coils by coating and/or laminating, there are many standard methods. But also in the area of coil coating, the quick reaction to new trends, the production of smallest series and the possibility of processing many different types of chemicals, becomes increasingly important.
Whereas in former times the coating plants were manufactured as mass-produced article with an according output performance, nowadays a trend towards a universal equipment of the plants can be observed.
Lux Research: Financing in the Hydrocosm:
Why Water IT is a Smart Bet
Join us for a Webinar on March 23
Space is limited.
Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/856053682
The economic turmoil over the last year has wrought dramatic change in the hydrocosm’s financing landscape since our last in-depth analysis of the space in 2008. The run-up in venture capital (VC) funding for water technologies that we reported then has dropped significantly as the global economy struggled and financiers tightened their purse strings. Our research shows that VCs interest lies in the equipment sector, despite the fact that since 1998, 73% of the IPOs in the hydrocosm have been service company exits, and of those equipment companies that did exit, none were VC backed. However, smart investment opportunities are available in the hydrocosm in the form of water IT companies.
Learn about:
• The current state of financing in the hydrocosm, including mergers and acquisitions and IPOs
• The segments within the hydrocosm that are receiving the most funding
• Why VCs should invest in water IT companies
• How water IT companies stack up on the Lux Innovation Grid
Title: Lux Research: Financing in the Hydrocosm: Why Water IT is a Smart Bet
Date: Tuesday, March 23, 2010
Time: 11:00 AM - 12:00 PM EDT
After registering you will receive a confirmation email containing information about joining the Webinar.
System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer
EUROPEAN BIOTECHNICA AWARD 2010:
Competition entries now being accepted
Hannover, Germany, March 10, 2010 / b3c newswire / - Entries for the EUROPEAN BIOTECHNICA AWARD 2010 are now being accepted. Upcoming European companies from the biotechnology sector and the life sciences have until 30 April 2010 to submit entries for this prize. Worth 75,000 Euros, the award is presented to new companies for innovative products and services and/or related concepts and business ideas.
By 31 July the international panel of nine experts will have selected three finalists on the basis of their evaluation of all the competition entries. In the next and final round, the three finalists are invited to present their concepts in person to the panel of judges.
The winner will be announced on 4 October during the opening ceremony of BIOTECHNICA. The first prize comprises 30,000 Euros. All three finalists also receive substantial non-cash benefits, such as business strategy and investment consulting services as well as media packages.
The terms and conditions of participation, application forms and information on previous winners have been posted online at www.biotechnica.de/award_e. The EUROPEAN BIOTECHNICA AWARD has been awarded annually since 2003 by trade fair organizers Deutsche Messe AG, Hannover, and their partners.
Baolab creates nanoscale MEMS inside the CMOS wafer
Uses standard CMOS technologies and lines to slash MEMS costs by up to two thirds
Barcelona, Spain - 8 March 2010. Baolab Microsystems has announced a new technology to construct nanoscale MEMS (Micro Electro Mechanical Systems) within the structure of the actual CMOS wafer itself using standard, high volume CMOS lines, which is much easier and quicker with fewer process steps than existing MEMS fabrication techniques that build the MEMS on the surface of the wafer. This significantly reduces the costs of a MEMS by up to two thirds and even more if several different MEMS are created together on the same chip.
The Baolab NanoEMS' technology uses the existing metal layers in a CMOS wafer to form the MEMS structure using standard mask techniques. The Inter Metal Dielectric (IMD) is then etched away through the pad openings in the passivation layer using vHF (vapour HF). The etching uses equipment that is already available for volume production and takes less than an hour, which is insignificant compared to the overall production time. The holes are then sealed and the chip packaged as required. As only standard CMOS processes are used, NanoEMS MEMS can be directly integrated with active circuitry as required.
"We have solved the challenge of building MEMS in a completely different way," explained Dave Doyle, Baolab?s CEO. "Existing MEMS technologies are slow, expensive and require specialist equipment. They have to be either built on top of the wafer at a post production stage or into a recess in the wafer. By contrast, our new NanoEMS technology enables MEMS to be built using standard CMOS technologies during the normal flow of the CMOS lines."
Baolab has successfully created MEMS devices using standard 0.18um 8? volume CMOS wafers with four or more metal layers, and has achieved minimum feature sizes down to 200 nanometres. This is an order of magnitude smaller than is currently possible with conventional MEMS devices, bringing the new NanoEMS MEMS into the realm of nanostructures, with the additional benefits of smaller sizes, lower power consumption and faster devices.
Baolab will be making a range of discrete MEMS including RF switches, electronic compasses and accelerometers, along with solutions that combine several functions in one chip. The prototype stage has already proved the NanoEMS technology and evaluation samples will be available later this year. These are aimed at handset designers and manufacturers, and Power Amplifier and RF Front End Module markets.
For further information on Baolab Microsystems, please go to www.baolab.com. e-mail: info@baolab.com
Institut Politècnic del Campus de Terrassa, 08220 Terrassa, Spain.
Tel.: +34-93-394-17-70
Yale University selects Vistec EBPG5000plus Electron-Beam Lithography Systemfor Advanced Nanotechnology Research
Vistec Lithography, Inc. announced today that Yale University, New Haven, Connecticut, selected Vistec's EBPG5000plus electron-beam lithography system for its future nanotechnology research programs. As part of the Yale Institute for Nanoscience and Quantum Engineering, it will enhance the effectiveness of research and education at Yale in emerging nanotechnology and will encourage multidisciplinary research involving Yale faculty, its students, and associated world-wide research partners.
The Yale EBPG5000plus represents the continued development of the highly successful EBPG product series. The high performance lithography system is based on reliable and well-proven system architecture. With further enhancements in resolution, noise reduction and beam stability, Yale's Vistec EBPG5000plus is set to generate structures to less than 8nm on substrates up to 150mm in diameter, including fragments and special substrates. Its electron-optical column (TFE source) is rated for acceleration voltages of 20, 50, and 100kV. The system is equipped for true 100kV / 1mm performance under regular electron-optical conditions with a wide current capability for high throughput applications. The pattern generator operates at up to 50MHz. The system incorporates an interactive graphical user interface (GUI) that provides ease of use for diverse,
multiuser, university type environments.
"The acquisition of the Vistec EBPG5000plus will enable the Yale research community to explore the expanding field of nanotechnology with a state-of-the-art electron-beam lithography patterning system. We will utilize the system for a wide variety of applications including Applied Physics, Electrical Engineering and Bio-technology. The Vistec system will allow Yale to remain at the forefront of nanotechnology today and well into the future", said Dr. Michael Rooks, Facilities Director of the Yale Institute for Nanoscience and Quantum Engineering. "The EBPG system will provide the Yale community with not only high quality nanolithography patterning, but with high flexibility and user friendliness for our various multidisciplinary activities. Vistec's system is perfect for our nanotechnology requirements."
"Vistec is pleased to be associated with Yale University. We look forward to our co-operation with Yale?s leading edge nanotechnology researchers and their programs", noted Rainer Schmid, General Manager Vistec Lithography, Inc. "Vistec?s association with Yale and its electron-beam research scientists will hopefully lead to further software and hardware enhancements for our highly successful EBPG series."
Yale Institute for Nanoscience and Quantum Engineering
The Yale Institute for Nanoscience and Quantum Engineering (YINQE) is a new initiative at Yale University intended to provide nanofabrication,microscopy and material characterization to disparate scientific disciplines centered on nanoscale research projects. YINQE builds on existing research strengths in engineering and the physical and life sciences to broaden interdisciplinary activity among faculty and students across the entire campus. The Institute provides improved nanomaterials fabrication capabilities, together with centralized shared characterization. These facilities complement Yale's microelectronics clean room, computational facilities and materials synthesis laboratories. Visit: http://nano.yale.edu for more information.
Konarka Announces Business Collaboration and
Strategic Investment with Konica Minolta
Konarka and Konica Minolta Joint Development Expected to Yield Production and Global Distribution of High Performance Organic Photovoltaic Panels
Lowell, Mass. – March 2, 2010 – Konarka Technologies, Inc., an innovator in development and commercialization of Konarka Power Plastic®, a material that converts light to energy, today announced the company has signed a comprehensive R&D collaboration and strategic investment agreement with Konica Minolta Holdings, Inc. (Konica Minolta). The companies reached agreement to start full-scale collaboration in April in the joint development and distribution of organic thin-film photovoltaics. Under the agreement, Konica Minolta has invested $20 million in Konarka.
“Konica Minolta positions the organic thin-film photovoltaic business as one of the most promising in the environment and energy field, next to the organic light emitting diode (OLED) business, where our photographic film manufacturing technology is leading mass production,” commented Masatoshi Matsuzaki, CEO at Konica Minolta. “We are pleased to be collaborating with Konarka, the first and world leader to commercialize organic thin-film photovoltaics because of its state-of-the-art polymer technology and its mass production facility in New Bedford, Massachusetts.”
The companies will organize respective strengths in materials, optical and coating technologies as well as joint development, aiming to improve organic thin-film photovoltaic performance including higher conversion efficiency, longer life and lower manufacturing costs, to realize mass production of next-generation photovoltaics. Currently, Konarka’s roll-to-roll process simplifies manufacturing scale-up, has significantly lower capital and labor costs than previous generations of solar cells and can be produced using existing coating and printing equipment.
Upon successful results of the joint development milestones, the companies are expected to establish a joint venture company in Japan to produce organic thin-film photovoltaic panels. Konica Minolta will be Konarka’s lead Asian business partner headquartered in Japan.
“We are delighted that Konica Minolta recognizes the value of Konarka’s patent-protected thin film solar material that is lightweight and flexible, uniquely lending itself to a wide range of applications where traditional photovoltaics are not effective,” commented Howard Berke, executive chairman and co-founder of Konarka. “With our collaboration efforts, Konarka and Konica Minolta are well positioned to deliver efficient, next-generation photovoltaic panels to meet the growing demand for personal and commercial solar energy solutions around the world.”
Konarka will be exhibiting with its key product application partner, Toppan Forms, at PV Expo Japan 2010, March 3-5, 2010 in Tokyo, Japan, booth #’s 31-32. For more information on the event, visit: http://www.pvexpo.jp/index_en.html
About Konica Minolta Holdings, Inc.
Konica Minolta Group globally offers diverse products, services, and solutions in a wide range of fields. Our business domain is broad, including office equipment, optical devices, medical imaging, graphic imaging and measuring instruments. Its largest office equipment business sector consecutively offers advanced network document solutions, taking advantage of its strengths in high-speed, color and networking technologies.
To create new pillar businesses in the environment and energy field, Konica Minolta is actively developing unique and cutting-edge technologies on the basis of proprietary materials, optical, nano-fabrication and imaging technologies. OLED lighting is notable development activities underway with potential for use in various applications. Organic thin-film photovoltaic panel is also typical example of the promising business in the environment and energy field. For additional information, visit http://konicaminolta.com
About Konarka Technologies, Inc.
Konarka develops and manufactures solar plastic films that convert light to energy – anywhere. As the leading developer of polymer-based, organic photovoltaic (OPV) technology that provides a source of renewable power in a variety of form factors, Konarka has a broad portfolio of patents, technology licenses and an accomplished technical, scientific and manufacturing team. Manufactured at low cost and low energy consumption, the company's Konarka Power Plastic® technology is lightweight, flexible, scalable and adaptable for use in a variety of commercial, industrial, government and consumer applications. Konarka Technologies is headquartered in Lowell, Mass., U.S.A. and has a full scale production manufacturing facility in New Bedford, Mass. U.S.A., with European headquarters in Nurnberg, Germany, business development offices in Asia and a research and development facility in Austria. For additional information, visit http://www.konarka.com
All trademarks recognized.
Exclusive introduction of Coatema´s new Minicoater
at the Printed Electronics in Dresden
Thomas Kolbusch, Vice President
The Printed Electronics in 2010 is one of the World’s largest events on printed and organic electronics. Coatema Coating Machinery - one of the pioneers in these fields with installations at VTT, Holst Centre, IPMS Dresden, IAP Potsdam and several other leading R&D institutions worldwide - is going to present a new development for small-scale, cost-efficient and multifunctional R&D roll to roll equipment.
The new unit called Minicoater includes different options of coating and printing systems, like doctor blade, slot die, impregnation, micro roller and engraved roller printing and a laminating device. With a working width of 100 mm the ink consumption can be minimized for the R&D process. Further the Coatema Minicoater is equipped with a 350 mm hot air dryer in EEx-layout. A laminating station provides the possibility to include encapsulation processes in the operation. Reproducibility is possible without any compromises. The multifunctional unit is equipped with 3-4 motors, load cells and a backward running operation mode. Those features make small sample production an easy operation. The whole unit is enclosed and can also be offered for glove box operations.
The Minicoater is released for publication at the Printed Electronic in Dresden. There Coatema´s Minicoater will be shown for the first time.
As Dr. Andreas Giessmann - owner of Coatema Coating Machinery - stated “this will be only one highlight of new equipment in 2010”, Coatema is ramping up a new range of lab and pilot coaters this year to support the ongoing success of the lab solutions programme of Coatema.
All units can be tested and rented for coating and printing trials in the Coatema R&D centre - with 11 pilot coaters and one production line one of the biggest centres worldwide.
The scale-up specialists at Coatema are looking forward to meet you at an exciting exhibition in Dresden. Do not miss the opportunity to meet us to discuss your coating, printing and laminating projects in the field of printed electronics. The Minicoater: Exclusive introduction at the Printed Electronics in Dresden Coatema R&D Centre Coatema Headquarter
About Coatema: The company Coatema Coating Machinery deals with the mechanical engineering for coating, laminating and printing plants for R2R applications. For more than 30 years now, Coatema has been developing solutions for the most different markets like textile, foil, paper and renewable energies. This can be lab plants, pilot plants as well as entire turn-key production solutions for the coating and laminating of R2R substrates. One area of Coatema, the R&D Solutions, deals with the service for coating and laminating like e.g. Coatema´s coating lab with more than 10 pilot plants and on production plant with a working with of 2.000 mm. An annual international coating symposium completes Coatema´s large range of services. Another of Coatema´s specialties is the special mechanical engineering for scale-up processes in the area of new technologies, like e.g. fuel cells or nano technologies. Actual information about the company: www.coatema.com
PI Publishes Digital Flash Catalog on
Piezo Technology and Nanopositioning
Auburn, MA, Feb 2010 -- PI (Physik Instrumente) has published a digital flash catalog on Piezo Technology and Nanopositioning Products